WO2004009158A2 - Systems and methods for performing peritoneal dialysis - Google Patents

Systems and methods for performing peritoneal dialysis Download PDF

Info

Publication number
WO2004009158A2
WO2004009158A2 PCT/US2003/022267 US0322267W WO2004009158A2 WO 2004009158 A2 WO2004009158 A2 WO 2004009158A2 US 0322267 W US0322267 W US 0322267W WO 2004009158 A2 WO2004009158 A2 WO 2004009158A2
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
patient
loop
dialysis
dialysate
Prior art date
Application number
PCT/US2003/022267
Other languages
French (fr)
Other versions
WO2004009158A3 (en
Inventor
Robert W. Childers
David S. Brown
Ramesh Wariar
Sujatha Karoor
Shahid Din
Leo Martis
Cody Buchmann
Paul Soltys
Original Assignee
Baxter International Inc.
Baxter Healthcare S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc., Baxter Healthcare S.A. filed Critical Baxter International Inc.
Priority to DE60336724T priority Critical patent/DE60336724D1/en
Priority to AU2003249296A priority patent/AU2003249296A1/en
Priority to AT03765630T priority patent/ATE505223T1/en
Priority to MXPA05000816A priority patent/MXPA05000816A/en
Priority to JP2004523474A priority patent/JP4890761B2/en
Priority to EP03765630A priority patent/EP1523350B1/en
Publication of WO2004009158A2 publication Critical patent/WO2004009158A2/en
Publication of WO2004009158A3 publication Critical patent/WO2004009158A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1694Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
    • A61M1/1696Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/153Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit the cassette being adapted for heating or cooling the treating fluid, e.g. the dialysate or the treating gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/154Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit with sensing means or components thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/155Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit with treatment-fluid pumping means or components thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/156Constructional details of the cassette, e.g. specific details on material or shape
    • A61M1/1561Constructional details of the cassette, e.g. specific details on material or shape at least one cassette surface or portion thereof being flexible, e.g. the cassette having a rigid base portion with preformed channels and being covered with a foil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/156Constructional details of the cassette, e.g. specific details on material or shape
    • A61M1/1565Details of valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/159Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit specially adapted for peritoneal dialysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/1658Degasification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/166Heating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/282Operational modes
    • A61M1/284Continuous flow peritoneal dialysis [CFPD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285Catheters therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/288Priming
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • A61M1/152Details related to the interface between cassette and machine
    • A61M1/1524Details related to the interface between cassette and machine the interface providing means for actuating on functional elements of the cassette, e.g. plungers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/12General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3306Optical measuring means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3327Measuring

Definitions

  • the present invention generally relates to dialysis systems. More specifically, the present invention relates to regeneration dialysis systems and continuous flow dialysis systems. The present invention also relates to methods of performing dialysis therapies.
  • urea urea, creatinine, uric acid, and others
  • Kidney failure and reduced kidney function have been treated with dialysis. Dialysis removes waste, toxins and excess water from the body that would otherwise have been removed by normal functioning kidneys. Dialysis treatment for replacement of kidney functions is critical to many people because the treatment is life saving. One who has failed kidneys could not continue to live without replacing at least the filtration functions of the kidneys. Hemodialysis and peritoneal dialysis are two types of dialysis therapies commonly used to treat loss of kidney function. Hemodialysis treatment utilizes the patient's blood to remove waste, toxins and excess water from the patient. The patient is connected to a hemodialysis machine and the patient's blood is pumped through the machine.
  • Catheters are inserted into the patient's veins and arteries to connect the blood flow to and from the hemodialysis machine.
  • the dialyzer removes the waste, toxins and excess water from the patient's blood and returns the blood to infuse back into the patient.
  • a large amount of dialysate for example about 120 liters, is used to dialyze the blood during a single hemodialysis therapy. The spent dialysate is then discarded.
  • Hemodialysis treatment lasts several hours and is generally performed in a treatment center about three or four times per week.
  • hemodialysis therapy is regenerative hemodialysis.
  • This therapy uses a hemodialysis system, which includes a cartridge for dialysate regeneration.
  • a cartridge for dialysate regeneration is manufactured under the name REDYTM by Sorb Technology, Oklahoma City, Oklahoma.
  • the dialysate fluid flow path must be properly cleaned before the hemodialysis machine can be used on another patient.
  • the dialysate fluid flow path is not a closed system, i.e., the dialysate fluid flow path is open to the atmosphere, such that oxygen from the atmosphere can contact fluid in the system and foster the growth of bacteria in same. Consequently, contamination of such a dialysis system can be a concern.
  • the dialysate fluid exiting the REDYTM cartridge is not suitable for peritoneal dialysis because the fluid is relatively acidic and not, therefore, physiologic. Moreover, this system requires the attention of medical personnel during therapy.
  • Peritoneal dialysis utilizes a sterile, pyrogen free dialysis solution or "dialysate", which is infused into a patient's peritoneal cavity.
  • the dialysate contacts the patient's peritoneal membrane in the peritoneal cavity. Waste, toxins and excess water pass from the patient's bloodstream through the peritoneal membrane and into the dialysate.
  • the transfer of waste, toxins, and water from the bloodstream into the dialysate occurs due to diffusion and osmosis, i.e., an osmotic gradient occurs across the membrane.
  • the spent dialysate drains from the patient's peritoneal cavity and removes the waste, toxins and excess water from the patient.
  • CAPD continuous ambulatory peritoneal dialysis
  • automated peritoneal dialysis CAPD is a manual dialysis treatment, in which the patient connects an implanted catheter to a drain and allows a spent dialysate fluid to drain from the peritoneal cavity. The patient then connects the catheter to a bag of fresh dialysate and manually infuses fresh dialysate through the catheter and into the patient's peritoneal cavity. The patient disconnects the catheter from the fresh dialysate bag and allows the dialysate to dwell within the cavity to transfer waste, toxins and excess water from the patient's bloodstream to the dialysate solution.
  • the patient repeats the manual dialysis procedure.
  • CAPD the patient performs several drain, fill, and dwell cycles during the day, for example, about four times per day.
  • Manual peritoneal dialysis performed by the patient requires a significant amount of time and effort from the patient. This inconvenient procedure leaves ample room for improvement and therapy enhancements to improve patient quality of life.
  • Automated peritoneal dialysis is similar to continuous peritoneal dialysis in that the dialysis treatment includes a drain, fill, and dwell cycle. However, a dialysis machine automatically performs three to four cycles of peritoneal dialysis treatment, typically overnight while the patient sleeps.
  • an automated dialysis machine fluidly connects to an implanted catheter.
  • the automated dialysis machine also fluidly connects to a source or bag of fresh dialysate and to a fluid drain.
  • the dialysis machine pumps spent dialysate from the peritoneal cavity, though the catheter, to the drain.
  • the dialysis machine then pumps fresh dialysate from the dialysate source, through the catheter, and into the patient's peritoneal cavity.
  • the automated machine allows the dialysate to dwell within the cavity so that the transfer of waste, toxins and excess water from the patient's bloodstream to the dialysate solution can take place.
  • a computer controls the automated dialysis machine so that the dialysis treatment occurs automatically when the patient is connected to the dialysis machine, for example, when the patient sleeps. That is, the dialysis system automatically and sequentially pumps fluid into the peritoneal cavity, allows for dwell, pumps fluid out of the peritoneal cavity, and repeats the procedure. Several drain, fill, and dwell cycles will occur during the treatment. Also, a
  • CFPD continuous flow peritoneal dialysis
  • these systems typically have a single pass fluid flow. That is, the dialysate flows into, through, and out of the peritoneal cavity one time before being sent to a drain.
  • the "spent" dialysate (waste laden dialysate) from the patient collects in a drain bag, which is discarded, or runs into a household drain or other drain.
  • Known CFPD systems therefore, typically use a volume of disalysate one time and then discard it. That is, the systems have no ability to regenerate or reuse a quantity of dialysate.
  • peritoneal dialysis therapies and existing systems which perform the therapies, depends upon the amount of dialysis fluid used.
  • typical peritoneal dialysis therapy requires about 4 to 6 exchanges of dialysate (drain, fill, dwell) with about 2 to 3 liters of dialysate for each exchange.
  • Peritoneal dialysis is a daily therapy performed 7 days per week. As a consequence, 240 to 540 liters of fresh dialysate must be delivered to and stored at a patient's home each month. Increasing dialysate dosage to increase therapy effectiveness will necessitate even more dialysate.
  • the present invention provides improved dialysis systems and improved methods of performing dialysis. More particularly, the present invention provides systems and methods for continuous flow dialysis (“CFD”) and regenerative dialysis, and in combination, continuous flow regenerative dialysis (“CFRD”). This invention also includes improved systems and methods for performing hemodialysis.
  • CFD continuous flow dialysis
  • CFRD continuous flow regenerative dialysis
  • the dialysis system of the present invention automatically performs dialysis therapy on a patient, for example, during nighttime while the patient sleeps.
  • the present invention automatically regenerates spent dialysate into fresh dialysate that is reintroduced into the patient to be used again for dialysis treatment. Further, the dialysis system provides continuous fluid flow simultaneously to and from the patient.
  • a system for providing dialysis includes a patient fluid loop having a first pump and multiple patient lumens.
  • the system includes a second fluid loop including a second pump and a medical fluid regenerator.
  • a membrane device is placed in fluid contact with and separates the patient and the second fluid loops. The membrane device allows at least one selected component of the fluid in the patient fluid loop to transfer to the second fluid loop. The second loop is otherwise closed except for the transfer of the selected component via the membrane device.
  • a controller is also provided that operates the first and second pumps to recirculate fluid in the patient loop and the second loop.
  • the system is adaptable to be used with various different types of components and to be arranged in a variety of ways.
  • the membrane device is a dialyzer.
  • a pressure gradient exists across the membrane device.
  • the patient loop is also closed except for the transfer of the selected component via the membrane device and the venting of air/gas.
  • the membrane device includes a nanofilter which allows urea to pass from the patient fluid loop to the second fluid loop.
  • the medical fluid regenerator includes a uremic toxin sorbent.
  • the medical fluid regenerator can include any or all of the following materials: urease, zirconium phosphate, zirconium oxide, and carbon.
  • the system includes a gas separator that removes gas from one or both of the patient and second fluid loops.
  • the gas separator and the medical fluid regenerator are provided in a single device.
  • the system includes a gas vent that vents gases from the patient and second fluid loops.
  • the second fluid loop includes a multi-analyte sensor that monitors a concentration of electrolytes in the medical fluid.
  • peritoneal dialysis fluid is circulated through the patient fluid loop.
  • blood is circulated through the patient fluid loop.
  • At least parts of the patient fluid loop and the second fluid loop are provided in a disposable device.
  • the second fluid loop includes a balance chamber that balances flow within the second fluid loop.
  • the controller enables fluid to flow in opposite directions through the multiple patient.
  • the system includes a dual lumen catheter that defines the multiple patient lumens.
  • one or both of the patient fluid loop and the second fluid loop includes an in-line fluid heater.
  • the in-line fluid heater includes a radiant heater and a plate heater.
  • the system includes a medical fluid sensor which senses one or more indicators including: ammonia, ammonium and pH.
  • the system includes a fluid volume sensor in or both of the patient and second fluid loops.
  • the fluid volume sensor includes a capacitance fluid volume sensor that uses a chamber in fluid communication with one or both of the fluid loops.
  • the chamber is a pump chamber.
  • the system includes an ultrafiltrate container in fluid communication with at least one of the patient and second fluid loops.
  • the system includes a fluid concentrate container in fluid communication with one or both of the patient and second fluid loops.
  • the system as described herein uses, in one embodiment, a disposable dialysis cassette.
  • the cassette includes a flexible membrane covering a patient pump chamber and a regeneration pump chamber.
  • the cassette includes an apparatus for fluidly connecting the patient pump chamber to a closed loop patient fluid path.
  • the cassette further includes an apparatus for fluidly connecting the regeneration pump chamber to a closed loop regeneration fluid path.
  • the patient path and the regeneration path each fluidly communicates with a dialyzer.
  • the cassette is adaptable to be used with various different types of components and to be arranged in a variety of ways.
  • the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate sorbent cartridge.
  • the disposable cassette defines a fluid path leading to a port that fluidly communicates with a gas separator. In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysis concentrate container.
  • the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate last bag. In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate bag.
  • the disposable cassette defines a fluid path leading to a port that fluidly communicates with a drain container.
  • the disposable cassette defines a fluid path leading to a port that fluidly communicates with a patient fluid connector.
  • the disposable cassette can define a fluid path for a twenty-four hour collection and/or a remote analyte sensor.
  • the disposable cassette operates with a dialysis therapy device.
  • the therapy device includes a housing having a portion that receives the disposable cassette.
  • the housing houses a patient pump actuator that pumps fluid through a patient path defined at least in part by the disposable cassette.
  • the housing also houses a regeneration pump actuator that pumps fluid through a regeneration path defined at least in part by the disposable cassette.
  • the dialysis therapy device is also adaptable to be used with various different types of components and to be arranged in a variety of ways.
  • the dialysis therapy device includes at least one fluid volume measurement sensor component that cooperates with the patient pump actuator and the regeneration pump actuator.
  • the housing houses a fluid heater.
  • the housing houses at least one sensor, such as an ammonia sensor, an ammonium sensor and a pH sensor.
  • the housing houses at least one valve actuator that operates with the disposable cassette.
  • the present invention includes a plurality of different methods for operating the systems and apparatuses described herein.
  • a method for moving fluid in a dialysis system. The method includes continuously recirculating a first fluid through a patient loop. The method includes continuously recirculating a second fluid through a regeneration loop. At least one waste component is simultaneously transferred from the patient loop to the regeneration loop through a device shared by both loops. The loops are otherwise closed except for the fluid transfer through the device. The method also includes removing the at least one waste component from the regeneration loop.
  • the first and second fluids can both include dialysate. Alternatively, the first fluid includes blood and the second fluid includes dialysate.
  • the method includes flowing the second fluid in the regeneration loop through a waste sorbent and absorbing at least some of the waste component. In an embodiment, the method includes the step of heating the at least one of the first and second fluids.
  • the method includes the step of removing ultrafiltrate from at least one of the first and second fluids.
  • the method includes the step of adding dialysate to at least one of the first and second fluids.
  • the method includes the step of adding concentrate to at least one of the first and second fluids.
  • the method includes the step of removing gas from at least one of the first and second fluids. In an embodiment, the method includes the step of balancing the flow of fluid in at least one of the patient loop and the regeneration loop.
  • the method includes the step of sensing a volume of flow of fluid in at least one of the patient loop and the regeneration loop.
  • recirculating dialysate fluid through the patient loop includes passing the fluid through a portion of a patient.
  • the method is for continuous flow peritoneal dialysis and includes passing the dialysate fluid and the regeneration fluid past opposite sides of a dialyzer membrane and regenerating the regeneration fluid after the regeneration fluid exits the dialyzer.
  • recirculating dialysate fluid through the closed patient loop includes passing the fluid through a sleeping patient. In an embodiment of the continuous flow peritoneal dialysis method, recirculating dialysate fluid through the closed patient loop includes passing the fluid through a patient at nighttime.
  • a method of moving fluid in a peritoneal dialysis system includes the steps of: (i) continuously recirculating dialysate through a container in a patient loop; (ii) continuously recirculating dialysate through the container in a regeneration loop; and (iii) continuously moving at least one waste component from the patient loop to the regeneration loop through the container shared by both loops, the loops being closed except for said transfer through said container.
  • the peritoneal dialysis method includes the step of recirculating dialysate through the regeneration loop at a different rate than a rate at which dialysate is recirculated through the patient loop.
  • performing continuous flow dialysis includes multiple dialysis disciplines.
  • the method includes performing continuous flow peritoneal dialysis with a closed loop dialysis device at a first point in time and performing continuous flow hemodialysis via the same closed loop dialysis device at a second point in time.
  • the continuous flow peritoneal dialysis and the continuous flow hemodialysis are performed on the same patient.
  • the method includes an intermediate step of removing a disposable cassette used with the device and coupling a new disposable cassette to the device.
  • the method includes an intermediate step of removing a dual lumen peritoneal dialysis catheter and replacing the catheter with a hemodialysis needle.
  • the method includes an intermediate step of removing a hemodialysis needle and replacing the needle with a dual lumen peritoneal dialysis catheter.
  • Another advantage of the present invention is to provide improved systems and methods for performing automated continuous flow dialysis systems and methods.
  • a further advantage of the present invention is to provide regenerative dialysis systems and methods of operating same.
  • Yet another advantage of the present invention is to provide a regenerative dialysis system that has quality of life advantages.
  • an advantage of the present invention is to provide a regenerative dialysis system that reduces the amount of dialysis fluid need to perform dialysis.
  • Another advantage of the present invention is to provide a closed loop dialysis system.
  • Fig. 1 schematically illustrates an embodiment of a dialysis system according to the principles of the present invention.
  • Fig. 2 shows a multi-lumen patient fluid connector according to the principles of the present invention.
  • Fig. 3 schematically illustrates another embodiment of a dialysis system according to the principles of the present invention.
  • Fig. 4 schematically illustrates a further embodiment of a dialysis system according to the principles of the present invention.
  • Fig. 5 illustrates an embodiment of a disposable cassette according to the present invention.
  • Fig. 6 illustrates another embodiment of a disposable cassette according to the present invention.
  • Fig. 7 illustrates a disposable cassette of the present invention connected to various fluid containers.
  • Fig. 8 schematically illustrates yet another embodiment of a dialysis system according to the principles of the present invention.
  • Fig. 9 schematically illustrates an embodiment of a dialysis system according to the principles of the present invention that provides hemodialysis.
  • Fig. 10 illustrates a combination container providing various components used in the dialysis systems of the present invention.
  • the present invention relates to dialysis systems and methods of performing dialysis.
  • the present invention pertains to continuous flow regeneration peritoneal dialysis systems and methods.
  • the present invention pertains to non-continuous flow regeneration peritoneal dialysis, and regeneration hemodialysis, both continuous and non-continuous flow.
  • the dialysis system automatically performs dialysis therapy on a patient, for example during nighttime while the patient sleeps.
  • the present invention can provide true continuous flow dialysis therapy (fluid simultaneously flowing into and out of the patient), and automatically regenerate spent dialysate into fresh dialysate that is again used for the dialysis treatment.
  • Continuous flow of dialysate tends to increase the efficacy of treatment by maximizing or maintaining a maximum osmotic gradient across the peritoneal membrane.
  • Regeneration of dialysate by the present invention significantly reduces the amount of dialysate required for a treatment.
  • the amount of dialysate fluid can be reduced from about fifty liters for CFPD therapy if performed by an existing cycler to about six to eight liters of same for therapy with the present invention.
  • the spent dialysate from the patient's peritoneal cavity passes through a regeneration unit and is regenerated into a useable dialysate.
  • the regenerated dialysate in a patient fluid loop is returned to the patient's peritoneal cavity to further dialyze the patient.
  • the regeneration unit removes undesirable components in the dialysate that were removed from the patient, for example, excess water (ultrafiltrate or UF), toxins, and metabolic wastes, so that the dialysate can be used for further dialysis.
  • Desirable components can be added to the dialysate by the system, such as glucose and electrolytes, for example.
  • Continuous flow peritoneal dialysis means that when the patient is being dialyzed (e.g., dialysate is being pumped to and removed from the peritoneal cavity), the dialysate is constantly and simultaneously flowing into and out of the patient.
  • the dialysis system pumps fresh dialysate into the patient's peritoneal cavity while simultaneously pumping spent dialysate out of the peritoneal cavity. Accordingly, the dialysis system can eliminate the dwell period inside the peritoneal cavity that is typical for existing dialysis systems.
  • the flow rate of the continuous dialysate flow can be constant or varied as desired, and is generally about 100-300 ml/min.
  • the dialysis system of the present invention can be controlled to provide various dialysis therapies, as desired. Accordingly, even though the dialysis system can provide continuous flow, the present invention also supports non-continuous flow or batch systems and methods. Also, the continuous flow into and out of the peritoneal cavity occurs during the main therapy treatment, so that a dwell during a last bag, for example, does not detract from the continuous flow feature. Furthermore, the fluid pumping mechanisms of the present invention may provide for brief intermittent fluid flow, such as the filling of a pump chamber, for example. The continuous fluid flow of the present invention is considered to include such brief intermittent fluid flow.
  • the dialysis systems and methods of the present invention provide advantages compared to other dialysis systems and therapies, such as clinical advantages, economic advantages, and quality of life advantages, for example. It is believed that the present invention has clinical advantages, such as, improved blood pressure ("BP") control, improved hematocrit (“HCT”) control, improved fluid volume control, improved preservation of residual renal function (“RRF”), improved adequacy vs. the National Kidney Foundation's DOQI standard, higher efficiency (clearances / time), lower glucose absorption, glucose profiling and ultrafiltrate management, and reduced catheter channeling.
  • BP blood pressure
  • HCT hematocrit
  • RRF residual renal function
  • present invention has economic advantages, such as, reduced therapy cost and reduced Epogen ("EPO") usage. Further, it is believed that present invention has quality of life advantages, such as, increased awake time free from dialysis devices, improved patient access, reduced complexity, reduced self- administration of drugs, reduced therapy training, elimination of the need for having a home water infrastructure, a reduced amount of fluid that the patient must handle and manage, simpler prescriptions and elimination of patient transportation to dialysis centers.
  • EPO Epogen
  • the dialysis systems and methods of the present invention more closely simulate and replace continuous kidney functioning as compared to intermittent dialysis therapies. This, in turn, can contribute to improved clinical outcomes (RRF, HCT, BP, for example) while minimally impacting the patient's lifestyle.
  • RRF radioactive lung disease
  • HCT high-density Cpherical pulmonary disease
  • BP blood pressure
  • the efficiency and convenience of the present invention provides patients with a renal replacement therapy that is relatively unrestrictive. This allows patients to have greater freedom from limitations experienced by dialysis devices and therapies.
  • the present invention can provide easier entrance into early dialysis therapy because the system can enable the physician to retain a patient's RRF while minimally impacting the patient's lifestyle.
  • a system 10 for providing dialysis treatment to a patient needing same is illustrated.
  • two loops are provided: a patient loop (a recirculating patient fluid flow path) 12 and a regeneration loop 14 (a recirculating dialysate fluid flow path).
  • the patient loop 12 is used to dialyze the patient 16 with dialysate in a peritoneal dialysis embodiment.
  • the regeneration loop 14 also contains dialysate and is used to regenerate the dialysate in the patient loop 12.
  • the patient loop 12 carries the patient's blood, and the regeneration loop 14 dialyzes the blood and regenerates the dialysate in the loop 14.
  • the patient loop 12 and the regeneration loop 14 are initially filled or primed with dialysate fluid from a bag 18 by pumping the dialysate through a pump, such as an ultrafiltrate pump 19.
  • a pump such as an ultrafiltrate pump 19.
  • Fig. 1 shows a single dialysate bag 18 for both the patient and regeneration loops 12 and 14; however, separate dialysate bags and/or fluid pumps could be individually used for the patient loop 12 and the regeneration loop 14.
  • the patient loop 12 can be primed with a suitable priming solution, such as a saline solution, and then connected to the patient's blood circulatory system.
  • the patient loop 12 is fluidly connected to the patient 16 by a multi-lumen patient fluid connector 20 and catheter.
  • the multi-lumen patient fluid connector 20 can have, for example, a single housing 70 having more than one separate lumen 72 (to patient lumen) and 74 (from patient lumen), or separate housings each having one of the lumens 72 and 74.
  • the multi-lumen patient fluid connector 20 can be connected to a dual lumen catheter 22 (illustrated in Fig.l), such as a catheter disclosed in co-pending U.S. patent application serial number 09/689,508, titled "Peritoneal Dialysis Catheters," inco ⁇ orated by reference or other multi-fluid path patient access.
  • the dual lumen catheter 22 is implanted in the patient 16 and provides fluid flow access to the patient's peritoneal cavity.
  • Two separate lumens 72 and 74 of the multi-lumen patient connector 20 are fluidly connected to separate lumens (not illustrated) of the dual lumen catheter 22.
  • Fluid in the patient loop 12 can continuously flow through the patient fluid connector 20 simultaneously and continuously in multiple directions, e.g. two different directions, into and out of the catheter 22 and the patient 16.
  • the multi-lumen patient fluid connector 20 is described in further detail below in Fig. 2.
  • the patient loop 12 can be fluidly connected to the patient by any device or devices that provides for fluid to simultaneously flow into and out of the patient.
  • the patient loop 12 can be connected to the dual lumen catheter to two single lumen catheters.
  • the patient loop 12 has a patient fluid pump 24 that pumps fluid through the patient loop 12.
  • the fluid in the patient loop 12 is pumped from the patient 16 (the patient's peritoneal cavity in a peritoneal dialysis embodiment) through the patient fluid connector 20, through a dialyzer 26, back through the patient fluid connector 20, and is returned to the patient 16.
  • the spent dialysate (laden with waste and excess water) in the patient loop 12 exiting from the patient 16 is cleansed or regenerated by passing through the dialyzer 26.
  • the waste, such as urea, creatinine and excess water passes from the patient loop 12 across a dialyzer membrane 28 to the regeneration loop 14 to produce fresh dialysate exiting the dialyzer in the patient loop 12.
  • the fresh dialysate is returned to the patient 16 for further dialysis treatment.
  • the fluid in the patient loop 12 is continuously recirculated through the patient loop 12 by the patient pump 24.
  • the dialyzer 26 provides a sterile independent barrier between the patient loop 12 and the regeneration loop 14.
  • Existing dialyzers used for dialysis is therapy are suitable for use with the present invention, for example.
  • the membrane 28 referred to in the dialyzer 26 includes any suitable filter material, such as hollow dialyzer fibers.
  • the patient loop 12 is connected to the patient's blood circuit rather than the peritoneal cavity.
  • the patient pump 24 continuously recirculates the blood, as the dialyzer 26 removes waste and excess from the blood.
  • the regeneration loop 14 removes the waste and excess water from the patient loop 12.
  • a fluid pump 30, pumps dialysate fluid in the regeneration loop 14 continuously to recirculate the dialysate through the loop 14.
  • the dialysate fluid pump 30 pumps the dialysate from the dialyzer 26, through a sorbent cartridge 32, and back to the dialyzer 26.
  • the fluid in the regeneration loop 14 flows past a side of the dialyzer membrane 28 opposite the side of the membrane 28 having the fluid in the patient loop 12.
  • the regeneration loop 14 provides for balanced fluid flow through the dialyzer 26, for example, by providing equal flow dialysate fluid pumps 30, and/or balance chambers.
  • waste and excess water passes from the fluid in the patient loop 12, across the dialyzer membrane 28, to the fluid in the regeneration loop 14.
  • the transfer across the dialyzer membrane 28 occurs at least in part due to diffusion and concentration gradients across the membrane 28.
  • the system 10 in an embodiment maintains a lower fluid pressure in the regeneration loop 14 relative to the patient loop 12. That is, there is a transmembrane pressure ("TMP") across the dialyzer membrane 28.
  • TMP transmembrane pressure
  • the fluid pressure differential draws fluid from the patient loop 12, across the dialyzer membrane 28, to the regeneration loop 14.
  • This fluid pressure differential can be maintained by removing fluid from the regeneration loop 14, for instance, by using the ultrafiltrate pump 19 to drain some of the fluid in the regeneration loop 14.
  • a sorbent cartridge or container 32 includes materials that absorb particular compounds from the dialysate. For example, certain sorbents within the sorbent cartridge 32 may absorb uremic toxins, such as urea, creatinine, uric acid, and other metabolism by-products. By removing these undesirable waste materials, the sorbent cartridge 32 at least partially regenerates the dialysate.
  • the sorbent cartridge 32 includes a body having a fluid inlet 34 and a fluid outlet 36.
  • One sorbent cartridge 32 contains four layers of materials, including a first layer of urease, a second layer of zirconium phosphate, a third layer of zirconium oxide and a fourth layer of carbon.
  • the interior of the cartridge 32 is constructed and arranged so that the fluid entering the interior from the inlet 34 flows (preferably upward and uniformly) through the first layer, the second layer, the third layer, the fourth layer and finally through the outlet 36.
  • the sorbent cartridge 32 can also use materials that selectively remove certain solutes from the dialysate.
  • the selective materials can include a binder or reactive sorbent material capable of selectively removing urea, a binder or reactive sorbent material capable of selectively removing phosphate and/or the like.
  • the use of materials capable of selective removal of solutes, particularly urea enhances the cleaning efficiency of the system of the present invention such that the amount of dialysate necessary for effective treatment can be minimized.
  • the materials that can selectively remove solutes from solution can include a variety of suitable and different materials including, for example, polymeric materials that are capable of removing nitrogen-containing compounds, such as urea, creatinine, other like metabolic waste and/or the like in solution.
  • these types of materials contain a functional group(s) that chemically binds with urea or other like solutes.
  • U.S. Patent Nos. 3,933,753 and 4,012,317 each incorporated herein by reference, disclose alkenylaromatic polymers containing phenylglyoxal that can function to chemically bind urea.
  • the phenylglyoxal polymeric material is made via acetylation performed in, for example, nitrobenzene followed by halogenation of the acetyl group and treatment with dimethylsulfoxide as disclosed in U.S. Patent Nos. 3,933,753 and 4,012,317.
  • the present invention can include any suitable type of material or combinations thereof to selectively remove solutes, such as urea, from solution as previously discussed.
  • the sorbent cartridge 32 may also modify the dialysate in the regeneration loop 14 in other ways.
  • the materials in the sorbent cartridge 32 mentioned above or additional materials added to the cartridge 32 may modify the pH of the fluid passing through the cartridge 32.
  • the pH of the dialysate in the regeneration loop 14 is modified as needed to maintain a physiologic level.
  • One sorbent cartridge 32 is described in further detail in a U.S. patent application titled “Method and Composition for Removing Uremic Toxins in Dialysis Processes," Serial Number 09/990,673, incorporated herein by reference.
  • the sorbent cartridge 32 can also include a number of components in addition to the sorbent materials capable of removing solutes from the dialysate.
  • the cleaning cartridge may have the capability to remove all or a portion of electrolytes, such as sodium, potassium, or the like, from the dialysate solution. In this case, an additional source of electrolytes in solution may be needed to replenish the dialysate after it has been cleaned.
  • the cartridge may also be configured to release bicarbonate or the like into the system depending on the type of sorbent material used. This can facilitate pH regulation of the dialysate.
  • the cartridge may be filtered to prevent proteins, particulate matter or like constituents from leaching or exiting from the cartridge and into the dialysate.
  • Ultrafiltrate (excess water) removed from the patient 16 can be removed from the dialysis system 10 by draining the ultrafiltrate to a drain bag 38 or other drain means.
  • the ultrafiltrate pump 19 removes fluid from the regeneration loop 14 at the exit end of the dialyzer 26 through valves 40 and 42 to the drain bag 38, wherein the fluid contains the waste and excess water removed from the patient loop 12 by the dialyzer 26.
  • the drain pump 19 can remove fluid from the regeneration loop 14 continuously or intermittently (e.g., batch operation), as desired.
  • the dialysis solution in the regeneration loop 14 is removed from the system along with the ultrafiltrate. Accordingly, a dialysate concentrate is provided in a concentrate container 44 to supply necessary compounds to the regeneration loop 14.
  • the concentrate from the container 44 mixes with the dialysate in the regeneration loop 14 and adds the compounds to the dialysate.
  • the concentrate in an embodiment also includes other components that are provided to the patient 16, for example, electrolytes.
  • a concentrate pump 46 and a valve 48 are provided to selectively pump the concentrate from the concentrate container 44 to the regeneration loop 14. The concentrate contributes to the regeneration of the dialysis solution in the regeneration loop 14.
  • the various fluid pumps can be controlled by a computer, processor, or microprocessor, collectively referred to herein as a "controller” (not illustrated), to pump their respective fluids intermittently, if desired.
  • the dialysis system 10 in an embodiment is a closed, sterile system. Air, moisture and fluids from the environment around the dialysis system 10 cannot enter into the patient loop 12 or the regeneration loop 14.
  • the dialysis system 10 does permit fluids (such as ultrafiltrate) and air to exit the fluid loops 12, 14 and fluids (such as concentrate) to be added to the fluid loops 12, 14 under controlled circumstances.
  • the dialysis system 10 is designed to prevent uncontrolled contact of the patient and the regeneration loops 12 and 14 with the surrounding environment.
  • Fig. 1 schematically shows an example of an gas separator 50 in the dialysis system 10.
  • gas is used herein to include gasses in general, including air, carbon dioxide (“CO 2 ”) and any other type of gas that can become entrained in fluid loops 12 and 14.
  • the regeneration fluid loops 12 and 14 can accumulate air for various reasons.
  • the fluid loops 12 and 14 may contain air prior to priming the system 10 with fluid or the storage containers may introduce air into the fluid loops 12 and 14.
  • the sorbent cartridge 32 may produce CO 2 and introduce the CO 2 gas into the loops 12 and 14.
  • the patient 16 can also produce certain gasses, which become entrained in the dialysate and enter the loops 12 and 14.
  • the gas separator 50 removes entrained gas from the fluid in the regeneration loop 14 and vents the gas to outside of the dialysis system 10. In this manner, gas is purged from the regeneration loop 14.
  • the gas separator 50 includes a one-way vent, i.e., it permits gas to vent from the fluid loops 12 and 14 to the atmosphere but prevents gas outside of the fluid loops 12 and 14 from entering into the loops.
  • the gas separator 50 and the sorbent cartridge 32 of Fig. 1 are combined into a single device 102.
  • One example of an gas separator 50/sorbant cartridge 32 combination is shown in the patent ' application titled "Method and Composition for Removing Uremic Toxins in Dialysis Processes," Serial Number 09/990,673, mentioned above.
  • the gas separator 50 can be a separate system component or inco ⁇ orated into system components other than the sorbent cartridge 32. It is also desirable to purge gas from the patient loop .12.
  • an additional gas separator (not illustrated) can be provided in the patient loop 12, which vents to the atmosphere.
  • the gas can be removed from the patient loop 12, fed to the gas separator 50 in the regeneration loop 14, e.g., via line 51, and vented to the atmosphere.
  • one or more gas sensor(s) 52 are provided at desired locations along the patient loop and/or the regeneration loop 14 to detect gas in the system 10.
  • gas sensors 52 electrically connect or are otherwise in communication with the system controller, which monitors gas content in the loops 12 and 14.
  • the controller can control the system to perform any desired function in response to the gas, such as, stopping fluid flow, changing the direction of fluid flow, or removing the gas.
  • the gas separator 50 can be any suitable device, which separates gas from fluid known to those of skill in the art. Gas separators, such as the separator 50, can be used which separate and vent the gas without being controlled by the system controller. In an embodiment, the gas separator 50 absorbs the gas rather than venting it to the atmosphere as illustrated.
  • the dialysis system 10 contains a fluid heater 54, shown schematically in Fig. 1.
  • the fluid heater 54 heats the fluid in the patient loop 12 to a desired temperature for supplying the fluid to the patient 16.
  • the fluid heater 54 is an in-line heater (continuous flow heater) that heats the fluid to the desired temperature as the fluid flows continuously past the heater 54.
  • heaters other than in-line heaters can be used, for example, bulk heaters.
  • the fluid heater 54 is shown in Fig. 1 in the patient loop 12 at the fluid supply to the patient 16. However, the fluid heater 54 can be positioned at other locations in the patient loop 12 and the regeneration loop 14, if desired. In another embodiment, one or both of the loops 12 and 14 include one or multiple heaters 54.
  • the fluid heater 54 is a dual heater, including an infrared heater 56 and a plate heater 58.
  • An example of such a dual heater 54 is disclosed in a patent application entitled, "Medical Fluid Heater Using Radiant Energy," Serial Number 10/051,609, inco ⁇ orated herein by reference.
  • Both the infrared heater 56 and the plate heater 58 are in-line heaters that heat the medical fluid that flows continuously past the heaters 56, 58.
  • the radiant energy or infrared heater 56 emits infrared energy that is directed to and absorbed by the fluid in the patient loop 12, thereby heating the fluid.
  • the radiant energy or infrared heater 56 is a primary or high capacity heater which can heat a relatively large volume of cold fluid to a desired temperature in a short period of time.
  • the plate heater 58 is a secondary or maintenance heater which has a relatively lower heating capacity relative to the infrared heater 56.
  • the plate heater 58 uses electrical resistance to increase the temperature of a plate that in turn heats the fluid flowing near the plate.
  • the heater 54 which includes both high and low capacity heaters, provides an efficient heater design that accommodates various fluid heating requirements.
  • the radiant or infrared heater 56 is particularly useful for quickly heating cool dialysate (high heat energy demand) that is supplied to the dialysis system 10, such as at the initial system fill or if there is severe heat loss during dialysis treatment.
  • the temperature of the dialysate at initial system fill can be quite low, such as 5°C to 10°C if the fluid is stored in cold ambient temperature.
  • Tb.e plate heater 58 is particularly useful to maintain a desired temperature (lower heat energy demand) of the fluid being supplied to the patient, e.g., due to a normal amount of heat loss during dialysis treatment.
  • the infrared heater 56 provides for the high heat demand in a small amount of fluid exposure space, while the plate heater 58 provides for maintenance heat demand and requires a lesser amount of input energy compared to the infrared or radiant heater 56.
  • the heating capacity of the heater 54 is increased if both the infrared and plate heaters 56 and 58 are used together to heat the fluid.
  • the infrared heater 56 and the plate heater 58 can be arranged in various configurations relative to each other.
  • the heaters 56 and 58 in an embodiment are arranged so that the fluid passes by the heaters sequentially (e.g., first the radiant or infrared heater and then the plate heater). In another embodiment, the fluid passes by the heaters simultaneously (both heaters at the same time) or in the reverse order.
  • the fluid flow path past the heaters 56 and 58 can be a common flow path for both heaters 56 and 58 or include independent flow paths for each heater 56 and 58.
  • radiant or infrared electrical resistance heating other types of heating such as convective, inductive, microwave and radio frequency (“RF”) heating may be used.
  • RF radio frequency
  • temperature sensors are provided at desired locations along one or both of the patient loop 12 and the regeneration loop 14.
  • the temperature sensors monitor various fluid temperatures and are connected to the system controller to control the fluid temperatures with the heater 54.
  • the system 10 in an embodiment, can include separate temperature sensors for each heater so that each heater can be controlled individually.
  • the dialysis system 10 in an embodiment also includes various other sensors to monitor various parameters.
  • fluid pressure sensors 60 and 62 are provided in the patient loop 12 of Fig. 1.
  • the fluid pressure sensors 60 and 62 electrically couple to or otherwise communicate with the controller to provide a signal that indicates the respective fluid pressure at that location. Based on the signals from the pressure sensors 60 and 62, the controller operates the fluid pumps and valves to obtain and maintain desired fluid pressures in the loop 12 running to and from the patient 16.
  • the pressure sensors 60 and 62 are non-invasive pressure sensors. That is, the pressure sensors 60 and 62 do not physically contact (and possibly contaminate) the medical fluid or dialysate.
  • the pressure sensors 60 and 62 measure the medical fluid pressure and help to maintain a steady flow within the closed fluid system.
  • other fluid devices such as flow rate sensors, pressure gauges, flowmeters, or pressure regulators, which are not illustrated Fig. 1, may be provided in any suitable quantity and at any desired location within either or both of the patient loop 12 and the regeneration loop 14.
  • the system 10 includes an ammonia sensor 64.
  • the ammonia sensor 64 measures the concentration of ammonia (NH3) and/or ammonium (NH4) in the fluid.
  • Ammonia and ammonium are produced by the regeneration sorbent cartridge 32 as a by-product of the urea catalysis urease.
  • the ammonia and ammonium are normally removed by a cation exchanger in the sorbent cartridge 32.
  • the dialysis system 10 monitors the fluid for ammoma/ammonium concentrations with the sensor 64 to confirm that the ammonia and ammonium are being removed and remain below safe threshold levels for the patient 16.
  • the total ammonia and ammonium in solution is primarily determined by three parameters: ammonia or ammonium, pH, and solution temperature. By measuring these parameters (or adjusting a parameter, such as adjusting the pH to a desired level), the total amount of ammonia and/or ammonium in the dialysate can be determined.
  • the sensor 64 determines the total ammonia and ammonium content of an aqueous solution.
  • the sensor 64 includes a hydrophobic ammonia sensing membrane, a pH indicator or conditioner, a temperature sensor and an optical sensor.
  • An algorithm stored in the controller calculates the combined ammonia and ammonium content from the three parameters (e.g., NH3, pH and temperature).
  • the ammonia gas which is highly soluble in water, is quantified by the hydrophobic sensing membrane that changes color based on the quantity of ammonia gas diffused into it.
  • a multi-wavelength optical sensor continuously measures the membrane color through a transparent window. The sensor 64 achieves a non- intrusive measurement by the using the optical sensor to monitor color changes in the disposable membrane placed inside the fluid path.
  • the dialysis system 10 also includes one or more fluid flow measurement devices or volume sensors 66 that measure the volume of the medical fluid pumped either intermittently or cumulatively through one or both of the loops 12 and 14.
  • the fluid flow measurement device 66 measures the amount of fluid supplied to the patient 16 by the patient loop 12.
  • the regeneration loop 14 and/or the ultrafiltrate drain line employ one or more fluid flow measurement devices 66 to measure the amount of ultrafiltrate removed from the patient 16.
  • Various types of fluid volume measurement or flowrate devices can be used with the dialysis system 10, such as orifice plates, mass flow meters or other flow measuring devices known to those of skill in the art.
  • FIG. 1 schematically illustrates one embodiment of a flow measurement device or volume sensing device 66, which includes a capacitance sensor that measures the volume of fluid pumped through a chamber, such as a pump chamber (dotted lines designating the device 66 shown encircling the pumps 19, 24 and 30).
  • the capacitive fluid sensor 66 is disclosed in greater detail in the patent application entitled, "Capacitance Fluid Volume Measurement,” Serial Number 10/054,487, inco ⁇ orated herein by reference.
  • the capacitance between the plates changes proportionally according to the function 1 / (R x V), wherein R is a known resistance and V is the voltage measured across the capacitor plates.
  • the sensor cooperates with the pump chamber.
  • the pump chamber in an embodiment includes shells or walls defining a fixed and known volume and a pair of flexible membranes operating between the shells, which expand to fill with fluid and contract to discharge fluid.
  • the capacitance sensor 66 includes capacitor plates disposed on opposite sides of the pump chamber. As the volume of fluid in the chamber or fluid pump changes (i.e., the pump chamber fills or empties), the dielectric property of the varying fluids between the capacitance plates changes. For example, the combined dielectric constant of dialysate and air changes as dialysate replaces air (or air replaces dialysate) within shells of the constant volume chamber.
  • This change in the overall dielectric constant affects a change in the capacitance between the two plates, which causes a change in voltage across the capacitance plates, wherein the change in voltage can be sensed by a voltage sensing device.
  • the controller monitors the change in voltage by the voltage sensing device and correlates (after a calibration of the sensor) the capacitance change to an amount of fluid pumped through the chamber.
  • the volume of the chamber or the pump chamber can vary, e.g., by movement of one or both the shells of the chamber.
  • the capacitance between the capacitor plates changes due to a changing distance d between the plates and/or a changing surface area S of one or more of the plates, wherein the dielectric constant k is static because only one fluid resides at all times between the capacitor plates.
  • the capacitance C between the capacitor plates changes based on any combination or all three of a change in dielectric constant k, distance d and surface area S.
  • the controller collects a multitude of voltage signals from capacitance changes from sensor 66 due to a plurality of chamber fill and drain cycles, wherein the controller calculates a total volume of medical fluid pumped over a length of time or number of pump cycles.
  • the capacitance sensor 66 monitors the medical fluid, e.g., dialysate, flow into or from the pump chamber on a real time basis, and in a non- invasive manner.
  • the capacitance sensor 66 enables the dialysis system 10 to maintain the volume of fluid that is provided to the patient 16 at desirable amounts and flow rates. Maintaining the fluid flow to the patient 16 within desired levels is particularly advantageous for peritoneal dialysis therapies.
  • Physiologic control such as sensing and/or adjusting parameters of the fluids, can take place at various locations in the dialysis system 10, including the patient loop 12 and the regeneration loop 14.
  • the sorbent cartridge 32 may include a pH sensor that adjusts the fluid in the regeneration loop 14, which then adjusts the fluid in the patient loop 12 via the dialyzer to be at a desired physiologic level.
  • the dual lumen connector 20 includes a housing 70 having. a lumen 72 for providing fluid to the patient lumen and a separate lumen 74 to remove fluid from the patient. Separate housings each having one of the lumens 12 and 74 may be provided.
  • the patient inflow lumen 72 connects to a patient inflow tube 76 of the patient loop 12.
  • the patient outflow lumen 74 connects to a patient outflow tube 78 of the patient loop 12.
  • a removable end cap 80 is provided to seal a cavity 82 defined by the housing 70.
  • the cavity 82 surrounds or abuts the lumens 72 and 74 and provides a connection area for the dual lumen catheter 22 (Fig. 1) to insert into the cavity 82 and mate with the lumens 72 and 74.
  • the housing 70, lumens 72 and 74 and the end cap 80 are made of any material suitable for medical applications, such as plastic for example.
  • one of the lumens, e.g., the patient inflow lumen 72 extends further into the cavity 82 than the other lumen, which helps facilitate mating of the connector 20 to the catheter 22.
  • both lumens 72 and 74 extend into the cavity 82 the same or different distance.
  • the dialysis system 10, particularly the patient loop 12, can be primed, e.g., filled, with the end cap 80 in sealing engagement with the housing 70.
  • the arrows 84 and 86 figuratively illustrate the recirculating fluid flow through the dual lumen connector 20.
  • the system 10 can therefore run without a fluid connection to the patient.
  • the system 10 may include a patient by-pass line between the patient inflow and outflow tubes 76, 78 to allow fluid flow through the patient loop 12 while by-passing the patient 16.
  • the end cap 80 is removed, e.g., pulled off or unscrewed, to expose the cavity 82 and the patient inflow and outflow lumens 72 and 74, respectively, for connection to the dual lumen catheter 22.
  • the patient fluid loop 12 directly connects to the dual lumen catheter 22 or to two separate single lumen catheters.
  • the connector 20 is adapted to connect to two separate single lumen catheters.
  • two separate connectors link single lumen catheters to incoming and outgoing lines of the patient fluid loop 12. Other configurations are also contemplated by the present invention.
  • the system 100 of Fig. 3 includes many of the same components as the system 10 of Fig. 1.
  • the system 100 includes two loops, a patient loop 12 and a regeneration loop 14.
  • the patient loop 12 passes a medical fluid, dialysate or blood, to and from a patient 16.
  • the patient loop 12 and regeneration loop 14 are initially filled and primed with dialysate from a dialysate bag 18.
  • the patient loop 12 fluidly connects to the patient 16 by the multi-lumen patient fluid connector 20 described above in connection with Fig. 2.
  • the multi-lumen connector 20 connects to a dual lumen catheter 22.
  • the patient loop 12 fluidly connects to a multi-lumen hemodialysis needle or other patient blood access device.
  • the system 100 includes multiple patient fluid pumps 24a and 24b. It has been found that using multiple pumps, such as the patient fluid pumps 24a and 24b, creates a steadier flow of fluid to and from the patient 16 within the patient loop 12. For example, fluid may be exiting the fluid pump 24a while the fluid pump 24b is filling with fluid. Balance chambers can be provided, in an embodiment, to balance fluid flow.
  • the system 100 includes the dialyzer 26 having the dialyzer membrane 28.
  • the spent dialysate (or blood in a hemodialysis embodiment) laden with waste and excess water in the patient fluid loop 12 is cleaned or regenerated when recirculated through the dialyzer 26.
  • the waste passes from the patient loop 12 across the dialyzer membrane 28 to the regeneration loop 14.
  • the fluid pumps 30, 30 continuously pump the regenerating dialysate through the combination device 102, which includes the absorbent cartridge 32 and the gas separator 50.
  • the system 100 includes dual dialysate fluid pumps 30 to provide balanced flow within the regeneration loop 14. That is, one of the fluid pumps 30 is being emptied of fluid while the other pump 30 is being filled with fluid.
  • balance chambers can be provided for balancing fluid flow.
  • the system 100 can drain ultrafiltrate and other fluids into the drain bag 38.
  • An ultrafiltrate pump 19 pumps the ultrafiltrate and fluids from the patient loop 12 or the regeneration loop 14, for example through valves 40 and 42, into the drain 38.
  • the system 100 also provides the ability to collect fluid in a twenty-four hour collection bag 39 for evaluation of the dialysis therapy.
  • one of the patient fluid pumps 24a or 24b pulls dialysate fluid from either the dialysate bag or container 18 or the last bag 21.
  • the last bag 21 includes a volume of fluid that is placed in the patient's peritoneal cavity just prior to the end of the dialysis treatment. The patient with the dialysate from the last bag 21 in the peritoneal cavity disconnects from the system 100 and is able to perform daily activities.
  • the next dialysis therapy begins with draining the last bag from the patient.
  • the system 100 includes a concentrate container 44, a concentrate pump 46 and valves 48.
  • the concentrate pump 46 provides concentrate from the concentrate container 44 to the regeneration loop 14, for example into the fluid line exiting from the outlet 36 of the combination absorbent cartridge and vent 102.
  • the concentrate container 44 supplies necessary compounds, such as electrolytes and osmotic agents, to the regeneration loop 14 of the system 100 to maintain the desired concentrations of those components.
  • the system 100 regenerates dialysate through the regeneration loop 14 and does not require fluids from an outside source.
  • the systems of the present invention are thus "closed loop systems".
  • the closed loop nature of the patient loop 12 and the regeneration loop 14 enables the loops to run continuously without absorbing or gathering outside contaminants.
  • the closed loop systems of the present invention also maintain sterility by preventing contamination from the environment.
  • the system 100 may generate gases over time, such as air and CO 2 .
  • the system 100 provides a plurality of gas sensors 52 that detect the various gases that may be in the system 100.
  • the gas sensors 52 are provided at an air separator which separates gas from the fluid in the patient loop 12.
  • a gas separation line 51 feeds the separated gas from the patient loop 12 to the inlet side 34 of the combination absorbent cartridge and gas separator device 102.
  • the gas is then purged out of the system 100 by the gas separator 50.
  • the gas separator 50 maintains the closed loop structure of the system 100 by preventing contaminants from entering the system 100.
  • the gas separator 50 can include a microbial filter which allows gas to exit the system 100, but prevents contaminants from entering the system 100.
  • the gas from the patient loop 12 may be purged from the system 100 by a separate gas purge device at the patient loop 12.
  • the gas sensors 52 in an embodiment, can send an electronic signal to the controller (not illustrated). When the controller detects gas, the controller causes one or more valves to open, wherein the gas from the loop 12 is fed to a one-way vent and purged from the system 100.
  • the system 100 further includes the inline heater 54, which, in an embodiment, includes an infrared or radiant heater 56 and a plate heater 58 as described above.
  • the heater 54 has an air separator which allows air to exit port 59 on be purged from the system.
  • the system 100 further includes an orifice device 61 that stabilizes the differential pressure in the dialyzer 26 across the membrane 28. That is, the orifice device 61 can restrict the flow in the patient loop 12 to create a pressure differential between the patient side and regeneration side of the dialyzer 26. The pressure gradient or differential occurs across the membrane 28 in which the patient loop 12 having a higher fluid pressure than the regeneration loop 14.
  • the orifice device can be a fixed or variable flow restriction and can provide a fixed or variable pressure differential.
  • the orifice device 61 can be electrically coupled to and operated by the controller, which can activate, e.g., open or close the orifice device as necessary.
  • the pressure differential across the membrane 28 (higher pressure in the patient loop 12 and lower pressure in the regeneration loop 14) created by the orifice 61 assists in maintaining a greater pressure in the regeneration loop 14 relative to atmosphere pressure external to the system 100.
  • the positive pressure in the regeneration loop 14 relative to the external atmosphere pressure aids in ensuring that external air is not pulled from the surrounding environment through the air vent 50 into the regeneration loop 14, i.e., air can only exit the system 100 and not enter into the system 100. Accordingly, the orifice 61 contributes to the closed loop nature of the system 100.
  • the system 100 provides a number of temperature sensors, such as sensors 63, 65 and 67, which monitor temperatures at various points within the patient loop 12.
  • the controller uses the sensed temperatures to maintain a desired temperature within the patient loop 12.
  • the temperature sensor 63 is located at or on the heater 54, which enables the system 100 to sense a temperature at a point very close to the constituent heaters 56 and 58, and to control the heaters 56, 58.
  • the system 100 further includes one or more pressure sensors 60 and 62, which reside at various points along the patient fluid loop 12.
  • the pressure sensors 60 and 62 can be used to prevent excessive positive or negative pressures from being applied to the patient.
  • the pressure within the system can be controlled by, e.g., activation of the patient fluid pumps 24a, 24b.
  • the system 100 also monitors the absorbent cartridge 32 with an ammonia/ammonium sensor.
  • Sample fluid exiting the absorbent cartridge 32 can be directed through a pH adjuster 71 to force the ammonia/ammonium equilibrium balance to a particular level.
  • the amount of ammonia and/or ammonium in the sample fluid is measured by a sensor 73. Accordingly, the effectiveness of the cartridge 32 to remove ammonia/ammonium after conversion from urea can be monitored.
  • the concentration of ammonia and/or ammonium reaches a threshold level, the system can produce a signal, or take other action such as shutting down, that indicates the cartridge 32 needs to be replaced.
  • the system 100 can monitor other fluid parameters and take appropriate action, as desired.
  • sample fluid can be taken at any desired location in the system 100.
  • fluids in the patient and regeneration loops 12, 14 can be tested or monitored directly rather than taking samples.
  • the system 100 also includes fluid volume sensors 66 which in an embodiment are capacitance sensors that sense a change in capacitance occurring between two capacitor plates. The capacitor plates surround the pumps 24 of the patient loop 12, the pumps 30 of the regeneration loop 14 and the pumps leading to the fluid containers.
  • Each of the pumps 24a, 24b, pump 30, pump 19 and pump 46 can be provided with the capacitance volume sensor 66 of the present invention.
  • Each of the sensors 66 sends a discrete signal to the controller (not illustrated), which measures and monitors the volume of fluid flowing through the pump chambers of the respective pumps. In other embodiments, any suitable fluid volume measurement device can be used.
  • the system 110 of Fig. 4 is similar to the system 100 of the Fig. 3 and is a closed loop system.
  • the system 110 includes various components of the system 100 described previously.
  • the system 110 has a regeneration loop 14 which has a pair of balanced dialysate fluid pumps created by a pair of chambers 75 that operate with the pumps 30.
  • Each balance chamber 75 includes a pair of chambers separated by a membrane. When one of the pumps 30 fills one side of the chambers of the balance chambers 75 fills with medical fluid, the membrane is forced toward the other chamber, which forces fluid out of that chamber.
  • the membrane acts to balance the flow of the dialysate fluid within the regeneration loop 14, so that there is no net flow of fluid across the dialyzer membrane except for the flow needed to replace the fluid removed by the ultrafiltrate pump 19.
  • the gas separator 50 in the illustrated embodiment of the system 110 is independent of the sorbent cartridge 32.
  • the gas separator 50 accepts gas through a vent line 51 that runs from the exit port 59 of the heater 54 in the patient fluid loop 12.
  • One or more gas sensors 52 monitor gas in the vent line 51 as illustrated.
  • a dialysis system having a disposable cassette 120 is illustrated.
  • the pumps 30 of system 120 draw fluid from accumulators A4 and A6 and discharge into accumulators A3 and A5.
  • Accumulators A3 to A6 smoothen the dialysate flow by dampening pressure fluctuations during pumping.
  • much of the flow logic and at least parts of the flow devices described above are provided in the disposable cassette 120.
  • the cassette 120 in an embodiment, has a rigid plastic body 122 with various fluid flow channels and fluid chambers defined in the body 122.
  • a flexible membrane is bonded to the front side of the cassette body 122 shown in Fig. 5.
  • the membrane covers the fluid channels and chambers and is sealed to the body 122 around the channels and chambers. Accordingly, the membrane forms a wall of the fluid flow paths and fluid chambers. Similarly, the back side of the cassette body 122 may also be covered with a membrane.
  • the body 122 in an embodiment, is approximately 12 inches high, eight inches wide, and one inch deep.
  • the flow components and flow lines defined by the body 122 fluidly connect to other system components.
  • pump actuators, valve actuators, sensors and other system components may interface with the cassette 120.
  • the body 122 provides a portion of the closed patient the regeneration loops 12 and 14.
  • the dual lumen catheter 22 that inserts into the peritoneal cavity of the patient 16 connects to the dual lumen connector 20 outside of the body 122 of the disposable cassette 120.
  • the patient loop 12 extends from an exit port 124 of the dialyzer 26 to a valve chamber 126 defined by the body 122.
  • the patient fluid loop 12 includes a series of manifolds and fluid flow paths that fluidly connect to the patient fluid ⁇ ump(s) 24.
  • the patient fluid pump 24 pumps the dialysate through the patient 16 and into an inlet 128 of the dialyzer 26.
  • the patient fluid loop 12 also connects via pathways defined by the body 122 of the disposable cassette 120 to various medical fluid bags.
  • the dialysate fluid bag 18, which is maintained outside of the disposable cassette 120 fluidly connects to a line 130 leading to the patient fluid loop 12.
  • the last bag 21 also connects via a line defined by the body 122 to the line 130 that fluidly communicates with the patient fluid loop 12.
  • the line 130 defined by the body 122 also fluidly communicates with the ultrafiltrate drain 38.
  • the body 122 of the disposable cassette 120 also defines chambers for the concentrate pump 46 and the ultrafiltrate pump 19.
  • the concentrate pump 46 fluidly connects to an external concentrate bag 44.
  • the twenty-four hour collection bag 39 described above fluidly connects along with the drain 38 to a fluid line defined by the body 122 that runs to the ultrafiltrate pump 19.
  • the disposable cassette 120 provides fluid flow paths and defines chambers and other types of fluid orifices for the fluid flow components described above. Specifically, the body 122 of the disposable cassette 120 defines a patient fluid pump chamber 24 and dialysate fluid pump chambers 30.
  • the disposable cassette 120 mounts to a separate non-disposable housing that includes the mechanical workings of the flow components, such as the pumps.
  • the pump chambers are bounded on one side by a flexible membrane (not illustrated) that is positioned adjacent to and driven by the pump plungers of the non-disposable housing.
  • At least one side of the cassette 120 is covered with the flexible, e.g., plastic membrane (not illustrated).
  • the disposable cassette 120 plugs into a cavity or portion of the non-disposable housing (not illustrated).
  • the housing provides the actuators for each of the pumps herein described, e.g., the patient pumps 24, the dialysate pumps 30, the ultrafiltrate pump 19 and the concentrate pump 46.
  • the housing also provides the actuators for the various valve chambers defined by the body 122 of the cassette 120, e.g., valve chamber 126.
  • the more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators and valve actuators, are kept and reused in the housing.
  • the disposable cassette 120 provides sterile, disposable fluid pathways, such as the pump chambers and the valve chambers.
  • the actuators of the non-disposable housing press against the flexible plastic membrane at the pump chambers and valve chambers to force or allow fluid through the system.
  • the membrane returns to its normal shape and no longer exerts a force on the fluid within the pump chamber.
  • the pump chamber fills with fluid as the membrane is drawn back. Also, the membrane can be positively drawn back by, for example, the pump actuator or vacuum pressure. The pump has thus made a cycle.
  • the body 122 of the disposable cassette 120 also defines at least a portion of a mounting area for housing the ammonia, ammonium or pH sensors or adjusters.
  • the disposable cassette 120 defines an area for housing the pH adjuster 71 and a disposable colormetric membrane (which changes color based on the arnmonia/ammonium concentration) of the ammonia/ammonium sensor 73, wherein the fluid within the body 122 of the cassette 120 can fluidly communicate with the sensor.
  • the optical color reader of the ammonia/ammonium sensor 64 is disposed in the non-disposable housing (not illustrated), wherein the sensor can receive electrical power as needed. If a pH sensor is used instead of the pH adjuster 71, a reusable portion of the pH sensor can also be located in the housing.
  • the housing also provides the in-line heater 54 and in an embodiment provides one of either the radiant heater 56 and the plate heater 58, which is described in detail in the patent application entitled, "Medical Fluid Heater Using Radiant Energy,” Serial Number 10/051,609, mentioned above. Further, the housing provides one of the capacitor plates of the fluid volume sensor 66 beneath one or more of the pump actuators, as described in detail in the patent application entitled, “Capacitance Fluid Volume Measurement,” Serial Number 10/054,487, mention above. Referring back to the cassette 120 of Fig. 5, the cassette 120 has an in-line heating fluid heating path 123 for heating the fluid. The fluid in the heating path 123 is heated by a heater external to the cassette.
  • the cassette 120 also has one or more gas separators 125 which separate gas from fluid in the cassette 120.
  • the gas separators 125 feed the separated gas through a line 127 to a vent 129.
  • the closed loop system of the present invention enables at least one waste component to pass through the membrane 28 of the dialyzer 26 from the patient fluid loop 12 to the regeneration loop 14.
  • the patient loop 12 extending outside of the body 122 fluidly connects to a valve chamber 132 defined by the body 122.
  • the regeneration loop 14 includes manifold sections defined by the body 122 and leads to pump chambers 30.
  • the closed loop system prevents air or other fluids from entering the system.
  • the pump chambers 30 fluidly communicate with the sorbent chemical cartridge 32 and the gas separator 50 of the combined device 102.
  • the regeneration loop 14 extends from the outlet 36 of the combined device 102 and returns to the body 122 of the disposable cassette 120 through the valve chamber 134. From the valve chamber 134, the regenerated dialysate is pumped through the pump chambers 30 and into the manifold system defined by the body 122.
  • FIG. 6 another closed loop system having another disposable cassette 140 is illustrated.
  • This embodiment of the disposable cassette 140 of the present invention includes many of the same flow components and flow chambers as the cassette 120 of Fig. 5.
  • the cassette 140 only includes a single regeneration pump body 30.
  • the cassette 140 in general, is less complicated than the cassette 120 and illustrates that the disposable cassettes of the present invention may be adapted for different embodiments of the closed loop dialysate regeneration systems described herein.
  • the cassette 140 is covered with a flexible, e.g., plastic membrane (not illustrated).
  • the disposable cassette 140 plugs into a non-disposable housing (not illustrated) that provides the actuators for the various pumps, e.g., the patient pump 24, the dialysate pump 30, the ultrafiltrate pump 19 and the concentrate pump 46.
  • the housing also provides the actuators for the various valve chambers defined by the body 122 of the cassette 140.
  • the more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators are again kept and reused in the housing. As described above, the actuators press against the flexible plastic membrane at the pump chambers to force fluid through the system.
  • the disposable cassette 120 or 140 in combination with certain external devices such as the dialyzer 26, sorbent cartridge and gas separator device 102 and the fill and drain bags, provides completely closed loop systems.
  • the only make-up or additional fluid that the regeneration system uses is that of the concentrate from the concentrate bag 44, which seals to a device within the body 122 of the cassettes 120 and 140. Also, other than the systems being connected to a patient, fluids and air cannot enter the closed loop system.
  • FIG. 7 a schematic diagram illustrates the different physical components of a disposable set of the regeneration systems of the present invention.
  • the disposable set is intended to be used for a single dialysis therapy and then discarded. Another disposable set is used for the next dialysis therapy.
  • Each of the above-described systems 10, 100 and 110 in an embodiment includes a disposable cassette, such as the cassette 120 or 140.
  • the disposable cassette 120 or 140 provides a port 141 that connects to the concentrate bag 44 via a line 147.
  • the cassette provides a port 142 that fluidly connects to the drain bag 38 via a line 148.
  • the cassette provides a port 143 that fluidly connects to the last bag 21 via a line 149.
  • the cassette defines a port 144 that fluidly connects to the dialysate bag 18 via a line 150.
  • the cassette provides ports 145 and 146 that run to and from the dual lumen connector 20 via patient lines 151 and 152, respectively.
  • each of the lines 147 to 152 are made of medical grade tubing, such as a flexible, sterile and inert plastic such as polyethylene, polystyrene, polypropylene or polyvinylchloride ("PVC").
  • PVC polyvinylchloride
  • the bags and the lines are clear so that the patient or operator can see fluids traveling from the bags and through the lines to a cassette 120 or 140.
  • the lines 147 to 152 connect to the ports 141 to 146 via any type of medical fluid connection known to those of skill in the art.
  • the connections are quick-type connections that enable the patient or operator to easily remove the line from its mating port.
  • the disposable cassette 120 or 140 includes at least one port 153 that fluidly connects to at least one outlet port 154 of the gas separator 50 or combination device 102.
  • the disposable cassette 120 or 140 includes at least one port 155 that fluidly connects to at least one inlet port 156 of the sorbent cartridge 32 or combination device 102.
  • the lines connecting the disposable cassette 120 or 140 to the sorbent cartridge 32, gas separator 50 or combination device 102 including same are made of medical grade tubing, such as a flexible, sterile and inert plastic such as polyethylene, polystyrene, polypropylene or polyvinyl chloride.
  • FIG. 8 an alternative closed loop regenerative system 160 is illustrated.
  • the system 160 is shown schematically, however, the system 160 may employ the disposable set described above such as the disposable cassette, the fluid pumps, the various sensors, valves and controller.
  • the system 160 includes a patient fluid loop 12 and a regeneration loop 14.
  • dialysate When dialysate is removed from the peritoneal cavity of the patient 16, the solution passes through an activated charcoal and anion exchanger 162.
  • the activated charcoal of the filter or exchanger 162 removes uric acid, creatinine, small molecular weight organics and middle molecules.
  • the anion exchange column of the exchanger 162 removes phosphate.
  • the solution exiting the filter or exchanger 162 enters a solution or dialysate bag 18.
  • the dialysate entering the solution bag 18 has two possible places to exit. One possibility includes exiting the solution bag 18 from a port 163, entering a filter 166 and returning to the peritoneal cavity of the patient 16. Another possibility includes exiting the solution bag 18 at a port 165 and entering a nanofilter 164.
  • the system 160 splits the dialysate fluid exiting the solution bag or container 18.
  • the nanofilter 164 operates similar to the dialyzer 26 described above.
  • the nanofilter 164 includes a membrane.
  • the membrane of the nanofilter 164 rejects most electrolytes, i.e., allows most of the electrolytes to return to the solution bag.
  • the nanofilter 164 filters most all of the urea and a small amount of sodium through the membrane and into a sorbent system cartridge 32, which is similar to the sorbent cartridges described above.
  • the sorbent cartridge 32 as described above absorbs and the urea from the fluid that is able to permeate through the membrane of the nanofilter 164.
  • a plurality of pumps (not illustrated) are provided to individually circulate medical fluid or dialysate through the patient loop 12 and the regeneration loop 14.
  • the pump or pumps that control the recirculation through the regeneration loop 14 are adapted to circulate the regenerating fluid at a different flow rate, i.e., much faster, than the flow rate of fluid pumped through the patient loop 12. It is believed that by using this method, the need for a concentration bag such as the concentration bags 44 described above would not be needed.
  • the system 160 is a closed loop system that does not require any sort of make-up materials or any continuous source of outside fluid. The system 160 is therefore very adept at keeping air and other contaminants from entering the system.
  • the a reverse osmosis membrane or an electrooxidation system replaces the sorbent cartridge 32.
  • a reconstitution or concentration bag such as the concentration bag 44, is likely to be necessary.
  • the regeneration loop 14 removes urea at a rate of approximately 50 to 80%.
  • the dialysate returns to the peritoneal cavity of the patient 16 substantially free from uric acid, creatinine, small molecular weight organics and middle molecules.
  • the nanofilter 164 can reject calcium magnesium at a rate of approximately 98% and glucose at a rate of approximately 80%.
  • the permeate stream exiting the nanofilter 164 includes urea, approximately 70% sodium chloride and approximately 20% glucose. It should be appreciated that the system 160 is useful for performing continuous flow peritoneal dialysis.
  • a system 170 is illustrated.
  • Each of the previous systems 10, 100 and 110 of Figs. 1, 3 and 4, respectively, can be used for peritoneal dialysis or hemodialysis.
  • each of the systems described above has been primarily described and illustrated using peritoneal dialysis, that is, the patient loop has been illustrated using a dialysis solution.
  • the system 170 illustrates that the dual lumen catheter or two single lumen catheters can be replaced by a hemodialysis needle 171, which connects to the arm (or other suitable portion) of the patient 16 to withdraw blood through the hemodialysis needle 171.
  • the system 170 illustrates that the patient's blood flows through the patient loop 12 while dialysate flows through the regeneration loop 14.
  • the patient's blood flows along one side of the membrane 28 of the dialyzer 26, while the dialysate flows along the outside or other side of the membrane 28 of the dialyzer 26.
  • the waste components and ultrafiltrate transfer from the patient's blood in the patient loop 12, through the membrane 28, into the dialysate in the regeneration loop 14.
  • the system 170 includes a fixed volume recirculating regeneration loop 14 that dialyzes the patient fluid loop 12.
  • a single pump 172 operates to remove the ultrafiltrate from the patient 16 to the ultrafiltrate container 38.
  • the pump 172 adds dialysis fluid from the dialysis bag 18 or concentrate from the concentrate bag 44 to the regeneration loop 14.
  • the concentrate can be metered into the dialysate of the regeneration loop 14 as a solid prior to or during therapy.
  • the volume of dialysate fluid flowing through the regeneration loop 14 can be determined using an electronic balance 174 illustrated below the dialysate bags.
  • the electronic balance 174 keeps track of the amount of dialysate that is supplied to the system during a priming of the system.
  • the electronic balance 174 also monitors any additional dialysate added to the patient loop 12 during dialysis treatment.
  • the electronic balance 174 measures the amount of ultrafiltrate that is withdrawn from the system and the amount of the concentrate that is added from the concentrate bag 44.
  • any of the systems described herein can be sensed using other types of flowmeters or devices employing Boyle's Law known to those of skill in the art.
  • the system 170 removes ultrafiltrate by opening a valve chamber and transferring a known volume of the fluid into the ultrafiltrate bag 38.
  • the removal of fluid creates a pressure differential across the membrane 28 of the dialyzer 26, which causes fluid to filter through the dialyzer membrane 28 and into the regeneration circuit 14.
  • Sterile dialysate from a supply bag 18 is infused into the patient circuit 12 as required.
  • Concentrate from the concentrate bag 44 can also be infused into the regenerating circuit 14 as needed.
  • Pressure sensors 176 monitor and control the rate at which the system 170 draws ultrafiltrate into the container 38.
  • Gas sensors 52 are used to prevent air from being delivered to the patientl ⁇ .
  • a multi-analyte sensor 178 is employed to monitor the concentration of electrolytes in the regenerated dialysate as well as the efficiency of the regeneration system in removing uremic toxins.
  • the output of the multi-analyte sensor 178 controls the rate of reconstitution from the concentrate bag 44, the efficiency of the regeneration system and can detect the presence of a leak in the dialyzer.
  • a vent 180 vents air that becomes trapped in the system or CO 2 that is generated by the absorbent cartridge 32.
  • an automated valve that is provided integrally with the adsorbent cartridge 32 replaces the mechanical vent 180.
  • the system 170 is illustrated as a hemodialysis system, the system 170 is easily converted to a peritoneal dialysis system by placing the catheter into the patient's peritoneal cavity and by running dialysate through the patient loop 12 as opposed to the patient's blood.
  • the ultrafiltrate bag 38, the dialysate container 18 and the concentrate container 44 each fluidly connect to the regeneration loop 14 and the patient circuit is kept relatively simple.
  • the system 170 is especially conducive for continuous flow of peritoneal dialysis, however, standard APD and TIDAL therapies could be performed in the system 170.
  • a combined absorbent cartridge, pump and valve system is placed into a single container, e.g., a canister, cartridge or cassette 190.
  • the combination container 190 is illustrated as housing the components specifically described in the system 170 of Figure 9. However, the combination container 190 is adaptable to house the components of any of the above-described systems, namely, the systems 10, 100 and 110.
  • the canister, cartridge or cassette is adaptable to be made of any material such as plastic or metal.
  • the container 190 includes the adsorbent cartridge 32, which is configured as described above. Alternatively, the container includes the combination device 102 that provides the adsorbent cartridge 32 and the gas separator 50.
  • the container 190 includes the pumps illustrated in Fig. 9 including the pump 172 that enables dialysate to be drawn from the dialysate bag 18 or concentrate to be drawn from the concentrate bag 44. Additionally, the pump 172 enables ultrafiltrate to be drained into the bag 38.
  • the container 190 includes the multi- analyte sensor 178 and the gas sensor 52, as described in the system 170 of Fig. 9.
  • the container 190 also includes the mechanical or automated vent 180 described in the system 170.
  • the only devices external to the container 190 are the dialysate bags and the hemodialysis needle 171 that is inserted in the patient's arm or other extremity to perform hemodialysis. Obviously, by the multi-lumen connector 20 and catheter 22 can replace the needle 171 to perform peritoneal dialysis.
  • the cassette 190 When the container 190 is provided in the form of a disposable cassette, the cassette 190, like the cassettes 120 and 140 of Figs. 5 and 6, is covered on at least one side with a flexible, e.g., plastic membrane (not illustrated).
  • the disposable cassette 190 plugs into a non-disposable housing that provides the actuators for the various pumps, e.g., the patient pumps 24, the dialysate pumps 30, the ultrafiltrate pump 19 and the concentrate pump 46.
  • the more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators, are again kept and reused in the housing.
  • the sorbent cartridge 32 and the gas vent 180 can be disposable.

Abstract

In a peritoneal dialysis embodiment of the present invention, spent dialysate from the patient's peritoneal cavity passes, along a patient loop, through a dialyzer having a membrane that separates waste components from the spent dialysate, wherein the patient loop returns fresh dialysate to the patient's peritoneal cavity. The waste components are carried away in a second regeneration loop to a regeneration unit or sorbent cartridge, which absorbs the waste components. The regeneration unit removes undesirable components in the dialysate that were removed from the patient loop by the dialyzer, for example, excess water (ultrafiltrate or UF), toxins and metabolic wastes. Desirable components can be added to the dialysate by the system, such as glucose and electrolytes. The additives assist in maintaining the proper osmotic gradients in the patient to perform dialysis and provide the necessary compounds to the patient.

Description

S P E C I F I C A T I O N
TITLE OF THE INVENTION
"SYSTEMS AND METHODS FOR PERFORMING PERITONEAL DIALYSIS"
BACKGROUND OF THE INVENTION The present invention generally relates to dialysis systems. More specifically, the present invention relates to regeneration dialysis systems and continuous flow dialysis systems. The present invention also relates to methods of performing dialysis therapies.
Due to disease, insult or other causes, a person's renal system can fail. In renal failure of any cause, there are several physiological derangements. The balance of water, minerals and the excretion of daily metabolic load is no longer possible in renal failure. During renal failure, toxic end products of nitrogen metabolism (urea, creatinine, uric acid, and others) can accumulate in blood and tissues.
Kidney failure and reduced kidney function have been treated with dialysis. Dialysis removes waste, toxins and excess water from the body that would otherwise have been removed by normal functioning kidneys. Dialysis treatment for replacement of kidney functions is critical to many people because the treatment is life saving. One who has failed kidneys could not continue to live without replacing at least the filtration functions of the kidneys. Hemodialysis and peritoneal dialysis are two types of dialysis therapies commonly used to treat loss of kidney function. Hemodialysis treatment utilizes the patient's blood to remove waste, toxins and excess water from the patient. The patient is connected to a hemodialysis machine and the patient's blood is pumped through the machine. Catheters are inserted into the patient's veins and arteries to connect the blood flow to and from the hemodialysis machine. As blood passes through a dialyzer in the hemodialysis machine, the dialyzer removes the waste, toxins and excess water from the patient's blood and returns the blood to infuse back into the patient. A large amount of dialysate, for example about 120 liters, is used to dialyze the blood during a single hemodialysis therapy. The spent dialysate is then discarded. Hemodialysis treatment lasts several hours and is generally performed in a treatment center about three or four times per week.
One type of hemodialysis therapy is regenerative hemodialysis. This therapy uses a hemodialysis system, which includes a cartridge for dialysate regeneration. One such cartridge is manufactured under the name REDY™ by Sorb Technology, Oklahoma City, Oklahoma. In this system, the dialysate fluid flow path must be properly cleaned before the hemodialysis machine can be used on another patient. Also, the dialysate fluid flow path is not a closed system, i.e., the dialysate fluid flow path is open to the atmosphere, such that oxygen from the atmosphere can contact fluid in the system and foster the growth of bacteria in same. Consequently, contamination of such a dialysis system can be a concern. Further, the dialysate fluid exiting the REDY™ cartridge is not suitable for peritoneal dialysis because the fluid is relatively acidic and not, therefore, physiologic. Moreover, this system requires the attention of medical personnel during therapy.
Peritoneal dialysis utilizes a sterile, pyrogen free dialysis solution or "dialysate", which is infused into a patient's peritoneal cavity. The dialysate contacts the patient's peritoneal membrane in the peritoneal cavity. Waste, toxins and excess water pass from the patient's bloodstream through the peritoneal membrane and into the dialysate. The transfer of waste, toxins, and water from the bloodstream into the dialysate occurs due to diffusion and osmosis, i.e., an osmotic gradient occurs across the membrane. The spent dialysate drains from the patient's peritoneal cavity and removes the waste, toxins and excess water from the patient. This cycle is repeated on a semi-continuous or continuous basis. There are various types of peritoneal dialysis therapies, including continuous ambulatory peritoneal dialysis ("CAPD") and automated peritoneal dialysis. CAPD is a manual dialysis treatment, in which the patient connects an implanted catheter to a drain and allows a spent dialysate fluid to drain from the peritoneal cavity. The patient then connects the catheter to a bag of fresh dialysate and manually infuses fresh dialysate through the catheter and into the patient's peritoneal cavity. The patient disconnects the catheter from the fresh dialysate bag and allows the dialysate to dwell within the cavity to transfer waste, toxins and excess water from the patient's bloodstream to the dialysate solution. After a dwell period, the patient repeats the manual dialysis procedure. In CAPD the patient performs several drain, fill, and dwell cycles during the day, for example, about four times per day. Each exchange or treatment cycle, which includes a drain, fill and dwell, takes about four hours. Manual peritoneal dialysis performed by the patient requires a significant amount of time and effort from the patient. This inconvenient procedure leaves ample room for improvement and therapy enhancements to improve patient quality of life.
Automated peritoneal dialysis is similar to continuous peritoneal dialysis in that the dialysis treatment includes a drain, fill, and dwell cycle. However, a dialysis machine automatically performs three to four cycles of peritoneal dialysis treatment, typically overnight while the patient sleeps.
With automated peritoneal dialysis, an automated dialysis machine fluidly connects to an implanted catheter. The automated dialysis machine also fluidly connects to a source or bag of fresh dialysate and to a fluid drain. The dialysis machine pumps spent dialysate from the peritoneal cavity, though the catheter, to the drain. The dialysis machine then pumps fresh dialysate from the dialysate source, through the catheter, and into the patient's peritoneal cavity. The automated machine allows the dialysate to dwell within the cavity so that the transfer of waste, toxins and excess water from the patient's bloodstream to the dialysate solution can take place. A computer controls the automated dialysis machine so that the dialysis treatment occurs automatically when the patient is connected to the dialysis machine, for example, when the patient sleeps. That is, the dialysis system automatically and sequentially pumps fluid into the peritoneal cavity, allows for dwell, pumps fluid out of the peritoneal cavity, and repeats the procedure. Several drain, fill, and dwell cycles will occur during the treatment. Also, a
"last fill" is often used at the end of the automated dialysis treatment, which remains in the peritoneal cavity of the patient when the patient disconnects from the dialysis machine for the day. Automated peritoneal dialysis frees the patient from having to manually performing the drain, dwell, and fill steps. Automated dialysis can improve the patient's dialysis treatment and undoubtedly improves the patient's quality of life.
So-called "continuous flow" peritoneal dialysis ("CFPD") systems that purport to provide continuous dialysate flow exist. However, these systems typically have a single pass fluid flow. That is, the dialysate flows into, through, and out of the peritoneal cavity one time before being sent to a drain. The "spent" dialysate (waste laden dialysate) from the patient collects in a drain bag, which is discarded, or runs into a household drain or other drain. Known CFPD systems, therefore, typically use a volume of disalysate one time and then discard it. That is, the systems have no ability to regenerate or reuse a quantity of dialysate. The effectiveness of existing peritoneal dialysis therapies, and existing systems which perform the therapies, depends upon the amount of dialysis fluid used. For example, typical peritoneal dialysis therapy requires about 4 to 6 exchanges of dialysate (drain, fill, dwell) with about 2 to 3 liters of dialysate for each exchange. Peritoneal dialysis is a daily therapy performed 7 days per week. As a consequence, 240 to 540 liters of fresh dialysate must be delivered to and stored at a patient's home each month. Increasing dialysate dosage to increase therapy effectiveness will necessitate even more dialysate.
Therefore, needs exist to provide improved dialysis systems and methods of performing dialysis. Particularly, needs exist to provide closed loop peritoneal dialysis systems and methods that regenerate or reuse spent dialysate. There are needs for such systems and methods to be compatible with CFPD treatment so that patients can perform the procedure at home without the need for storing an inordinate amount of fresh dialysate bags. There are further needs for such systems and methods to be automated so that the procedure can be largely performed at night while the patient sleeps.
SUMMARY OF THE INVENTION
Generally, the present invention provides improved dialysis systems and improved methods of performing dialysis. More particularly, the present invention provides systems and methods for continuous flow dialysis ("CFD") and regenerative dialysis, and in combination, continuous flow regenerative dialysis ("CFRD"). This invention also includes improved systems and methods for performing hemodialysis.
The dialysis system of the present invention automatically performs dialysis therapy on a patient, for example, during nighttime while the patient sleeps. The present invention automatically regenerates spent dialysate into fresh dialysate that is reintroduced into the patient to be used again for dialysis treatment. Further, the dialysis system provides continuous fluid flow simultaneously to and from the patient.
To this end, in one embodiment of the present invention a system for providing dialysis is provided. The system includes a patient fluid loop having a first pump and multiple patient lumens. The system includes a second fluid loop including a second pump and a medical fluid regenerator. A membrane device is placed in fluid contact with and separates the patient and the second fluid loops. The membrane device allows at least one selected component of the fluid in the patient fluid loop to transfer to the second fluid loop. The second loop is otherwise closed except for the transfer of the selected component via the membrane device. A controller is also provided that operates the first and second pumps to recirculate fluid in the patient loop and the second loop.
The system is adaptable to be used with various different types of components and to be arranged in a variety of ways.
For example, in an embodiment, the membrane device is a dialyzer.
In an embodiment, a pressure gradient exists across the membrane device. In an embodiment, the patient loop is also closed except for the transfer of the selected component via the membrane device and the venting of air/gas.
In an embodiment, the membrane device includes a nanofilter which allows urea to pass from the patient fluid loop to the second fluid loop.
In an embodiment, the medical fluid regenerator includes a uremic toxin sorbent.
In an embodiment, the medical fluid regenerator can include any or all of the following materials: urease, zirconium phosphate, zirconium oxide, and carbon.
In an embodiment, the system includes a gas separator that removes gas from one or both of the patient and second fluid loops. In an embodiment, the gas separator and the medical fluid regenerator are provided in a single device.
In an embodiment, the system includes a gas vent that vents gases from the patient and second fluid loops.
In an embodiment, the second fluid loop includes a multi-analyte sensor that monitors a concentration of electrolytes in the medical fluid.
In an embodiment, peritoneal dialysis fluid is circulated through the patient fluid loop.
In an embodiment, blood is circulated through the patient fluid loop.
In an embodiment, at least parts of the patient fluid loop and the second fluid loop are provided in a disposable device.
In an embodiment, the second fluid loop includes a balance chamber that balances flow within the second fluid loop. In an embodiment, the controller enables fluid to flow in opposite directions through the multiple patient.
In an embodiment, the system includes a dual lumen catheter that defines the multiple patient lumens. In an embodiment, one or both of the patient fluid loop and the second fluid loop includes an in-line fluid heater.
In an embodiment, the in-line fluid heater includes a radiant heater and a plate heater.
In an embodiment, the system includes a medical fluid sensor which senses one or more indicators including: ammonia, ammonium and pH.
In an embodiment, the system includes a fluid volume sensor in or both of the patient and second fluid loops.
In an embodiment, the fluid volume sensor includes a capacitance fluid volume sensor that uses a chamber in fluid communication with one or both of the fluid loops. In an embodiment, the chamber is a pump chamber.
In an embodiment, the system includes an ultrafiltrate container in fluid communication with at least one of the patient and second fluid loops.
In an embodiment, the system includes a fluid concentrate container in fluid communication with one or both of the patient and second fluid loops. The system as described herein uses, in one embodiment, a disposable dialysis cassette. The cassette includes a flexible membrane covering a patient pump chamber and a regeneration pump chamber. The cassette includes an apparatus for fluidly connecting the patient pump chamber to a closed loop patient fluid path. The cassette further includes an apparatus for fluidly connecting the regeneration pump chamber to a closed loop regeneration fluid path. The patient path and the regeneration path each fluidly communicates with a dialyzer.
The cassette is adaptable to be used with various different types of components and to be arranged in a variety of ways.
For example, in an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate sorbent cartridge.
In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a gas separator. In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysis concentrate container.
In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate last bag. In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a dialysate bag.
In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a drain container.
In an embodiment, the disposable cassette defines a fluid path leading to a port that fluidly communicates with a patient fluid connector.
Further, the disposable cassette can define a fluid path for a twenty-four hour collection and/or a remote analyte sensor.
The disposable cassette operates with a dialysis therapy device. The therapy device includes a housing having a portion that receives the disposable cassette. The housing houses a patient pump actuator that pumps fluid through a patient path defined at least in part by the disposable cassette. The housing also houses a regeneration pump actuator that pumps fluid through a regeneration path defined at least in part by the disposable cassette.
The dialysis therapy device is also adaptable to be used with various different types of components and to be arranged in a variety of ways.
For example, in an embodiment, the dialysis therapy device includes at least one fluid volume measurement sensor component that cooperates with the patient pump actuator and the regeneration pump actuator.
In an embodiment, the housing houses a fluid heater. In an embodiment, the housing houses at least one sensor, such as an ammonia sensor, an ammonium sensor and a pH sensor.
In an embodiment, the housing houses at least one valve actuator that operates with the disposable cassette.
The present invention includes a plurality of different methods for operating the systems and apparatuses described herein. In one embodiment, a method is provided for moving fluid in a dialysis system. The method includes continuously recirculating a first fluid through a patient loop. The method includes continuously recirculating a second fluid through a regeneration loop. At least one waste component is simultaneously transferred from the patient loop to the regeneration loop through a device shared by both loops. The loops are otherwise closed except for the fluid transfer through the device. The method also includes removing the at least one waste component from the regeneration loop. The first and second fluids can both include dialysate. Alternatively, the first fluid includes blood and the second fluid includes dialysate.
In an embodiment, the method includes flowing the second fluid in the regeneration loop through a waste sorbent and absorbing at least some of the waste component. In an embodiment, the method includes the step of heating the at least one of the first and second fluids.
In an embodiment, the method includes the step of removing ultrafiltrate from at least one of the first and second fluids.
In an embodiment, the method includes the step of adding dialysate to at least one of the first and second fluids.
In an embodiment, the method includes the step of adding concentrate to at least one of the first and second fluids.
In an embodiment, the method includes the step of removing gas from at least one of the first and second fluids. In an embodiment, the method includes the step of balancing the flow of fluid in at least one of the patient loop and the regeneration loop.
In an embodiment, the method includes the step of sensing a volume of flow of fluid in at least one of the patient loop and the regeneration loop.
In an embodiment of any of the methods described herein, recirculating dialysate fluid through the patient loop includes passing the fluid through a portion of a patient.
In an embodiment, the method is for continuous flow peritoneal dialysis and includes passing the dialysate fluid and the regeneration fluid past opposite sides of a dialyzer membrane and regenerating the regeneration fluid after the regeneration fluid exits the dialyzer.
In an embodiment of the continuous flow peritoneal dialysis method, recirculating dialysate fluid through the closed patient loop includes passing the fluid through a sleeping patient. In an embodiment of the continuous flow peritoneal dialysis method, recirculating dialysate fluid through the closed patient loop includes passing the fluid through a patient at nighttime.
In another embodiment, a method of moving fluid in a peritoneal dialysis system is provided. The peritoneal dialysis method, includes the steps of: (i) continuously recirculating dialysate through a container in a patient loop; (ii) continuously recirculating dialysate through the container in a regeneration loop; and (iii) continuously moving at least one waste component from the patient loop to the regeneration loop through the container shared by both loops, the loops being closed except for said transfer through said container.
In an embodiment, the peritoneal dialysis method includes the step of recirculating dialysate through the regeneration loop at a different rate than a rate at which dialysate is recirculated through the patient loop.
In a further method of the present invention, performing continuous flow dialysis includes multiple dialysis disciplines. The method includes performing continuous flow peritoneal dialysis with a closed loop dialysis device at a first point in time and performing continuous flow hemodialysis via the same closed loop dialysis device at a second point in time.
In an embodiment, the continuous flow peritoneal dialysis and the continuous flow hemodialysis are performed on the same patient.
In an embodiment, the method includes an intermediate step of removing a disposable cassette used with the device and coupling a new disposable cassette to the device.
In an embodiment, the method includes an intermediate step of removing a dual lumen peritoneal dialysis catheter and replacing the catheter with a hemodialysis needle.
In an embodiment, the method includes an intermediate step of removing a hemodialysis needle and replacing the needle with a dual lumen peritoneal dialysis catheter. One advantage of the present invention is to provide improved systems and methods for performing .dialysis.
Another advantage of the present invention is to provide improved systems and methods for performing automated continuous flow dialysis systems and methods. A further advantage of the present invention is to provide regenerative dialysis systems and methods of operating same.
Still another advantage of the present invention is to provide a regenerative dialysis system that has clinical advantages. Still a further advantage of the present invention is to provide a regenerative dialysis system that has economic advantages.
Yet another advantage of the present invention is to provide a regenerative dialysis system that has quality of life advantages.
Still further, an advantage of the present invention is to provide a regenerative dialysis system that reduces the amount of dialysis fluid need to perform dialysis.
Another advantage of the present invention is to provide a closed loop dialysis system.
Other advantages of the present invention are to provide systems and methods for performing both peritoneal dialysis and hemodialysis. Additional features and advantages of the present invention are described in, and will be apparent from, the following Detailed Description of the Invention and the figures.
BRIEF DESCRIPTION OF THE FIGURES
Fig. 1 schematically illustrates an embodiment of a dialysis system according to the principles of the present invention.
Fig. 2 shows a multi-lumen patient fluid connector according to the principles of the present invention.
Fig. 3 schematically illustrates another embodiment of a dialysis system according to the principles of the present invention.
Fig. 4 schematically illustrates a further embodiment of a dialysis system according to the principles of the present invention.
Fig. 5 illustrates an embodiment of a disposable cassette according to the present invention. Fig. 6 illustrates another embodiment of a disposable cassette according to the present invention. Fig. 7 illustrates a disposable cassette of the present invention connected to various fluid containers.
Fig. 8 schematically illustrates yet another embodiment of a dialysis system according to the principles of the present invention.
Fig. 9 schematically illustrates an embodiment of a dialysis system according to the principles of the present invention that provides hemodialysis.
Fig. 10 illustrates a combination container providing various components used in the dialysis systems of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
Generally, the present invention relates to dialysis systems and methods of performing dialysis. In an embodiment, the present invention pertains to continuous flow regeneration peritoneal dialysis systems and methods. In other embodiments the present invention pertains to non-continuous flow regeneration peritoneal dialysis, and regeneration hemodialysis, both continuous and non-continuous flow.
The dialysis system automatically performs dialysis therapy on a patient, for example during nighttime while the patient sleeps. The present invention can provide true continuous flow dialysis therapy (fluid simultaneously flowing into and out of the patient), and automatically regenerate spent dialysate into fresh dialysate that is again used for the dialysis treatment. Continuous flow of dialysate tends to increase the efficacy of treatment by maximizing or maintaining a maximum osmotic gradient across the peritoneal membrane. Regeneration of dialysate by the present invention significantly reduces the amount of dialysate required for a treatment. For example, the amount of dialysate fluid can be reduced from about fifty liters for CFPD therapy if performed by an existing cycler to about six to eight liters of same for therapy with the present invention.
In a peritoneal dialysis embodiment of the present invention, the spent dialysate from the patient's peritoneal cavity passes through a regeneration unit and is regenerated into a useable dialysate. The regenerated dialysate in a patient fluid loop is returned to the patient's peritoneal cavity to further dialyze the patient. The regeneration unit removes undesirable components in the dialysate that were removed from the patient, for example, excess water (ultrafiltrate or UF), toxins, and metabolic wastes, so that the dialysate can be used for further dialysis. Desirable components can be added to the dialysate by the system, such as glucose and electrolytes, for example. The additives assist in maintaining the proper osmotic gradients in the patient to perform dialysis and provide the necessary compounds to the patient. Continuous flow peritoneal dialysis according to the present invention means that when the patient is being dialyzed (e.g., dialysate is being pumped to and removed from the peritoneal cavity), the dialysate is constantly and simultaneously flowing into and out of the patient. The dialysis system pumps fresh dialysate into the patient's peritoneal cavity while simultaneously pumping spent dialysate out of the peritoneal cavity. Accordingly, the dialysis system can eliminate the dwell period inside the peritoneal cavity that is typical for existing dialysis systems. The flow rate of the continuous dialysate flow can be constant or varied as desired, and is generally about 100-300 ml/min.
The dialysis system of the present invention can be controlled to provide various dialysis therapies, as desired. Accordingly, even though the dialysis system can provide continuous flow, the present invention also supports non-continuous flow or batch systems and methods. Also, the continuous flow into and out of the peritoneal cavity occurs during the main therapy treatment, so that a dwell during a last bag, for example, does not detract from the continuous flow feature. Furthermore, the fluid pumping mechanisms of the present invention may provide for brief intermittent fluid flow, such as the filling of a pump chamber, for example. The continuous fluid flow of the present invention is considered to include such brief intermittent fluid flow.
The dialysis systems and methods of the present invention provide advantages compared to other dialysis systems and therapies, such as clinical advantages, economic advantages, and quality of life advantages, for example. It is believed that the present invention has clinical advantages, such as, improved blood pressure ("BP") control, improved hematocrit ("HCT") control, improved fluid volume control, improved preservation of residual renal function ("RRF"), improved adequacy vs. the National Kidney Foundation's DOQI standard, higher efficiency (clearances / time), lower glucose absorption, glucose profiling and ultrafiltrate management, and reduced catheter channeling.
It is also believed that the present invention has economic advantages, such as, reduced therapy cost and reduced Epogen ("EPO") usage. Further, it is believed that present invention has quality of life advantages, such as, increased awake time free from dialysis devices, improved patient access, reduced complexity, reduced self- administration of drugs, reduced therapy training, elimination of the need for having a home water infrastructure, a reduced amount of fluid that the patient must handle and manage, simpler prescriptions and elimination of patient transportation to dialysis centers.
The dialysis systems and methods of the present invention more closely simulate and replace continuous kidney functioning as compared to intermittent dialysis therapies. This, in turn, can contribute to improved clinical outcomes (RRF, HCT, BP, for example) while minimally impacting the patient's lifestyle. The efficiency and convenience of the present invention provides patients with a renal replacement therapy that is relatively unrestrictive. This allows patients to have greater freedom from limitations experienced by dialysis devices and therapies. The present invention can provide easier entrance into early dialysis therapy because the system can enable the physician to retain a patient's RRF while minimally impacting the patient's lifestyle.
Dual Loop System Referring now to the drawings and in particular to Fig. 1, a system 10 for providing dialysis treatment to a patient needing same is illustrated. As illustrated in Fig. 1, two loops are provided: a patient loop (a recirculating patient fluid flow path) 12 and a regeneration loop 14 (a recirculating dialysate fluid flow path). However, it should be noted that the present invention can be used in a system including only one loop or more than two loops. The patient loop 12 is used to dialyze the patient 16 with dialysate in a peritoneal dialysis embodiment. The regeneration loop 14 also contains dialysate and is used to regenerate the dialysate in the patient loop 12. In a hemodialysis embodiment, the patient loop 12 carries the patient's blood, and the regeneration loop 14 dialyzes the blood and regenerates the dialysate in the loop 14.
As illustrated generally in Fig. 1, the patient loop 12 and the regeneration loop 14 are initially filled or primed with dialysate fluid from a bag 18 by pumping the dialysate through a pump, such as an ultrafiltrate pump 19. Fig. 1 shows a single dialysate bag 18 for both the patient and regeneration loops 12 and 14; however, separate dialysate bags and/or fluid pumps could be individually used for the patient loop 12 and the regeneration loop 14. In a hemodialysis embodiment, the patient loop 12 can be primed with a suitable priming solution, such as a saline solution, and then connected to the patient's blood circulatory system.
The patient loop 12 is fluidly connected to the patient 16 by a multi-lumen patient fluid connector 20 and catheter. Referring to Figs. 1 and 2, the multi-lumen patient fluid connector 20 can have, for example, a single housing 70 having more than one separate lumen 72 (to patient lumen) and 74 (from patient lumen), or separate housings each having one of the lumens 72 and 74. In a peritoneal dialysis embodiment, the multi-lumen patient fluid connector 20 can be connected to a dual lumen catheter 22 (illustrated in Fig.l), such as a catheter disclosed in co-pending U.S. patent application serial number 09/689,508, titled "Peritoneal Dialysis Catheters," incoφorated by reference or other multi-fluid path patient access.
The dual lumen catheter 22 is implanted in the patient 16 and provides fluid flow access to the patient's peritoneal cavity. Two separate lumens 72 and 74 of the multi-lumen patient connector 20 are fluidly connected to separate lumens (not illustrated) of the dual lumen catheter 22. Fluid in the patient loop 12 can continuously flow through the patient fluid connector 20 simultaneously and continuously in multiple directions, e.g. two different directions, into and out of the catheter 22 and the patient 16. The multi-lumen patient fluid connector 20 is described in further detail below in Fig. 2. In a continuous flow embodiment, the patient loop 12 can be fluidly connected to the patient by any device or devices that provides for fluid to simultaneously flow into and out of the patient. For example, the patient loop 12 can be connected to the dual lumen catheter to two single lumen catheters.
In Fig. 1, the patient loop 12 has a patient fluid pump 24 that pumps fluid through the patient loop 12. The fluid in the patient loop 12 is pumped from the patient 16 (the patient's peritoneal cavity in a peritoneal dialysis embodiment) through the patient fluid connector 20, through a dialyzer 26, back through the patient fluid connector 20, and is returned to the patient 16. In a peritoneal dialysis embodiment, the spent dialysate (laden with waste and excess water) in the patient loop 12 exiting from the patient 16 is cleansed or regenerated by passing through the dialyzer 26. The waste, such as urea, creatinine and excess water passes from the patient loop 12 across a dialyzer membrane 28 to the regeneration loop 14 to produce fresh dialysate exiting the dialyzer in the patient loop 12. The fresh dialysate is returned to the patient 16 for further dialysis treatment. In an embodiment, the fluid in the patient loop 12 is continuously recirculated through the patient loop 12 by the patient pump 24. Also, the dialyzer 26 provides a sterile independent barrier between the patient loop 12 and the regeneration loop 14. Existing dialyzers used for dialysis is therapy are suitable for use with the present invention, for example. Also, the membrane 28 referred to in the dialyzer 26 includes any suitable filter material, such as hollow dialyzer fibers.
In a hemodialysis embodiment, the patient loop 12 is connected to the patient's blood circuit rather than the peritoneal cavity. The patient pump 24 continuously recirculates the blood, as the dialyzer 26 removes waste and excess from the blood. The regeneration loop 14 removes the waste and excess water from the patient loop 12. In the embodiment illustrated in Fig. 1, a fluid pump 30, pumps dialysate fluid in the regeneration loop 14 continuously to recirculate the dialysate through the loop 14. The dialysate fluid pump 30 pumps the dialysate from the dialyzer 26, through a sorbent cartridge 32, and back to the dialyzer 26. The fluid in the regeneration loop 14 flows past a side of the dialyzer membrane 28 opposite the side of the membrane 28 having the fluid in the patient loop 12. In an embodiment, the regeneration loop 14 provides for balanced fluid flow through the dialyzer 26, for example, by providing equal flow dialysate fluid pumps 30, and/or balance chambers.
As mentioned above, waste and excess water passes from the fluid in the patient loop 12, across the dialyzer membrane 28, to the fluid in the regeneration loop 14. The transfer across the dialyzer membrane 28 occurs at least in part due to diffusion and concentration gradients across the membrane 28. Also, the system 10 in an embodiment maintains a lower fluid pressure in the regeneration loop 14 relative to the patient loop 12. That is, there is a transmembrane pressure ("TMP") across the dialyzer membrane 28. The fluid pressure differential draws fluid from the patient loop 12, across the dialyzer membrane 28, to the regeneration loop 14. This fluid pressure differential can be maintained by removing fluid from the regeneration loop 14, for instance, by using the ultrafiltrate pump 19 to drain some of the fluid in the regeneration loop 14. The amount or rate of fluid removed from the regeneration loop 14 by the ultrafiltrate pump 19 determines the amount or rate of fluid transferring from the patient loop 12, across the dialyzer membrane 28, to the regeneration loop 14. This amount or rate equals the amount or rate of fluid removed from the patient 16 to the patient loop 12. A sorbent cartridge or container 32 includes materials that absorb particular compounds from the dialysate. For example, certain sorbents within the sorbent cartridge 32 may absorb uremic toxins, such as urea, creatinine, uric acid, and other metabolism by-products. By removing these undesirable waste materials, the sorbent cartridge 32 at least partially regenerates the dialysate. The sorbent cartridge 32 includes a body having a fluid inlet 34 and a fluid outlet 36. One sorbent cartridge 32 according to the invention contains four layers of materials, including a first layer of urease, a second layer of zirconium phosphate, a third layer of zirconium oxide and a fourth layer of carbon. The interior of the cartridge 32 is constructed and arranged so that the fluid entering the interior from the inlet 34 flows (preferably upward and uniformly) through the first layer, the second layer, the third layer, the fourth layer and finally through the outlet 36.
The sorbent cartridge 32 can also use materials that selectively remove certain solutes from the dialysate. The selective materials can include a binder or reactive sorbent material capable of selectively removing urea, a binder or reactive sorbent material capable of selectively removing phosphate and/or the like. The use of materials capable of selective removal of solutes, particularly urea, enhances the cleaning efficiency of the system of the present invention such that the amount of dialysate necessary for effective treatment can be minimized. The materials that can selectively remove solutes from solution, such as binder materials, can include a variety of suitable and different materials including, for example, polymeric materials that are capable of removing nitrogen-containing compounds, such as urea, creatinine, other like metabolic waste and/or the like in solution. In general, these types of materials contain a functional group(s) that chemically binds with urea or other like solutes.
For example, U.S. Patent Nos. 3,933,753 and 4,012,317, each incorporated herein by reference, disclose alkenylaromatic polymers containing phenylglyoxal that can function to chemically bind urea. In general, the phenylglyoxal polymeric material is made via acetylation performed in, for example, nitrobenzene followed by halogenation of the acetyl group and treatment with dimethylsulfoxide as disclosed in U.S. Patent Nos. 3,933,753 and 4,012,317. Another example of a polymeric material that is capable of selectively removing solutes, such as urea, from solution includes polymeric materials that contain a tricarbonyl functionality commonly known as ninhydrin as disclosed in U.S. Patent No. 4,897,200, incorporated herein by reference. However, it should be appreciated that the present invention can include any suitable type of material or combinations thereof to selectively remove solutes, such as urea, from solution as previously discussed. In addition to absorbing certain materials from the dialysate, the sorbent cartridge 32 may also modify the dialysate in the regeneration loop 14 in other ways. For example, the materials in the sorbent cartridge 32 mentioned above or additional materials added to the cartridge 32 may modify the pH of the fluid passing through the cartridge 32. In an embodiment, the pH of the dialysate in the regeneration loop 14 is modified as needed to maintain a physiologic level. One sorbent cartridge 32 is described in further detail in a U.S. patent application titled "Method and Composition for Removing Uremic Toxins in Dialysis Processes," Serial Number 09/990,673, incorporated herein by reference.
The sorbent cartridge 32 can also include a number of components in addition to the sorbent materials capable of removing solutes from the dialysate. For example, the cleaning cartridge may have the capability to remove all or a portion of electrolytes, such as sodium, potassium, or the like, from the dialysate solution. In this case, an additional source of electrolytes in solution may be needed to replenish the dialysate after it has been cleaned. The cartridge may also be configured to release bicarbonate or the like into the system depending on the type of sorbent material used. This can facilitate pH regulation of the dialysate. As necessary, the cartridge may be filtered to prevent proteins, particulate matter or like constituents from leaching or exiting from the cartridge and into the dialysate.
Ultrafiltrate (excess water) removed from the patient 16 can be removed from the dialysis system 10 by draining the ultrafiltrate to a drain bag 38 or other drain means. In one embodiment, the ultrafiltrate pump 19 removes fluid from the regeneration loop 14 at the exit end of the dialyzer 26 through valves 40 and 42 to the drain bag 38, wherein the fluid contains the waste and excess water removed from the patient loop 12 by the dialyzer 26. The drain pump 19 can remove fluid from the regeneration loop 14 continuously or intermittently (e.g., batch operation), as desired. The dialysis solution in the regeneration loop 14 is removed from the system along with the ultrafiltrate. Accordingly, a dialysate concentrate is provided in a concentrate container 44 to supply necessary compounds to the regeneration loop 14. The concentrate from the container 44 mixes with the dialysate in the regeneration loop 14 and adds the compounds to the dialysate. The concentrate in an embodiment also includes other components that are provided to the patient 16, for example, electrolytes. A concentrate pump 46 and a valve 48 are provided to selectively pump the concentrate from the concentrate container 44 to the regeneration loop 14. The concentrate contributes to the regeneration of the dialysis solution in the regeneration loop 14.
Although the fluids in both the patient loop 12 and the regeneration loop 14 are, in an embodiment, recirculated continuously through their respective loops, the various fluid pumps can be controlled by a computer, processor, or microprocessor, collectively referred to herein as a "controller" (not illustrated), to pump their respective fluids intermittently, if desired.
The dialysis system 10 in an embodiment is a closed, sterile system. Air, moisture and fluids from the environment around the dialysis system 10 cannot enter into the patient loop 12 or the regeneration loop 14. The dialysis system 10 does permit fluids (such as ultrafiltrate) and air to exit the fluid loops 12, 14 and fluids (such as concentrate) to be added to the fluid loops 12, 14 under controlled circumstances. The dialysis system 10 is designed to prevent uncontrolled contact of the patient and the regeneration loops 12 and 14 with the surrounding environment. Fig. 1 schematically shows an example of an gas separator 50 in the dialysis system 10. The term "gas" is used herein to include gasses in general, including air, carbon dioxide ("CO2") and any other type of gas that can become entrained in fluid loops 12 and 14. The regeneration fluid loops 12 and 14 can accumulate air for various reasons. For example, the fluid loops 12 and 14 may contain air prior to priming the system 10 with fluid or the storage containers may introduce air into the fluid loops 12 and 14. The sorbent cartridge 32 may produce CO2 and introduce the CO2 gas into the loops 12 and 14. The patient 16 can also produce certain gasses, which become entrained in the dialysate and enter the loops 12 and 14.
It is desirable to remove gas from the fluid loops 12 and 14. The gas separator 50 removes entrained gas from the fluid in the regeneration loop 14 and vents the gas to outside of the dialysis system 10. In this manner, gas is purged from the regeneration loop 14. The gas separator 50 includes a one-way vent, i.e., it permits gas to vent from the fluid loops 12 and 14 to the atmosphere but prevents gas outside of the fluid loops 12 and 14 from entering into the loops.
In one embodiment illustrated in Fig. 3, the gas separator 50 and the sorbent cartridge 32 of Fig. 1 are combined into a single device 102. One example of an gas separator 50/sorbant cartridge 32 combination is shown in the patent 'application titled "Method and Composition for Removing Uremic Toxins in Dialysis Processes," Serial Number 09/990,673, mentioned above. As illustrated in Fig. 1, however, the gas separator 50 can be a separate system component or incoφorated into system components other than the sorbent cartridge 32. It is also desirable to purge gas from the patient loop .12. In an embodiment, an additional gas separator (not illustrated) can be provided in the patient loop 12, which vents to the atmosphere. In another embodiment, the gas can be removed from the patient loop 12, fed to the gas separator 50 in the regeneration loop 14, e.g., via line 51, and vented to the atmosphere. In an embodiment, one or more gas sensor(s) 52 are provided at desired locations along the patient loop and/or the regeneration loop 14 to detect gas in the system 10. In an embodiment, gas sensors 52 electrically connect or are otherwise in communication with the system controller, which monitors gas content in the loops 12 and 14. The controller can control the system to perform any desired function in response to the gas, such as, stopping fluid flow, changing the direction of fluid flow, or removing the gas. The gas separator 50 can be any suitable device, which separates gas from fluid known to those of skill in the art. Gas separators, such as the separator 50, can be used which separate and vent the gas without being controlled by the system controller. In an embodiment, the gas separator 50 absorbs the gas rather than venting it to the atmosphere as illustrated.
In an embodiment, the dialysis system 10 contains a fluid heater 54, shown schematically in Fig. 1. The fluid heater 54 heats the fluid in the patient loop 12 to a desired temperature for supplying the fluid to the patient 16. The fluid heater 54 is an in-line heater (continuous flow heater) that heats the fluid to the desired temperature as the fluid flows continuously past the heater 54. In other embodiments, heaters other than in-line heaters can be used, for example, bulk heaters. The fluid heater 54 is shown in Fig. 1 in the patient loop 12 at the fluid supply to the patient 16. However, the fluid heater 54 can be positioned at other locations in the patient loop 12 and the regeneration loop 14, if desired. In another embodiment, one or both of the loops 12 and 14 include one or multiple heaters 54.
In an embodiment, the fluid heater 54 is a dual heater, including an infrared heater 56 and a plate heater 58. An example of such a dual heater 54 is disclosed in a patent application entitled, "Medical Fluid Heater Using Radiant Energy," Serial Number 10/051,609, incoφorated herein by reference. Both the infrared heater 56 and the plate heater 58 are in-line heaters that heat the medical fluid that flows continuously past the heaters 56, 58. The radiant energy or infrared heater 56 emits infrared energy that is directed to and absorbed by the fluid in the patient loop 12, thereby heating the fluid. The radiant energy or infrared heater 56 is a primary or high capacity heater which can heat a relatively large volume of cold fluid to a desired temperature in a short period of time.
The plate heater 58 is a secondary or maintenance heater which has a relatively lower heating capacity relative to the infrared heater 56. The plate heater 58 uses electrical resistance to increase the temperature of a plate that in turn heats the fluid flowing near the plate.
The heater 54, which includes both high and low capacity heaters, provides an efficient heater design that accommodates various fluid heating requirements. For example, the radiant or infrared heater 56 is particularly useful for quickly heating cool dialysate (high heat energy demand) that is supplied to the dialysis system 10, such as at the initial system fill or if there is severe heat loss during dialysis treatment. The temperature of the dialysate at initial system fill can be quite low, such as 5°C to 10°C if the fluid is stored in cold ambient temperature.
Tb.e plate heater 58 is particularly useful to maintain a desired temperature (lower heat energy demand) of the fluid being supplied to the patient, e.g., due to a normal amount of heat loss during dialysis treatment. The infrared heater 56 provides for the high heat demand in a small amount of fluid exposure space, while the plate heater 58 provides for maintenance heat demand and requires a lesser amount of input energy compared to the infrared or radiant heater 56. Furthermore, the heating capacity of the heater 54 is increased if both the infrared and plate heaters 56 and 58 are used together to heat the fluid.
The infrared heater 56 and the plate heater 58 can be arranged in various configurations relative to each other. The heaters 56 and 58 in an embodiment are arranged so that the fluid passes by the heaters sequentially (e.g., first the radiant or infrared heater and then the plate heater). In another embodiment, the fluid passes by the heaters simultaneously (both heaters at the same time) or in the reverse order. The fluid flow path past the heaters 56 and 58 can be a common flow path for both heaters 56 and 58 or include independent flow paths for each heater 56 and 58. Besides radiant or infrared electrical resistance heating, other types of heating such as convective, inductive, microwave and radio frequency ("RF") heating may be used.
In an embodiment, temperature sensors are provided at desired locations along one or both of the patient loop 12 and the regeneration loop 14. The temperature sensors monitor various fluid temperatures and are connected to the system controller to control the fluid temperatures with the heater 54. When two or more heaters, such as the infrared heater 56 and the plate heater 58, are provided in the dialysis system 10, the system 10, in an embodiment, can include separate temperature sensors for each heater so that each heater can be controlled individually. The dialysis system 10 in an embodiment also includes various other sensors to monitor various parameters. For example, fluid pressure sensors 60 and 62 are provided in the patient loop 12 of Fig. 1. The fluid pressure sensors 60 and 62 electrically couple to or otherwise communicate with the controller to provide a signal that indicates the respective fluid pressure at that location. Based on the signals from the pressure sensors 60 and 62, the controller operates the fluid pumps and valves to obtain and maintain desired fluid pressures in the loop 12 running to and from the patient 16.
In an embodiment, the pressure sensors 60 and 62 are non-invasive pressure sensors. That is, the pressure sensors 60 and 62 do not physically contact (and possibly contaminate) the medical fluid or dialysate. The pressure sensors 60 and 62 measure the medical fluid pressure and help to maintain a steady flow within the closed fluid system. Of course, other fluid devices, such as flow rate sensors, pressure gauges, flowmeters, or pressure regulators, which are not illustrated Fig. 1, may be provided in any suitable quantity and at any desired location within either or both of the patient loop 12 and the regeneration loop 14.
In the illustrated embodiment, the system 10 includes an ammonia sensor 64. The ammonia sensor 64 measures the concentration of ammonia (NH3) and/or ammonium (NH4) in the fluid. Ammonia and ammonium are produced by the regeneration sorbent cartridge 32 as a by-product of the urea catalysis urease. The ammonia and ammonium are normally removed by a cation exchanger in the sorbent cartridge 32. However, the dialysis system 10 monitors the fluid for ammoma/ammonium concentrations with the sensor 64 to confirm that the ammonia and ammonium are being removed and remain below safe threshold levels for the patient 16. The total ammonia and ammonium in solution is primarily determined by three parameters: ammonia or ammonium, pH, and solution temperature. By measuring these parameters (or adjusting a parameter, such as adjusting the pH to a desired level), the total amount of ammonia and/or ammonium in the dialysate can be determined.
One sensor 64 according to the present invention is described in a patent application entitled, "Ammonia and Ammonium Sensors," Serial Number 10/024,170, incoφorated herein by reference. The sensor 64 determines the total ammonia and ammonium content of an aqueous solution. The sensor 64 includes a hydrophobic ammonia sensing membrane, a pH indicator or conditioner, a temperature sensor and an optical sensor. An algorithm stored in the controller calculates the combined ammonia and ammonium content from the three parameters (e.g., NH3, pH and temperature). The ammonia gas, which is highly soluble in water, is quantified by the hydrophobic sensing membrane that changes color based on the quantity of ammonia gas diffused into it. A multi-wavelength optical sensor continuously measures the membrane color through a transparent window. The sensor 64 achieves a non- intrusive measurement by the using the optical sensor to monitor color changes in the disposable membrane placed inside the fluid path.
In the illustrated embodiment of Fig. 1, the dialysis system 10 also includes one or more fluid flow measurement devices or volume sensors 66 that measure the volume of the medical fluid pumped either intermittently or cumulatively through one or both of the loops 12 and 14. In an embodiment, the fluid flow measurement device 66 measures the amount of fluid supplied to the patient 16 by the patient loop 12. Additionally or alternatively, the regeneration loop 14 and/or the ultrafiltrate drain line employ one or more fluid flow measurement devices 66 to measure the amount of ultrafiltrate removed from the patient 16. Various types of fluid volume measurement or flowrate devices can be used with the dialysis system 10, such as orifice plates, mass flow meters or other flow measuring devices known to those of skill in the art. Fig. 1 schematically illustrates one embodiment of a flow measurement device or volume sensing device 66, which includes a capacitance sensor that measures the volume of fluid pumped through a chamber, such as a pump chamber (dotted lines designating the device 66 shown encircling the pumps 19, 24 and 30). The capacitive fluid sensor 66 is disclosed in greater detail in the patent application entitled, "Capacitance Fluid Volume Measurement," Serial Number 10/054,487, incoφorated herein by reference.
The capacitance C between two capacitor plates changes according to the function C = k x (S / d), wherein k is the dielectric constant, S is the surface area of the individual plates and d is the distance between the plates. The capacitance between the plates changes proportionally according to the function 1 / (R x V), wherein R is a known resistance and V is the voltage measured across the capacitor plates.
In one embodiment of the capacitance sensor 66, the sensor cooperates with the pump chamber. The pump chamber in an embodiment includes shells or walls defining a fixed and known volume and a pair of flexible membranes operating between the shells, which expand to fill with fluid and contract to discharge fluid. The capacitance sensor 66 includes capacitor plates disposed on opposite sides of the pump chamber. As the volume of fluid in the chamber or fluid pump changes (i.e., the pump chamber fills or empties), the dielectric property of the varying fluids between the capacitance plates changes. For example, the combined dielectric constant of dialysate and air changes as dialysate replaces air (or air replaces dialysate) within shells of the constant volume chamber. This change in the overall dielectric constant affects a change in the capacitance between the two plates, which causes a change in voltage across the capacitance plates, wherein the change in voltage can be sensed by a voltage sensing device. The controller monitors the change in voltage by the voltage sensing device and correlates (after a calibration of the sensor) the capacitance change to an amount of fluid pumped through the chamber.
In another embodiment, the volume of the chamber or the pump chamber can vary, e.g., by movement of one or both the shells of the chamber. In this embodiment, the capacitance between the capacitor plates changes due to a changing distance d between the plates and/or a changing surface area S of one or more of the plates, wherein the dielectric constant k is static because only one fluid resides at all times between the capacitor plates. In a further alternative embodiment of the measurement device 66, the capacitance C between the capacitor plates changes based on any combination or all three of a change in dielectric constant k, distance d and surface area S.
The controller collects a multitude of voltage signals from capacitance changes from sensor 66 due to a plurality of chamber fill and drain cycles, wherein the controller calculates a total volume of medical fluid pumped over a length of time or number of pump cycles. The capacitance sensor 66 monitors the medical fluid, e.g., dialysate, flow into or from the pump chamber on a real time basis, and in a non- invasive manner. The capacitance sensor 66 enables the dialysis system 10 to maintain the volume of fluid that is provided to the patient 16 at desirable amounts and flow rates. Maintaining the fluid flow to the patient 16 within desired levels is particularly advantageous for peritoneal dialysis therapies.
Also, it is desirable to maintain the fluid provided to the patient at physiologic levels. Physiologic control, such as sensing and/or adjusting parameters of the fluids, can take place at various locations in the dialysis system 10, including the patient loop 12 and the regeneration loop 14. For example, as mentioned above, the sorbent cartridge 32 may include a pH sensor that adjusts the fluid in the regeneration loop 14, which then adjusts the fluid in the patient loop 12 via the dialyzer to be at a desired physiologic level.
Dual Lumen Connector Referring now to Fig. 2, one embodiment of a dual lumen patient fluid connector 20 of the present invention is described in further detail. As described above, the dual lumen connector 20 includes a housing 70 having. a lumen 72 for providing fluid to the patient lumen and a separate lumen 74 to remove fluid from the patient. Separate housings each having one of the lumens 12 and 74 may be provided. The patient inflow lumen 72 connects to a patient inflow tube 76 of the patient loop 12. Similarly, the patient outflow lumen 74 connects to a patient outflow tube 78 of the patient loop 12. A removable end cap 80 is provided to seal a cavity 82 defined by the housing 70. The cavity 82 surrounds or abuts the lumens 72 and 74 and provides a connection area for the dual lumen catheter 22 (Fig. 1) to insert into the cavity 82 and mate with the lumens 72 and 74. The housing 70, lumens 72 and 74 and the end cap 80, in an embodiment, are made of any material suitable for medical applications, such as plastic for example. In an embodiment, one of the lumens, e.g., the patient inflow lumen 72 extends further into the cavity 82 than the other lumen, which helps facilitate mating of the connector 20 to the catheter 22. In another embodiment both lumens 72 and 74 extend into the cavity 82 the same or different distance.
The dialysis system 10, particularly the patient loop 12, can be primed, e.g., filled, with the end cap 80 in sealing engagement with the housing 70. The arrows 84 and 86 figuratively illustrate the recirculating fluid flow through the dual lumen connector 20. The system 10 can therefore run without a fluid connection to the patient. Also, the system 10 may include a patient by-pass line between the patient inflow and outflow tubes 76, 78 to allow fluid flow through the patient loop 12 while by-passing the patient 16. The end cap 80 is removed, e.g., pulled off or unscrewed, to expose the cavity 82 and the patient inflow and outflow lumens 72 and 74, respectively, for connection to the dual lumen catheter 22.
In an alternative embodiment, the patient fluid loop 12 directly connects to the dual lumen catheter 22 or to two separate single lumen catheters. In a further alternative embodiment, the connector 20 is adapted to connect to two separate single lumen catheters. In yet another alternative embodiment, two separate connectors link single lumen catheters to incoming and outgoing lines of the patient fluid loop 12. Other configurations are also contemplated by the present invention.
Alternative Dual Loop System With Balanced Flow Referring now to Fig. 3, a system 100 for providing dialysis treatment to a patient is illustrated. The system 100 of Fig. 3 includes many of the same components as the system 10 of Fig. 1. For example, the system 100 includes two loops, a patient loop 12 and a regeneration loop 14. The patient loop 12 passes a medical fluid, dialysate or blood, to and from a patient 16. In a peritoneal dialysis embodiment, the patient loop 12 and regeneration loop 14 are initially filled and primed with dialysate from a dialysate bag 18. The patient loop 12 fluidly connects to the patient 16 by the multi-lumen patient fluid connector 20 described above in connection with Fig. 2. In a peritoneal dialysis embodiment, the multi-lumen connector 20 connects to a dual lumen catheter 22. In a hemodialysis embodiment, the patient loop 12 fluidly connects to a multi-lumen hemodialysis needle or other patient blood access device.
The system 100 includes multiple patient fluid pumps 24a and 24b. It has been found that using multiple pumps, such as the patient fluid pumps 24a and 24b, creates a steadier flow of fluid to and from the patient 16 within the patient loop 12. For example, fluid may be exiting the fluid pump 24a while the fluid pump 24b is filling with fluid. Balance chambers can be provided, in an embodiment, to balance fluid flow.
The system 100 includes the dialyzer 26 having the dialyzer membrane 28. The spent dialysate (or blood in a hemodialysis embodiment) laden with waste and excess water in the patient fluid loop 12 is cleaned or regenerated when recirculated through the dialyzer 26. The waste passes from the patient loop 12 across the dialyzer membrane 28 to the regeneration loop 14. In the regeneration loop 14, the fluid pumps 30, 30 continuously pump the regenerating dialysate through the combination device 102, which includes the absorbent cartridge 32 and the gas separator 50. The system 100 includes dual dialysate fluid pumps 30 to provide balanced flow within the regeneration loop 14. That is, one of the fluid pumps 30 is being emptied of fluid while the other pump 30 is being filled with fluid. In an embodiment, balance chambers can be provided for balancing fluid flow. The system 100 can drain ultrafiltrate and other fluids into the drain bag 38.
An ultrafiltrate pump 19 pumps the ultrafiltrate and fluids from the patient loop 12 or the regeneration loop 14, for example through valves 40 and 42, into the drain 38. The system 100 also provides the ability to collect fluid in a twenty-four hour collection bag 39 for evaluation of the dialysis therapy. In an embodiment, one of the patient fluid pumps 24a or 24b pulls dialysate fluid from either the dialysate bag or container 18 or the last bag 21. The last bag 21 includes a volume of fluid that is placed in the patient's peritoneal cavity just prior to the end of the dialysis treatment. The patient with the dialysate from the last bag 21 in the peritoneal cavity disconnects from the system 100 and is able to perform daily activities. The next dialysis therapy begins with draining the last bag from the patient. The system 100 includes a concentrate container 44, a concentrate pump 46 and valves 48. The concentrate pump 46 provides concentrate from the concentrate container 44 to the regeneration loop 14, for example into the fluid line exiting from the outlet 36 of the combination absorbent cartridge and vent 102. The concentrate container 44 supplies necessary compounds, such as electrolytes and osmotic agents, to the regeneration loop 14 of the system 100 to maintain the desired concentrations of those components. Besides the concentrate that is contained in the concentrate container 44, the system 100 regenerates dialysate through the regeneration loop 14 and does not require fluids from an outside source. Hence the system 100, as are each of the systems described herein, is completely closed to the outside. The systems of the present invention are thus "closed loop systems". The closed loop nature of the patient loop 12 and the regeneration loop 14 enables the loops to run continuously without absorbing or gathering outside contaminants. The closed loop systems of the present invention also maintain sterility by preventing contamination from the environment.
The system 100, like the system 10, may generate gases over time, such as air and CO2. The system 100 provides a plurality of gas sensors 52 that detect the various gases that may be in the system 100. hi the system 100, the gas sensors 52 are provided at an air separator which separates gas from the fluid in the patient loop 12. A gas separation line 51 feeds the separated gas from the patient loop 12 to the inlet side 34 of the combination absorbent cartridge and gas separator device 102. The gas is then purged out of the system 100 by the gas separator 50. The gas separator 50 maintains the closed loop structure of the system 100 by preventing contaminants from entering the system 100. For example, the gas separator 50 can include a microbial filter which allows gas to exit the system 100, but prevents contaminants from entering the system 100. In another embodiment, the gas from the patient loop 12 may be purged from the system 100 by a separate gas purge device at the patient loop 12. The gas sensors 52, in an embodiment, can send an electronic signal to the controller (not illustrated). When the controller detects gas, the controller causes one or more valves to open, wherein the gas from the loop 12 is fed to a one-way vent and purged from the system 100.
The system 100 further includes the inline heater 54, which, in an embodiment, includes an infrared or radiant heater 56 and a plate heater 58 as described above. In an embodiment, the heater 54 has an air separator which allows air to exit port 59 on be purged from the system. The system 100 further includes an orifice device 61 that stabilizes the differential pressure in the dialyzer 26 across the membrane 28. That is, the orifice device 61 can restrict the flow in the patient loop 12 to create a pressure differential between the patient side and regeneration side of the dialyzer 26. The pressure gradient or differential occurs across the membrane 28 in which the patient loop 12 having a higher fluid pressure than the regeneration loop 14. The orifice device can be a fixed or variable flow restriction and can provide a fixed or variable pressure differential. Also, the orifice device 61 can be electrically coupled to and operated by the controller, which can activate, e.g., open or close the orifice device as necessary. The pressure differential across the membrane 28 (higher pressure in the patient loop 12 and lower pressure in the regeneration loop 14) created by the orifice 61 assists in maintaining a greater pressure in the regeneration loop 14 relative to atmosphere pressure external to the system 100. The positive pressure in the regeneration loop 14 relative to the external atmosphere pressure aids in ensuring that external air is not pulled from the surrounding environment through the air vent 50 into the regeneration loop 14, i.e., air can only exit the system 100 and not enter into the system 100. Accordingly, the orifice 61 contributes to the closed loop nature of the system 100.
The system 100 provides a number of temperature sensors, such as sensors 63, 65 and 67, which monitor temperatures at various points within the patient loop 12. The controller uses the sensed temperatures to maintain a desired temperature within the patient loop 12. As illustrated, the temperature sensor 63 is located at or on the heater 54, which enables the system 100 to sense a temperature at a point very close to the constituent heaters 56 and 58, and to control the heaters 56, 58. The system 100 further includes one or more pressure sensors 60 and 62, which reside at various points along the patient fluid loop 12. The pressure sensors 60 and 62 can be used to prevent excessive positive or negative pressures from being applied to the patient. The pressure within the system can be controlled by, e.g., activation of the patient fluid pumps 24a, 24b. The system 100 also monitors the absorbent cartridge 32 with an ammonia/ammonium sensor. Sample fluid exiting the absorbent cartridge 32 can be directed through a pH adjuster 71 to force the ammonia/ammonium equilibrium balance to a particular level. The amount of ammonia and/or ammonium in the sample fluid is measured by a sensor 73. Accordingly, the effectiveness of the cartridge 32 to remove ammonia/ammonium after conversion from urea can be monitored. When the concentration of ammonia and/or ammonium reaches a threshold level, the system can produce a signal, or take other action such as shutting down, that indicates the cartridge 32 needs to be replaced.
Of course, the system 100 can monitor other fluid parameters and take appropriate action, as desired. Also, sample fluid can be taken at any desired location in the system 100. Further, fluids in the patient and regeneration loops 12, 14 can be tested or monitored directly rather than taking samples. The system 100 also includes fluid volume sensors 66 which in an embodiment are capacitance sensors that sense a change in capacitance occurring between two capacitor plates. The capacitor plates surround the pumps 24 of the patient loop 12, the pumps 30 of the regeneration loop 14 and the pumps leading to the fluid containers. Each of the pumps 24a, 24b, pump 30, pump 19 and pump 46 can be provided with the capacitance volume sensor 66 of the present invention. Each of the sensors 66 sends a discrete signal to the controller (not illustrated), which measures and monitors the volume of fluid flowing through the pump chambers of the respective pumps. In other embodiments, any suitable fluid volume measurement device can be used.
Alternative Dual Loop System With Gas Separation Referring now to Fig. 4, a system 110 of the present invention is illustrated. The system 110 of Fig. 4 is similar to the system 100 of the Fig. 3 and is a closed loop system. The system 110 includes various components of the system 100 described previously. The system 110 has a regeneration loop 14 which has a pair of balanced dialysate fluid pumps created by a pair of chambers 75 that operate with the pumps 30. Each balance chamber 75 includes a pair of chambers separated by a membrane. When one of the pumps 30 fills one side of the chambers of the balance chambers 75 fills with medical fluid, the membrane is forced toward the other chamber, which forces fluid out of that chamber. In this way, the membrane acts to balance the flow of the dialysate fluid within the regeneration loop 14, so that there is no net flow of fluid across the dialyzer membrane except for the flow needed to replace the fluid removed by the ultrafiltrate pump 19. Another difference of the system 110 of Fig. 4 compared to the system 100 of Fig. 3 is the gas separator 50. The gas separator 50 in the illustrated embodiment of the system 110 is independent of the sorbent cartridge 32. The gas separator 50 accepts gas through a vent line 51 that runs from the exit port 59 of the heater 54 in the patient fluid loop 12. One or more gas sensors 52 monitor gas in the vent line 51 as illustrated.
Disposable Cassettes Referring now to Fig. 5, a dialysis system having a disposable cassette 120 according to the present invention is illustrated. In this variation of the system 100 of Fig. 3, the pumps 30 of system 120 draw fluid from accumulators A4 and A6 and discharge into accumulators A3 and A5. Accumulators A3 to A6 smoothen the dialysate flow by dampening pressure fluctuations during pumping. In an embodiment, much of the flow logic and at least parts of the flow devices described above are provided in the disposable cassette 120. The cassette 120, in an embodiment, has a rigid plastic body 122 with various fluid flow channels and fluid chambers defined in the body 122. A flexible membrane is bonded to the front side of the cassette body 122 shown in Fig. 5. The membrane covers the fluid channels and chambers and is sealed to the body 122 around the channels and chambers. Accordingly, the membrane forms a wall of the fluid flow paths and fluid chambers. Similarly, the back side of the cassette body 122 may also be covered with a membrane.
The body 122, in an embodiment, is approximately 12 inches high, eight inches wide, and one inch deep. The flow components and flow lines defined by the body 122 fluidly connect to other system components. Also, pump actuators, valve actuators, sensors and other system components may interface with the cassette 120.
Specifically, the body 122 provides a portion of the closed patient the regeneration loops 12 and 14. The dual lumen catheter 22 that inserts into the peritoneal cavity of the patient 16 connects to the dual lumen connector 20 outside of the body 122 of the disposable cassette 120. The patient loop 12 extends from an exit port 124 of the dialyzer 26 to a valve chamber 126 defined by the body 122. The patient fluid loop 12 includes a series of manifolds and fluid flow paths that fluidly connect to the patient fluid ρump(s) 24. The patient fluid pump 24 pumps the dialysate through the patient 16 and into an inlet 128 of the dialyzer 26.
The patient fluid loop 12 also connects via pathways defined by the body 122 of the disposable cassette 120 to various medical fluid bags. For instance, the dialysate fluid bag 18, which is maintained outside of the disposable cassette 120, fluidly connects to a line 130 leading to the patient fluid loop 12. Similarly, the last bag 21 also connects via a line defined by the body 122 to the line 130 that fluidly communicates with the patient fluid loop 12. The line 130 defined by the body 122 also fluidly communicates with the ultrafiltrate drain 38. The body 122 of the disposable cassette 120 also defines chambers for the concentrate pump 46 and the ultrafiltrate pump 19. The concentrate pump 46 fluidly connects to an external concentrate bag 44. The twenty-four hour collection bag 39 described above fluidly connects along with the drain 38 to a fluid line defined by the body 122 that runs to the ultrafiltrate pump 19. The disposable cassette 120 provides fluid flow paths and defines chambers and other types of fluid orifices for the fluid flow components described above. Specifically, the body 122 of the disposable cassette 120 defines a patient fluid pump chamber 24 and dialysate fluid pump chambers 30. The disposable cassette 120 mounts to a separate non-disposable housing that includes the mechanical workings of the flow components, such as the pumps. The pump chambers are bounded on one side by a flexible membrane (not illustrated) that is positioned adjacent to and driven by the pump plungers of the non-disposable housing.
At least one side of the cassette 120 is covered with the flexible, e.g., plastic membrane (not illustrated). The disposable cassette 120 plugs into a cavity or portion of the non-disposable housing (not illustrated). The housing provides the actuators for each of the pumps herein described, e.g., the patient pumps 24, the dialysate pumps 30, the ultrafiltrate pump 19 and the concentrate pump 46. The housing also provides the actuators for the various valve chambers defined by the body 122 of the cassette 120, e.g., valve chamber 126. The more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators and valve actuators, are kept and reused in the housing.
The disposable cassette 120 provides sterile, disposable fluid pathways, such as the pump chambers and the valve chambers. The actuators of the non-disposable housing press against the flexible plastic membrane at the pump chambers and valve chambers to force or allow fluid through the system. When the pump actuator pulls back from pressing against the membrane, the membrane returns to its normal shape and no longer exerts a force on the fluid within the pump chamber. The pump chamber fills with fluid as the membrane is drawn back. Also, the membrane can be positively drawn back by, for example, the pump actuator or vacuum pressure. The pump has thus made a cycle.
The body 122 of the disposable cassette 120 also defines at least a portion of a mounting area for housing the ammonia, ammonium or pH sensors or adjusters. In the illustrated embodiment, the disposable cassette 120 defines an area for housing the pH adjuster 71 and a disposable colormetric membrane (which changes color based on the arnmonia/ammonium concentration) of the ammonia/ammonium sensor 73, wherein the fluid within the body 122 of the cassette 120 can fluidly communicate with the sensor. The optical color reader of the ammonia/ammonium sensor 64 is disposed in the non-disposable housing (not illustrated), wherein the sensor can receive electrical power as needed. If a pH sensor is used instead of the pH adjuster 71, a reusable portion of the pH sensor can also be located in the housing.
The housing also provides the in-line heater 54 and in an embodiment provides one of either the radiant heater 56 and the plate heater 58, which is described in detail in the patent application entitled, "Medical Fluid Heater Using Radiant Energy," Serial Number 10/051,609, mentioned above. Further, the housing provides one of the capacitor plates of the fluid volume sensor 66 beneath one or more of the pump actuators, as described in detail in the patent application entitled, "Capacitance Fluid Volume Measurement," Serial Number 10/054,487, mention above. Referring back to the cassette 120 of Fig. 5, the cassette 120 has an in-line heating fluid heating path 123 for heating the fluid. The fluid in the heating path 123 is heated by a heater external to the cassette.
The cassette 120 also has one or more gas separators 125 which separate gas from fluid in the cassette 120. The gas separators 125 feed the separated gas through a line 127 to a vent 129.
The closed loop system of the present invention enables at least one waste component to pass through the membrane 28 of the dialyzer 26 from the patient fluid loop 12 to the regeneration loop 14. The patient loop 12 extending outside of the body 122 fluidly connects to a valve chamber 132 defined by the body 122. The regeneration loop 14 includes manifold sections defined by the body 122 and leads to pump chambers 30. The closed loop system prevents air or other fluids from entering the system. The pump chambers 30 fluidly communicate with the sorbent chemical cartridge 32 and the gas separator 50 of the combined device 102. The regeneration loop 14 extends from the outlet 36 of the combined device 102 and returns to the body 122 of the disposable cassette 120 through the valve chamber 134. From the valve chamber 134, the regenerated dialysate is pumped through the pump chambers 30 and into the manifold system defined by the body 122.
Referring now to Fig. 6, another closed loop system having another disposable cassette 140 is illustrated. This embodiment of the disposable cassette 140 of the present invention includes many of the same flow components and flow chambers as the cassette 120 of Fig. 5. The cassette 140, however, only includes a single regeneration pump body 30. The cassette 140 in general, is less complicated than the cassette 120 and illustrates that the disposable cassettes of the present invention may be adapted for different embodiments of the closed loop dialysate regeneration systems described herein.
Like the cassette 120 of Fig. 5, at least one side of the cassette 140 is covered with a flexible, e.g., plastic membrane (not illustrated). The disposable cassette 140 plugs into a non-disposable housing (not illustrated) that provides the actuators for the various pumps, e.g., the patient pump 24, the dialysate pump 30, the ultrafiltrate pump 19 and the concentrate pump 46. The housing also provides the actuators for the various valve chambers defined by the body 122 of the cassette 140. The more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators, are again kept and reused in the housing. As described above, the actuators press against the flexible plastic membrane at the pump chambers to force fluid through the system.
As illustrated in both Figs. 5 and 6, the disposable cassette 120 or 140, in combination with certain external devices such as the dialyzer 26, sorbent cartridge and gas separator device 102 and the fill and drain bags, provides completely closed loop systems. The only make-up or additional fluid that the regeneration system uses is that of the concentrate from the concentrate bag 44, which seals to a device within the body 122 of the cassettes 120 and 140. Also, other than the systems being connected to a patient, fluids and air cannot enter the closed loop system.
Referring now to Fig. 7, a schematic diagram illustrates the different physical components of a disposable set of the regeneration systems of the present invention. The disposable set is intended to be used for a single dialysis therapy and then discarded. Another disposable set is used for the next dialysis therapy. Each of the above-described systems 10, 100 and 110 in an embodiment includes a disposable cassette, such as the cassette 120 or 140. The disposable cassette 120 or 140 provides a port 141 that connects to the concentrate bag 44 via a line 147. The cassette provides a port 142 that fluidly connects to the drain bag 38 via a line 148. The cassette provides a port 143 that fluidly connects to the last bag 21 via a line 149. The cassette defines a port 144 that fluidly connects to the dialysate bag 18 via a line 150. The cassette provides ports 145 and 146 that run to and from the dual lumen connector 20 via patient lines 151 and 152, respectively. In an embodiment, each of the lines 147 to 152 are made of medical grade tubing, such as a flexible, sterile and inert plastic such as polyethylene, polystyrene, polypropylene or polyvinylchloride ("PVC"). In an embodiment, the bags and the lines are clear so that the patient or operator can see fluids traveling from the bags and through the lines to a cassette 120 or 140. The lines 147 to 152 connect to the ports 141 to 146 via any type of medical fluid connection known to those of skill in the art. In an embodiment, the connections are quick-type connections that enable the patient or operator to easily remove the line from its mating port.
The disposable cassette 120 or 140 includes at least one port 153 that fluidly connects to at least one outlet port 154 of the gas separator 50 or combination device 102. The disposable cassette 120 or 140 includes at least one port 155 that fluidly connects to at least one inlet port 156 of the sorbent cartridge 32 or combination device 102. The lines connecting the disposable cassette 120 or 140 to the sorbent cartridge 32, gas separator 50 or combination device 102 including same are made of medical grade tubing, such as a flexible, sterile and inert plastic such as polyethylene, polystyrene, polypropylene or polyvinyl chloride.
Alternative Dual Loop System Referring now to Fig. 8, an alternative closed loop regenerative system 160 is illustrated. The system 160 is shown schematically, however, the system 160 may employ the disposable set described above such as the disposable cassette, the fluid pumps, the various sensors, valves and controller. The system 160 includes a patient fluid loop 12 and a regeneration loop 14.
When dialysate is removed from the peritoneal cavity of the patient 16, the solution passes through an activated charcoal and anion exchanger 162. The activated charcoal of the filter or exchanger 162 removes uric acid, creatinine, small molecular weight organics and middle molecules. The anion exchange column of the exchanger 162 removes phosphate. The solution exiting the filter or exchanger 162 enters a solution or dialysate bag 18. The dialysate entering the solution bag 18 has two possible places to exit. One possibility includes exiting the solution bag 18 from a port 163, entering a filter 166 and returning to the peritoneal cavity of the patient 16. Another possibility includes exiting the solution bag 18 at a port 165 and entering a nanofilter 164. The system 160 splits the dialysate fluid exiting the solution bag or container 18.
The nanofilter 164 operates similar to the dialyzer 26 described above. The nanofilter 164 includes a membrane. The membrane of the nanofilter 164 rejects most electrolytes, i.e., allows most of the electrolytes to return to the solution bag. The nanofilter 164, however, filters most all of the urea and a small amount of sodium through the membrane and into a sorbent system cartridge 32, which is similar to the sorbent cartridges described above. The sorbent cartridge 32 as described above absorbs and the urea from the fluid that is able to permeate through the membrane of the nanofilter 164. A plurality of pumps (not illustrated) are provided to individually circulate medical fluid or dialysate through the patient loop 12 and the regeneration loop 14. The pump or pumps that control the recirculation through the regeneration loop 14 are adapted to circulate the regenerating fluid at a different flow rate, i.e., much faster, than the flow rate of fluid pumped through the patient loop 12. It is believed that by using this method, the need for a concentration bag such as the concentration bags 44 described above would not be needed. Thus, it should be appreciated that the system 160 is a closed loop system that does not require any sort of make-up materials or any continuous source of outside fluid. The system 160 is therefore very adept at keeping air and other contaminants from entering the system.
In an alternative embodiment, the a reverse osmosis membrane or an electrooxidation system replaces the sorbent cartridge 32. In this alternative embodiment, a reconstitution or concentration bag, such as the concentration bag 44, is likely to be necessary.
The regeneration loop 14 removes urea at a rate of approximately 50 to 80%. The dialysate returns to the peritoneal cavity of the patient 16 substantially free from uric acid, creatinine, small molecular weight organics and middle molecules. Further, the nanofilter 164 can reject calcium magnesium at a rate of approximately 98% and glucose at a rate of approximately 80%. The permeate stream exiting the nanofilter 164 includes urea, approximately 70% sodium chloride and approximately 20% glucose. It should be appreciated that the system 160 is useful for performing continuous flow peritoneal dialysis.
Dual Loop System for Hemodialysis Referring now to Fig. 9, a system 170 is illustrated. Each of the previous systems 10, 100 and 110 of Figs. 1, 3 and 4, respectively, can be used for peritoneal dialysis or hemodialysis. However, each of the systems described above has been primarily described and illustrated using peritoneal dialysis, that is, the patient loop has been illustrated using a dialysis solution. The system 170 illustrates that the dual lumen catheter or two single lumen catheters can be replaced by a hemodialysis needle 171, which connects to the arm (or other suitable portion) of the patient 16 to withdraw blood through the hemodialysis needle 171. The system 170 illustrates that the patient's blood flows through the patient loop 12 while dialysate flows through the regeneration loop 14. The patient's blood flows along one side of the membrane 28 of the dialyzer 26, while the dialysate flows along the outside or other side of the membrane 28 of the dialyzer 26. The waste components and ultrafiltrate transfer from the patient's blood in the patient loop 12, through the membrane 28, into the dialysate in the regeneration loop 14.
The system 170 includes a fixed volume recirculating regeneration loop 14 that dialyzes the patient fluid loop 12. A single pump 172 operates to remove the ultrafiltrate from the patient 16 to the ultrafiltrate container 38. The pump 172 adds dialysis fluid from the dialysis bag 18 or concentrate from the concentrate bag 44 to the regeneration loop 14. In an alternative embodiment, the concentrate can be metered into the dialysate of the regeneration loop 14 as a solid prior to or during therapy. As an alternative to the capacitance volume sensing described above, the volume of dialysate fluid flowing through the regeneration loop 14 can be determined using an electronic balance 174 illustrated below the dialysate bags. The electronic balance 174 keeps track of the amount of dialysate that is supplied to the system during a priming of the system. The electronic balance 174 also monitors any additional dialysate added to the patient loop 12 during dialysis treatment. The electronic balance 174 measures the amount of ultrafiltrate that is withdrawn from the system and the amount of the concentrate that is added from the concentrate bag 44. In other alternative embodiments, any of the systems described herein can be sensed using other types of flowmeters or devices employing Boyle's Law known to those of skill in the art.
The system 170 removes ultrafiltrate by opening a valve chamber and transferring a known volume of the fluid into the ultrafiltrate bag 38. The removal of fluid creates a pressure differential across the membrane 28 of the dialyzer 26, which causes fluid to filter through the dialyzer membrane 28 and into the regeneration circuit 14. Sterile dialysate from a supply bag 18 is infused into the patient circuit 12 as required. Concentrate from the concentrate bag 44 can also be infused into the regenerating circuit 14 as needed. Pressure sensors 176 monitor and control the rate at which the system 170 draws ultrafiltrate into the container 38.
Gas sensors 52 are used to prevent air from being delivered to the patientlό. In an embodiment, a multi-analyte sensor 178 is employed to monitor the concentration of electrolytes in the regenerated dialysate as well as the efficiency of the regeneration system in removing uremic toxins. The output of the multi-analyte sensor 178 controls the rate of reconstitution from the concentrate bag 44, the efficiency of the regeneration system and can detect the presence of a leak in the dialyzer. A vent 180 vents air that becomes trapped in the system or CO2 that is generated by the absorbent cartridge 32. In an alternative embodiment, an automated valve that is provided integrally with the adsorbent cartridge 32 replaces the mechanical vent 180. Although the system 170 is illustrated as a hemodialysis system, the system 170 is easily converted to a peritoneal dialysis system by placing the catheter into the patient's peritoneal cavity and by running dialysate through the patient loop 12 as opposed to the patient's blood. The ultrafiltrate bag 38, the dialysate container 18 and the concentrate container 44 each fluidly connect to the regeneration loop 14 and the patient circuit is kept relatively simple. The system 170 is especially conducive for continuous flow of peritoneal dialysis, however, standard APD and TIDAL therapies could be performed in the system 170.
Multi-Puφose Container
Referring now to Fig. 10, a combined absorbent cartridge, pump and valve system is placed into a single container, e.g., a canister, cartridge or cassette 190. The combination container 190 is illustrated as housing the components specifically described in the system 170 of Figure 9. However, the combination container 190 is adaptable to house the components of any of the above-described systems, namely, the systems 10, 100 and 110. The canister, cartridge or cassette is adaptable to be made of any material such as plastic or metal. The container 190 includes the adsorbent cartridge 32, which is configured as described above. Alternatively, the container includes the combination device 102 that provides the adsorbent cartridge 32 and the gas separator 50.
The container 190 includes the pumps illustrated in Fig. 9 including the pump 172 that enables dialysate to be drawn from the dialysate bag 18 or concentrate to be drawn from the concentrate bag 44. Additionally, the pump 172 enables ultrafiltrate to be drained into the bag 38. In an embodiment, the container 190 includes the multi- analyte sensor 178 and the gas sensor 52, as described in the system 170 of Fig. 9. The container 190 also includes the mechanical or automated vent 180 described in the system 170. Thus, the only devices external to the container 190 are the dialysate bags and the hemodialysis needle 171 that is inserted in the patient's arm or other extremity to perform hemodialysis. Obviously, by the multi-lumen connector 20 and catheter 22 can replace the needle 171 to perform peritoneal dialysis.
When the container 190 is provided in the form of a disposable cassette, the cassette 190, like the cassettes 120 and 140 of Figs. 5 and 6, is covered on at least one side with a flexible, e.g., plastic membrane (not illustrated). The disposable cassette 190 plugs into a non-disposable housing that provides the actuators for the various pumps, e.g., the patient pumps 24, the dialysate pumps 30, the ultrafiltrate pump 19 and the concentrate pump 46. The more expensive mechanical and electromechanical pieces of the flow components, e.g., the pump actuators, are again kept and reused in the housing. The sorbent cartridge 32 and the gas vent 180 can be disposable.
The above specification has been broken down into headings for proposes of readability, clarification and to promote the enablement of the present invention. The headings are in no way intended to limit the combined teachings of the present invention. The features taught under any given heading are not limited to the embodiments disclosed under the heading. The present invention includes any combination of features from the disclosures under the different headings provided herein. Further, while the presently preferred embodiments have been illustrated and described, numerous changes and modifications can be made without significantly departing from the spirit and scope of this invention. Therefore, the inventors intend that such changes and modifications are covered by the appended claims.

Claims

CLAIMS:The invention is claimed as follows:
1. A system for providing dialysis comprising: a patient fluid loop including a first pump and multiple patient lumens; a second fluid loop including a second pump and a medical fluid regenerator; a membrane device in fluid contact with and separating the patient fluid loop and the second fluid loop, the membrane device allowing at least one selected component of the fluid in the patient fluid loop to transfer to the second fluid loop; the second loop being closed except for the transfer of the selected component via the membrane device; and a controller that operates the first and second pumps to recirculate fluid in the patient loop and the second loop.
2. The dialysis system of Claim 1, wherein the membrane device is a dialyzer.
3. The dialysis system of Claim 1, wherein a pressure gradient exists across the membrane device.
4. The dialysis system of Claim 1, wherein the patient loop is closed except for the transfer of the selected component via the membrane device.
5. The dialysis system of Claim 1, wherein the membrane device includes a nanofilter which allows urea to pass from the patient fluid loop to the second fluid loop.
6. The dialysis system of Claim 1, wherein the medical fluid regenerator includes a uremic toxin sorbent.
7. The dialysis system of Claim 1, wherein the medical fluid regenerator includes at least one of: urease, zirconium phosphate, zircomum oxide, and carbon.
8. The dialysis system of Claim 1, which includes a gas separator that removes gas from at least one of the patient and second fluid loops.
9. The dialysis system of Claim 8, wherein the gas separator and the medical fluid regenerator are provided in a single device.
10. The dialysis system of Claim 1, which includes a gas vent that vents gases from the patient and second fluid loops.
11. The dialysis system of Claim 1, wherein the second fluid loop includes a multi-analyte sensor that monitors a concentration of electrolytes in the medical fluid.
12. The dialysis system of Claim 1, wherein peritoneal dialysis fluid is circulated through the patient fluid loop.
13. The dialysis system of Claim 1, wherein blood is circulated through the patient fluid loop.
14. The dialysis system of Claim 1, wherein at least parts of the patient fluid loop and the second fluid loop are provided in a disposable device.
15. The dialysis system of Claim 1, wherein the second fluid loop includes a balance chamber that balances flow within the second fluid loop.
16. The dialysis system of Claim 1, wherein the controller enables fluid to flow in opposite directions through the multiple patient.
17. The dialysis system of Claim 1, which includes a dual lumen catheter that defines the multiple patient lumens.
18. The dialysis system of Claim 1, wherein at least one of the patient fluid loop and the second fluid loop includes an in-line fluid heater.
19. The dialysis system of Claim 18, wherein the in-line fluid heater includes a radiant heater and a plate heater.
20. The dialysis system of Claim 1, which includes at least one medical fluid sensor that senses at least one indicator selected from the group consisting of: ammonia, ammonium and pH.
21. The dialysis system of Claim 1, which includes a fluid volume sensor in at least one of the patient and second fluid loops.
22. The dialysis system of Claim 21, wherein the fluid volume sensor includes a capacitance fluid volume sensor that uses a chamber in fluid communication with the at least one fluid loop.
23. The dialysis system of Claim 22, wherein the chamber is a pump chamber.
24. The dialysis system of Claim 1 , which includes an ultrafiltrate container in fluid communication with at least one of the patient and second fluid loops.
25. The dialysis system of Claim 1, which includes a fluid concentrate container in fluid communication with at least one of the patient and second fluid loops.
26. The system of Claim 1, wherein the controller operates the first pump continuously to pump fluid into and out of a patient.
27. A disposable dialysis cassette comprising: a flexible membrane covering a patient pump chamber and a regeneration pump chamber; means for fluidly connecting the patient pump chamber to a closed loop patient fluid path; and means for fluidly connecting the regeneration pump chamber to a closed loop regeneration fluid path, wherein the patient path fluidly communicates with the regeneration path via a dialyzer.
28. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a dialysate sorbent cartridge.
29. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a gas separator.
30. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a dialysis concentrate container.
31. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a dialysate last bag.
32. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a dialysate bag.
33. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a drain container.
34. The disposable dialysis cassette of Claim 27, which defines a fluid path that fluidly communicates with a patient fluid connector.
35. A dialysis therapy device for use with a disposable cassette, the device comprising: a housing having a portion that receives the disposable cassette; a patient pump actuator in the housing that pumps fluid through a patient path defined at least in part by the disposable cassette; and a regeneration pump actuator in the housing that pumps fluid through a regeneration path defined at least in part by the disposable cassette.
36. The dialysis therapy device of Claim 35, which includes at least one fluid volume measurement sensor component that cooperates with at least one of the patient pump actuator and the regeneration pump actuator.
37. The dialysis therapy device of Claim 35, wherein the housing houses a fluid heater.
38. The dialysis therapy device of Claim 35, wherein the housing houses at least one sensor selected from the group of: an ammonia sensor, an ammonium sensor and a pH sensor.
39. The dialysis therapy device of Claim 35, wherein the housing houses at least one valve actuator that operates with the disposable cassette.
40. A method of moving fluid in a dialysis system comprising the steps of: continuously recirculating a first fluid through a patient loop; continuously recirculating a second fluid through a regeneration loop; transferring at least one waste component from the patient loop to the regeneration loop through a device shared by both loops, the loops being closed except for said transfer through said device; and removing the at least one waste component from the regeneration loop.
41. The method of Claim 40, wherein the first and second fluids include dialysate.
42. The method of Claim 40, wherein the first fluid includes blood and the second fluid includes dialysate.
43. The method of Claim 40, wherein removing the waste component includes flowing the second fluid in the regeneration loop through a waste sorbent and absorbing at least some of the waste component.
44. The method of Claim 40, which includes the step of heating the at least one of the first and second fluids.
45. The method of Claim 40, which includes the step of removing ultrafiltrate from at least one of the first and second fluids.
46. The method of Claim 40, which includes the step of adding dialysate to at least one of the first and second fluids.
47. The method of Claim 40, which includes the step of adding concentrate to at least one of the first and second fluids.
48. The method of Claim 40, which includes the step of removing gas from at least one of the first and second fluids.
49. The method of Claim 40, which includes the step of balancing the flow of fluid in at least one of the patient loop and the regeneration loop.
50. The method of Claim 40, which includes the step of sensing a volume of flow of fluid in at least one of the patient loop and the regeneration loop.
51. A method of moving fluid in a peritoneal dialysis system comprising the steps of: continuously recirculating dialysate through a container in a patient loop; continuously recirculating dialysate through the container in a regeneration loop; and continuously moving at least one waste component from the patient loop to the regeneration loop through the container shared by both loops, the loops being closed except for the transfer through the container.
52. . The method of Claim 51, which includes the step of recirculating dialysate through the regeneration loop at a different rate than a rate at which dialysate is recirculated through the patient loop.
53. A method of performing continuous flow peritoneal dialysis comprising the steps of: continuously recirculating dialysate fluid through a closed patient loop; continuously recirculating regeneration fluid through a closed regeneration loop; passing the dialysate fluid and the regeneration fluid past opposite sides of a dialyzer membrane; and regenerating the regeneration fluid after the regeneration fluid exits the dialyzer.
54. The method of Claim 53, wherein recirculating dialysate fluid through the closed patient loop includes passing the fluid through a portion of a patient.
55. The method of Claim 53, wherein recirculating dialysate fluid through the closed patient loop includes passing the fluid through a sleeping patient.
56. The method of Claim 53, wherein recirculating dialysate fluid through the closed patient loop includes passing the fluid through a patient at nighttime.
57. A method of performing continuous flow dialysis comprising the steps of: performing continuous flow peritoneal dialysis with a closed loop dialysis device at a first point in time; and performing continuous flow hemodialysis via the same closed loop dialysis device at a second point in time.
58. The method of Claim 57, wherein the continuous flow peritoneal dialysis and the continuous flow hemodialysis are performed on the same patient.
59. The method of Claim 57, which includes an intermediate step of removing a disposable cassette used with the device and coupling a new disposable cassette to the device.
60. The method of Claim 57, which includes an intermediate step of removing a dual lumen peritoneal dialysis catheter and replacing said catheter with a hemodialysis needle.
61. The method of Claim 57, which includes an intermediate step of removing a hemodialysis needle and replacing said needle with a dual lumen peritoneal dialysis catheter.
PCT/US2003/022267 2002-07-19 2003-07-16 Systems and methods for performing peritoneal dialysis WO2004009158A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE60336724T DE60336724D1 (en) 2002-07-19 2003-07-16 SYSTEM FOR PERITONEAL DIALYSIS
AU2003249296A AU2003249296A1 (en) 2002-07-19 2003-07-16 Systems and methods for performing peritoneal dialysis
AT03765630T ATE505223T1 (en) 2002-07-19 2003-07-16 SYSTEM FOR PERITONEAL DIALYSIS
MXPA05000816A MXPA05000816A (en) 2002-07-19 2003-07-16 Systems and methods for performing peritoneal dialysis.
JP2004523474A JP4890761B2 (en) 2002-07-19 2003-07-16 System and method for performing peritoneal dialysis
EP03765630A EP1523350B1 (en) 2002-07-19 2003-07-16 System for performing peritoneal dialysis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39713102P 2002-07-19 2002-07-19
US60/397,131 2002-07-19

Publications (2)

Publication Number Publication Date
WO2004009158A2 true WO2004009158A2 (en) 2004-01-29
WO2004009158A3 WO2004009158A3 (en) 2004-04-08

Family

ID=30771006

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/022267 WO2004009158A2 (en) 2002-07-19 2003-07-16 Systems and methods for performing peritoneal dialysis

Country Status (8)

Country Link
US (9) US7867214B2 (en)
EP (1) EP1523350B1 (en)
JP (4) JP4890761B2 (en)
AT (1) ATE505223T1 (en)
AU (1) AU2003249296A1 (en)
DE (1) DE60336724D1 (en)
MX (1) MXPA05000816A (en)
WO (1) WO2004009158A2 (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028056A2 (en) * 2005-09-02 2007-03-08 Advanced Renal Therapies, Inc. Extracorporeal renal dialysis system
WO2007103411A2 (en) 2006-03-08 2007-09-13 Fresenius Medical Care Holdings, Inc. Wearable kidney
CN100435863C (en) * 2006-01-10 2008-11-26 赵滨宇 One-way hematodialysis circulating device
WO2009006498A2 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Dialysis system having dual patient line connection and prime
US7572922B2 (en) 2003-01-27 2009-08-11 Merck & Co., Inc. Substituted pyrazoles, compositions containing such compounds and methods of use
US7598285B2 (en) 2004-06-04 2009-10-06 Merck & Co., Inc Pyrazole derivatives, compositions containing such compounds and methods of use
US7625938B2 (en) 2004-07-22 2009-12-01 Merck & Co., Inc. Substituted pyrazoles, compositions containing such compounds and methods of use
WO2010024963A1 (en) * 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
US7709658B2 (en) 2005-07-26 2010-05-04 Merck Sharp & Dohme Corp. Process for synthesizing a substituted pyrazole
US8012118B2 (en) 2006-03-08 2011-09-06 Fresenius Medical Care Holdings, Inc. Artificial kidney dialysis system
WO2012095301A3 (en) * 2011-01-10 2012-09-20 Fresenius Medical Care Deutschland Gmbh Dialysis supply system
WO2012050781A3 (en) * 2010-10-12 2012-11-01 Fresenius Medical Care Holdings, Inc. Systems and methods for compensation of compliant behavior in regenerative dialysis systems
CN103857420A (en) * 2011-10-03 2014-06-11 菲斯蒂亚 Dialysis machine including ultrafiltration and backfiltration means
US8777892B2 (en) 2008-11-03 2014-07-15 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9302036B2 (en) 2011-04-29 2016-04-05 Medtronic, Inc. Blood fluid removal system performance monitoring
EP2237814A4 (en) * 2007-11-29 2017-10-11 Fresenius Medical Care Holdings, Inc. System and method for conducting hemodialysis and hemofiltration
US9943633B2 (en) 2009-09-30 2018-04-17 Medtronic Inc. System and method to regulate ultrafiltration
US10076283B2 (en) 2013-11-04 2018-09-18 Medtronic, Inc. Method and device to manage fluid volumes in the body
US10197180B2 (en) 2009-01-12 2019-02-05 Fresenius Medical Care Holdings, Inc. Valve system
US10258731B2 (en) 2007-09-13 2019-04-16 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US10539450B2 (en) 2012-12-24 2020-01-21 Fresenius Medical Care Holdings, Inc. Load suspension and weighing system for a dialysis machine reservoir
US10758662B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
US10758868B2 (en) 2008-10-30 2020-09-01 Fresenius Medical Care Holdings, Inc. Methods and systems for leak detection in a dialysis system
US10817004B2 (en) 2013-11-11 2020-10-27 Fresenius Medical Care Holdings, Inc. Valve system with a pressure sensing displacement member
WO2021041313A1 (en) * 2019-08-30 2021-03-04 Fresenius Medical Care Holdings, Inc. Multi-lumen tube assemblies for medical fluid pumping systems
US10994064B2 (en) 2016-08-10 2021-05-04 Medtronic, Inc. Peritoneal dialysate flow path sensing
US11013843B2 (en) 2016-09-09 2021-05-25 Medtronic, Inc. Peritoneal dialysis fluid testing system
US11071811B2 (en) 2007-09-13 2021-07-27 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
US11169137B2 (en) 2008-10-30 2021-11-09 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US11224841B2 (en) 2007-09-25 2022-01-18 Fresenius Medical Care Holdings, Inc. Integrated disposable component system for use in dialysis systems
US11318248B2 (en) 2007-09-13 2022-05-03 Fresenius Medical Care Holdings, Inc. Methods for heating a reservoir unit in a dialysis system
US11525798B2 (en) 2012-12-21 2022-12-13 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction
US11806456B2 (en) 2018-12-10 2023-11-07 Mozarc Medical Us Llc Precision peritoneal dialysis therapy based on dialysis adequacy measurements
US11806457B2 (en) 2018-11-16 2023-11-07 Mozarc Medical Us Llc Peritoneal dialysis adequacy meaurements
US11883576B2 (en) 2016-08-10 2024-01-30 Mozarc Medical Us Llc Peritoneal dialysis intracycle osmotic agent adjustment

Families Citing this family (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
ATE505223T1 (en) 2002-07-19 2011-04-15 Baxter Int SYSTEM FOR PERITONEAL DIALYSIS
US7776006B2 (en) 2003-11-05 2010-08-17 Baxter International Inc. Medical fluid pumping system having real time volume determination
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
US8038639B2 (en) * 2004-11-04 2011-10-18 Baxter International Inc. Medical fluid system with flexible sheeting disposable unit
US7776210B2 (en) * 2004-06-09 2010-08-17 Renal Solutions, Inc. Dialysis system
EP1850910A1 (en) * 2005-02-07 2007-11-07 Medtronic, Inc. Ion imbalance detector
SE532147C2 (en) * 2005-02-16 2009-11-03 Triomed Ab Portable dialysis system
US7219021B2 (en) * 2005-09-13 2007-05-15 Honeywell International Inc. Multiple wireless sensors for dialysis application
US7871391B2 (en) * 2005-10-21 2011-01-18 Fresenius Medical Care Holdings, Inc. Extracorporeal fluid circuit
US8409864B2 (en) * 2006-01-06 2013-04-02 Renal Solutions, Inc. Ammonia sensor and system for use
US10537671B2 (en) 2006-04-14 2020-01-21 Deka Products Limited Partnership Automated control mechanisms in a hemodialysis apparatus
US7794141B2 (en) 2006-04-14 2010-09-14 Deka Products Limited Partnership Thermal and coductivity sensing systems, devices and methods
US9717834B2 (en) 2011-05-24 2017-08-01 Deka Products Limited Partnership Blood treatment systems and methods
US8226595B2 (en) 2006-05-26 2012-07-24 Baxter International Inc. Automated dialysis system driven by gravity and vacuum
US8631683B2 (en) * 2007-02-06 2014-01-21 Fresenius Medical Care Holdings, Inc. Dialysis systems including non-invasive multi-function sensor systems
US8562834B2 (en) * 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8425471B2 (en) * 2007-02-27 2013-04-23 Deka Products Limited Partnership Reagent supply for a hemodialysis system
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8357298B2 (en) * 2007-02-27 2013-01-22 Deka Products Limited Partnership Hemodialysis systems and methods
US9028691B2 (en) * 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8491184B2 (en) * 2007-02-27 2013-07-23 Deka Products Limited Partnership Sensor apparatus systems, devices and methods
KR101861192B1 (en) 2007-02-27 2018-05-28 데카 프로덕츠 리미티드 파트너쉽 Hemodialysis apparatus and methods
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US8317492B2 (en) 2007-02-27 2012-11-27 Deka Products Limited Partnership Pumping cassette
US8409441B2 (en) 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
JP5079372B2 (en) * 2007-04-09 2012-11-21 日東電工株式会社 Membrane separation method and membrane separation apparatus
US8512553B2 (en) * 2007-07-05 2013-08-20 Baxter International Inc. Extracorporeal dialysis ready peritoneal dialysis machine
US7909795B2 (en) 2007-07-05 2011-03-22 Baxter International Inc. Dialysis system having disposable cassette and interface therefore
DE102007039939B4 (en) * 2007-08-23 2013-03-14 Albutec Gmbh Device for saving diafiltrate
US8040493B2 (en) 2007-10-11 2011-10-18 Fresenius Medical Care Holdings, Inc. Thermal flow meter
US8535522B2 (en) 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
US7892197B2 (en) * 2007-09-19 2011-02-22 Fresenius Medical Care Holdings, Inc. Automatic prime of an extracorporeal blood circuit
MX2010003106A (en) * 2007-09-19 2010-04-09 Fresenius Med Care Hldg Inc Safety vent structure for extracorporeal circuit.
MX2010003105A (en) 2007-09-19 2010-04-09 Fresenius Med Care Hldg Inc Dialysis systems and related components.
US7892332B2 (en) * 2007-10-01 2011-02-22 Baxter International Inc. Dialysis systems having air traps with internal structures to enhance air removal
US20100056975A1 (en) * 2008-08-27 2010-03-04 Deka Products Limited Partnership Blood line connector for a medical infusion device
AU2013209332C1 (en) * 2007-10-24 2015-06-04 Baxter Healthcare Sa Personal hemodialysis system including priming sequence and methods for same
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
US8580112B2 (en) 2007-11-16 2013-11-12 Fresenius Medical Care Holdings, Inc. Dialysis systems and methods
US8889004B2 (en) 2007-11-16 2014-11-18 Fresenius Medical Care Holdings, Inc. Dialysis systems and methods
CN107376045B (en) * 2008-01-18 2020-08-07 弗雷塞尼斯医疗保健控股公司 Removal of carbon dioxide gas from a fluid circuit of a dialysis device
KR102413397B1 (en) 2008-01-23 2022-06-27 데카 프로덕츠 리미티드 파트너쉽 Pump cassette and methods for use in medical treatment system using a plurality of fluid lines
US10195330B2 (en) 2008-01-23 2019-02-05 Deka Products Limited Partnership Medical treatment system and methods using a plurality of fluid lines
US11833281B2 (en) 2008-01-23 2023-12-05 Deka Products Limited Partnership Pump cassette and methods for use in medical treatment system using a plurality of fluid lines
US9101716B2 (en) * 2008-02-01 2015-08-11 Baxter International Inc. Multi-pass dialysis
RU2525205C2 (en) * 2008-06-23 2014-08-10 Темасек Политехник Flow system of dialysis device and portable dialysis device
US9821105B2 (en) * 2008-07-01 2017-11-21 Baxter International Inc. Nanoclay sorbents for dialysis
DE102008031662A1 (en) * 2008-07-04 2010-01-07 Fresenius Medical Care Deutschland Gmbh Device for peritoneal dialysis
US8057679B2 (en) * 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
JP6288903B2 (en) 2008-09-15 2018-03-07 デカ・プロダクツ・リミテッド・パートナーシップ Systems and methods for fluid delivery
US11278653B2 (en) * 2009-01-29 2022-03-22 Baxter International Inc. Method and apparatus for trending automated peritoneal dialysis treatments
US8663463B2 (en) * 2009-02-18 2014-03-04 Fresenius Medical Care Holdings, Inc. Extracorporeal fluid circuit and related components
US20100312174A1 (en) * 2009-06-06 2010-12-09 Hoffman Josef C A Peritoneal Dialysis System
US20100312172A1 (en) * 2009-06-06 2010-12-09 Hoffman Josef C A Method of Peritoneal Dialysis
US8080161B2 (en) 2009-06-11 2011-12-20 Baxter International Inc. Dialysis treatment devices for removing urea
US9526820B2 (en) 2009-08-04 2016-12-27 Fresenius Medical Care Holdings, Inc. Dialysis systems, components, and methods
CA2772629C (en) * 2009-09-08 2018-02-27 Fresenius Medical Care Holdings, Inc. Peritoneal dialysis system
MX2012005088A (en) 2009-10-30 2012-10-03 Deka Products Lp Apparatus and method for detecting disconnection of an intravascular access device.
US9220832B2 (en) 2010-01-07 2015-12-29 Fresenius Medical Care Holdings, Inc. Dialysis systems and methods
US8500994B2 (en) 2010-01-07 2013-08-06 Fresenius Medical Care Holdings, Inc. Dialysis systems and methods
DE102010005745A1 (en) * 2010-01-26 2011-07-28 Fresenius Medical Care Deutschland GmbH, 61352 dialysis machine
US8449686B2 (en) 2010-04-26 2013-05-28 Fresenius Medical Care Holdings, Inc. Methods for cleaning a drain line of a dialysis machine
US20110272352A1 (en) * 2010-05-05 2011-11-10 C-Tech Biomedical, Inc. Membrane electrolyzer and hemodialysis system using the same
DE102010025516A1 (en) 2010-06-29 2011-12-29 Fresenius Medical Care Deutschland Gmbh Medical functional device, process fluid and medical treatment device
EP2591385B1 (en) 2010-07-07 2017-10-11 DEKA Products Limited Partnership Medical treatment system and methods using a plurality of fluid lines
AU2011303906B9 (en) * 2010-09-16 2014-11-13 Gambro Lundia Ab Blood treatment apparatus with flow divider for limiting an electrical current
GB201019228D0 (en) * 2010-11-15 2010-12-29 Corp Dialysis device and method of dialysis
US8506684B2 (en) 2010-12-15 2013-08-13 Fresenius Medical Care Holdings, Inc. Gas release devices for extracorporeal fluid circuits and related methods
US8382711B2 (en) 2010-12-29 2013-02-26 Baxter International Inc. Intravenous pumping air management systems and methods
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
EP2688602B1 (en) 2011-03-23 2019-11-06 NxStage Medical, Inc. Peritoneal dialysis systems, devices, and methods
WO2012127513A1 (en) * 2011-03-24 2012-09-27 Arnaldi E Gaetani Associati S.R.L. Device for management and sampling of dialysis fluids for use with systems of the cgms type (continuous glucose monitoring systems) and the like
US8945936B2 (en) * 2011-04-06 2015-02-03 Fresenius Medical Care Holdings, Inc. Measuring chemical properties of a sample fluid in dialysis systems
AU2012239900B2 (en) * 2011-04-08 2016-11-03 M. Robert Garfield Iii Methods and devices for detecting bowel perforation
US9848778B2 (en) 2011-04-29 2017-12-26 Medtronic, Inc. Method and device to monitor patients with kidney disease
US9456755B2 (en) 2011-04-29 2016-10-04 Medtronic, Inc. Method and device to monitor patients with kidney disease
US9320842B2 (en) * 2011-04-29 2016-04-26 Medtronic, Inc. Multimodal dialysis system
US9333286B2 (en) 2011-05-12 2016-05-10 Fresenius Medical Care Holdings, Inc. Medical tubing installation detection
US8836519B2 (en) 2011-05-12 2014-09-16 Fresenius Medical Care Holdings, Inc. Determining the absence or presence of fluid in a dialysis system
US9999717B2 (en) 2011-05-24 2018-06-19 Deka Products Limited Partnership Systems and methods for detecting vascular access disconnection
CA3078889C (en) 2011-05-24 2022-08-30 Deka Products Limited Partnership Hemodialysis system
US9375524B2 (en) 2011-06-03 2016-06-28 Fresenius Medical Care Holdings, Inc. Method and arrangement for venting gases from a container having a powdered concentrate for use in hemodialysis
MY171156A (en) 2011-06-24 2019-09-27 Richard W C Lo Multi-container systems and uses thereof
DE102011078695A1 (en) 2011-07-05 2013-01-10 Charité - Universitätsmedizin Berlin Dialysis procedure for removing protein-bound toxins from the blood of patients using high-frequency electromagnetic fields
CN103889481B (en) 2011-08-02 2016-03-09 美敦力公司 With the hemodialysis system of flow path with controlled compliance volume
US10857277B2 (en) 2011-08-16 2020-12-08 Medtronic, Inc. Modular hemodialysis system
US9707330B2 (en) 2011-08-22 2017-07-18 Medtronic, Inc. Dual flow sorbent cartridge
US8906240B2 (en) 2011-08-29 2014-12-09 Fresenius Medical Care Holdings, Inc. Early detection of low bicarbonate level
WO2013067359A2 (en) 2011-11-04 2013-05-10 Deka Products Limited Partnership Medical treatment system and methods using a plurality of fluid lines
ES2731659T3 (en) * 2011-11-08 2019-11-18 Temasek Polytechnic Sensor system for the detection of a substance in a dialysate
US8992777B2 (en) 2011-11-18 2015-03-31 Fresenius Medical Care Holdings, Inc. Systems and methods for providing notifications in dialysis systems
US9713668B2 (en) 2012-01-04 2017-07-25 Medtronic, Inc. Multi-staged filtration system for blood fluid removal
WO2013116799A1 (en) * 2012-02-01 2013-08-08 Lumasense Technologies Holding, Inc. System and method for monitoring asset health by dissolved gas measurement
US9165112B2 (en) 2012-02-03 2015-10-20 Fresenius Medical Care Holdings, Inc. Systems and methods for displaying objects at a medical treatment apparatus display screen
DE102012002372B4 (en) * 2012-02-08 2013-11-21 Fresenius Medical Care Deutschland Gmbh Concentrate for a dialysis fluid and dialysis fluid prepared therefrom
DE102012008551B4 (en) * 2012-04-30 2017-09-07 Fresenius Medical Care Deutschland Gmbh Apparatus for carrying out a method for preserving a blood treatment device and method for preserving a blood treatment device
EP2712637B1 (en) * 2012-09-28 2016-10-19 Gambro Lundia AB Extracorporeal blood treatment apparatus and method of setting an extracorporeal blood treatment.
US10905816B2 (en) * 2012-12-10 2021-02-02 Medtronic, Inc. Sodium management system for hemodialysis
US9399090B2 (en) 2012-12-10 2016-07-26 Medtronic, Inc. Potassium loaded ion-exchange material for use in a dialysate regeneration system
US20140158588A1 (en) * 2012-12-10 2014-06-12 Medtronic, Inc. pH AND BUFFER MANAGEMENT SYSTEM FOR HEMODIALYSIS SYSTEMS
DE102013100050A1 (en) * 2013-01-04 2014-07-10 Charité - Universitätsmedizin Berlin Apparatus and method for removing protein-bound toxins from the blood of patients using a high-frequency electromagnetic field and a DC electrostatic field
US9707328B2 (en) 2013-01-09 2017-07-18 Medtronic, Inc. Sorbent cartridge to measure solute concentrations
US11565029B2 (en) 2013-01-09 2023-01-31 Medtronic, Inc. Sorbent cartridge with electrodes
US9713666B2 (en) 2013-01-09 2017-07-25 Medtronic, Inc. Recirculating dialysate fluid circuit for blood measurement
US11154648B2 (en) 2013-01-09 2021-10-26 Medtronic, Inc. Fluid circuits for sorbent cartridge with sensors
US10010663B2 (en) 2013-02-01 2018-07-03 Medtronic, Inc. Fluid circuit for delivery of renal replacement therapies
US9526822B2 (en) 2013-02-01 2016-12-27 Medtronic, Inc. Sodium and buffer source cartridges for use in a modular controlled compliant flow path
EP2950838B1 (en) * 2013-02-01 2020-04-01 Medtronic, Inc. Sorbent cartridge with electrodes
US10850016B2 (en) 2013-02-01 2020-12-01 Medtronic, Inc. Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection
WO2014121159A1 (en) * 2013-02-01 2014-08-07 Medtronic, Inc. Fluid circuits for sorbent cartridges with sensors
EP2950836B1 (en) * 2013-02-01 2019-11-06 Medtronic, Inc. Sorbent cartridge to measure solute concentrations
US9623164B2 (en) 2013-02-01 2017-04-18 Medtronic, Inc. Systems and methods for multifunctional volumetric fluid control
US10543052B2 (en) 2013-02-01 2020-01-28 Medtronic, Inc. Portable dialysis cabinet
US9827361B2 (en) 2013-02-02 2017-11-28 Medtronic, Inc. pH buffer measurement system for hemodialysis systems
US9144640B2 (en) 2013-02-02 2015-09-29 Medtronic, Inc. Sorbent cartridge configurations for improved dialysate regeneration
DE112014001309T5 (en) * 2013-03-13 2016-01-07 Nxstage Medical, Inc. Single pass dialysis in combination with multiple pass albumin dialysis
US20140263062A1 (en) 2013-03-14 2014-09-18 Fresenius Medical Care Holdings, Inc. Universal portable machine for online hemodiafiltration using regenerated dialysate
US9433720B2 (en) * 2013-03-14 2016-09-06 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
KR102123007B1 (en) 2013-03-14 2020-06-17 백스터 인터내셔널 인코포레이티드 System and method for peritoneal dialysis exchanges having reusable energizing unit
GB201305757D0 (en) * 2013-03-28 2013-05-15 Quanta Fluid Solutions Ltd Disposable Cartridge System for use with Sorbent
US9433721B2 (en) 2013-06-25 2016-09-06 Fresenius Medical Care Holdings, Inc. Vial spiking assemblies and related methods
US10004839B2 (en) 2013-11-26 2018-06-26 Medtronic, Inc. Multi-use sorbent cartridge
US9943780B2 (en) 2013-11-26 2018-04-17 Medtronic, Inc. Module for in-line recharging of sorbent materials with optional bypass
US10537875B2 (en) 2013-11-26 2020-01-21 Medtronic, Inc. Precision recharging of sorbent materials using patient and session data
US10052612B2 (en) 2013-11-26 2018-08-21 Medtronic, Inc. Zirconium phosphate recharging method and apparatus
US9895477B2 (en) 2013-11-26 2018-02-20 Medtronic, Inc. Detachable module for recharging sorbent materials with optional bypass
US9884145B2 (en) 2013-11-26 2018-02-06 Medtronic, Inc. Parallel modules for in-line recharging of sorbents using alternate duty cycles
CN105992552B (en) 2013-11-27 2019-06-18 美敦力公司 Accurate dialysis monitoring and synchronization system
DE102014104396A1 (en) * 2014-03-28 2015-10-01 Olympus Winter & Ibe Gmbh Device for heating liquids to be supplied to the human body
JP6523614B2 (en) * 2014-04-22 2019-06-05 日機装株式会社 Dehydrator for used dialysate and dialysate regeneration system using the same
EP3160532B1 (en) 2014-06-24 2019-09-18 Medtronic Inc. A urease introduction system for replenishing urease in a sorbent cartridge
US10016553B2 (en) 2014-06-24 2018-07-10 Medtronic, Inc. Replenishing urease in dialysis systems using a urease introducer
WO2015199768A1 (en) 2014-06-24 2015-12-30 Medtronic, Inc. Stacked sorbent assembly
WO2015199764A1 (en) 2014-06-24 2015-12-30 Medtronic, Inc. Replenishing urease in dialysis systems using urease pouches
US10172991B2 (en) 2014-06-24 2019-01-08 Medtronic, Inc. Modular dialysate regeneration assembly
EP3160533B1 (en) 2014-06-24 2020-08-12 Medtronic Inc. Sorbent pouch
JP6388118B2 (en) 2014-09-19 2018-09-12 澁谷工業株式会社 Artificial dialysis machine
EP3220975B1 (en) 2014-11-21 2024-01-24 Triomed AB Apparatus for performing peritoneal ultrafiltration
US9713665B2 (en) 2014-12-10 2017-07-25 Medtronic, Inc. Degassing system for dialysis
US10098993B2 (en) 2014-12-10 2018-10-16 Medtronic, Inc. Sensing and storage system for fluid balance
US9895479B2 (en) 2014-12-10 2018-02-20 Medtronic, Inc. Water management system for use in dialysis
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
JP6335333B2 (en) 2014-12-25 2018-05-30 アサヒカセイメディカルヨーロッパゲーエムベーハー Solution generator and blood purification system
US9974942B2 (en) 2015-06-19 2018-05-22 Fresenius Medical Care Holdings, Inc. Non-vented vial drug delivery
WO2016207206A1 (en) 2015-06-25 2016-12-29 Gambro Lundia Ab Medical device system and method having a distributed database
DE102015012519A1 (en) 2015-09-26 2017-03-30 Fresenius Medical Care Deutschland Gmbh Determination in blood of dissolved gases in the extracorporeal circulation
CN108136096B (en) 2015-10-14 2021-01-15 甘布罗伦迪亚股份公司 Renal failure treatment system with electro-flotation fluid path
US10926018B2 (en) 2015-10-14 2021-02-23 Gambro Lundia Ab Renal failure therapy system and method for electrically safe treatment
WO2017064252A1 (en) 2015-10-14 2017-04-20 Gambro Lundia Ab Dialysis system and method including a flow path insulator
WO2017078965A1 (en) 2015-11-06 2017-05-11 Medtronic, Inc Dialysis prescription optimization for decreased arrhythmias
US20180353672A1 (en) * 2015-12-04 2018-12-13 Qidni Labs, Inc. Implantable renal replacement therapy
US9945838B2 (en) 2015-12-17 2018-04-17 Fresenius Medical Care Holdings, Inc. Extracorporeal circuit blood chamber having an integrated deaeration device
US10391222B2 (en) 2015-12-31 2019-08-27 Baxter International Inc. Devices for urea electrolysis and methods of using same
WO2017116515A1 (en) 2015-12-31 2017-07-06 Baxter International Inc. Methods and apparatuses using urea permselective diffusion through charged membranes
EP3397301B1 (en) * 2015-12-31 2024-01-03 Baxter International Inc. Methods and apparatuses using urea permselective diffusion through charged membranes
US10406270B2 (en) 2015-12-31 2019-09-10 Baxter International Inc. Devices for urea electrolysis with combination electrodialysis and urea oxidation cell and methods of using same
US10625009B2 (en) 2016-02-17 2020-04-21 Baxter International Inc. Airtrap, system and method for removing microbubbles from a fluid stream
JP6826852B2 (en) * 2016-09-23 2021-02-10 日機装株式会社 Blood purification device
US10441702B2 (en) * 2016-10-04 2019-10-15 Fresenius Medical Care Holdings, Inc. Medical fluid temperature control
US10981148B2 (en) 2016-11-29 2021-04-20 Medtronic, Inc. Zirconium oxide module conditioning
WO2018114346A1 (en) 2016-12-21 2018-06-28 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
US11167070B2 (en) 2017-01-30 2021-11-09 Medtronic, Inc. Ganged modular recharging system
US10960381B2 (en) 2017-06-15 2021-03-30 Medtronic, Inc. Zirconium phosphate disinfection recharging and conditioning
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
US10806842B2 (en) * 2017-09-11 2020-10-20 Fresenius Medical Care Holdings, Inc. Hydrophobic filters for air management in dialysis machines
US20190125954A1 (en) * 2017-10-30 2019-05-02 Baxter International Inc. Dialysis system and method having extended use point of care dialysis fluid generation
US11278654B2 (en) 2017-12-07 2022-03-22 Medtronic, Inc. Pneumatic manifold for a dialysis system
AU2018385767A1 (en) 2017-12-15 2020-06-11 Gastroklenz Inc. Sensor monitoring system for in-dwelling catheter based treatments
US10881347B2 (en) 2017-12-29 2021-01-05 Fresenius Medical Care Holdings, Inc. Closed loop dialysis treatment using adaptive ultrafiltration rates
US11033667B2 (en) 2018-02-02 2021-06-15 Medtronic, Inc. Sorbent manifold for a dialysis system
US11110215B2 (en) 2018-02-23 2021-09-07 Medtronic, Inc. Degasser and vent manifolds for dialysis
CA3092575A1 (en) 2018-02-28 2019-09-06 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems
WO2019183464A1 (en) 2018-03-22 2019-09-26 Cryolife, Inc. Central nervous system localized hypothermia apparatus and methods
BR112020019993A2 (en) 2018-03-30 2021-01-26 Deka Products Limited Partnership liquid pumping cassettes and associated pressure distribution manifold and related methods
DE102018118564A1 (en) * 2018-07-31 2020-02-06 Fresenius Medical Care Deutschland Gmbh Device and method for producing a dialysis solution
US11213616B2 (en) 2018-08-24 2022-01-04 Medtronic, Inc. Recharge solution for zirconium phosphate
US11918717B2 (en) 2018-08-27 2024-03-05 Nikkiso Co., Ltd. Blood purification device
USD984637S1 (en) 2019-06-26 2023-04-25 Gastroklenz Inc. Measurement vessel
USD903126S1 (en) 2019-06-26 2020-11-24 Gastroklenz Inc. Monitoring device
JP2022538264A (en) 2019-06-26 2022-09-01 ガストロクレンツ インコーポレイテッド Fluid monitoring system, apparatus and method
WO2021094140A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
CN114728114A (en) 2019-11-12 2022-07-08 费森尤斯医疗护理德国有限责任公司 Blood treatment system
EP4058093A1 (en) 2019-11-12 2022-09-21 Fresenius Medical Care Deutschland GmbH Blood treatment systems
CN114728116A (en) 2019-11-12 2022-07-08 费森尤斯医疗护理德国有限责任公司 Blood treatment system
EP4136336A1 (en) * 2020-04-15 2023-02-22 Byonyks Medical Device, Inc. Damping devices, including damping devices for automated peritoneal dialysis systems, and associated systems, devices, and methods
US11690940B2 (en) * 2020-11-02 2023-07-04 Fresenius Medical Care Holdings, Inc. Preserving sorbent devices in dialysis systems
US11850344B2 (en) 2021-08-11 2023-12-26 Mozarc Medical Us Llc Gas bubble sensor
WO2023060069A1 (en) * 2021-10-06 2023-04-13 Baxter International Inc. Peritoneal dialysis cycler using sorbent
WO2023170680A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669880A (en) * 1969-06-30 1972-06-13 Cci Aerospace Corp Recirculation dialysate system for use with an artificial kidney machine
FR2154983A5 (en) * 1971-10-01 1973-05-18 Thomson Csf Artificial kidney machine - uses closed circuit regeneration of small volume of dialysis liquid
US4137168A (en) * 1976-10-02 1979-01-30 Klauschenz & Perrot Kg Device for dialysation of blood
US4213859A (en) * 1977-04-12 1980-07-22 Akzo N.V. Dialysis with ion exchange extraction of phosphates
US4269708A (en) * 1978-05-03 1981-05-26 Vittorio Bonomini Hemodialysis and/or ultrafiltration apparatus
DE3110128A1 (en) * 1981-03-16 1982-09-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Process and apparatus for the detoxication and regeneration of blood, blood constituents and solutions resulting from the purification of blood, as well as kit for carrying out the process
US4464172A (en) * 1979-04-30 1984-08-07 Lichtenstein Eric Stefan Computer-control medical care system
US4684460A (en) * 1984-12-14 1987-08-04 Gerald Issautier Haemodialysis device automatically monitoring loss of weight
US5522998A (en) * 1993-03-18 1996-06-04 Fresenius Ag Hemodialysis apparatus having a single balance chamber and method of dialyzing blood therewith
WO2002030489A2 (en) * 2000-10-12 2002-04-18 Baxter International Inc. Peritoneal dialysis catheters
WO2003041764A1 (en) * 2001-11-13 2003-05-22 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US20030113931A1 (en) * 2001-12-14 2003-06-19 Li Pan Ammonia and ammonium sensors

Family Cites Families (683)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US250868A (en) 1881-12-13 Phillips abbott
US2736332A (en) * 1956-02-28 simmons
US927476A (en) 1909-02-09 1909-07-13 Arthur W Barker Natural-gas separator.
US1505050A (en) 1920-02-19 1924-08-12 Ohio Body Weir meter
US2122509A (en) 1935-08-22 1938-07-05 Stephen B Beliaeff Hair waving or curling device
US2292007A (en) 1941-01-22 1942-08-04 American Brake Shoe & Foundry Liquid dispensing apparatus
US2529028A (en) 1947-07-31 1950-11-07 Landon Standard Pools Chemical feeder
BE513471A (en) 1951-08-31
US3044236A (en) 1960-07-21 1962-07-17 Phillips Petroleum Co System for removal of gases from liquids
US3074645A (en) 1960-11-21 1963-01-22 Bell & Gossett Co Air separator fitting for hydronic systems
DE1302684B (en) 1961-06-21 1971-04-01 Automatic Process Control Inc
US3095062A (en) 1961-11-10 1963-06-25 California Research Corp Oil change system
US3287885A (en) 1964-08-05 1966-11-29 Odederlin & Cie Ag Air separator for drain pipes
US3342019A (en) 1964-08-12 1967-09-19 Technicon Corp Gas and liquid separator for gas analysis
US3332737A (en) 1965-01-28 1967-07-25 Kurt A Kraus Process for separating inorganic anions with hydrous oxide anion exchangers
US3388803A (en) 1965-04-16 1968-06-18 Applied Biolog Sciences Lab In Wearable dialysis apparatus
US3527572A (en) 1965-10-11 1970-09-08 A Edward Urkiewicz Apparatus for treating blood
US3295297A (en) 1965-10-19 1967-01-03 Cobe Lab Filter and bubble trap
US3412760A (en) 1966-01-10 1968-11-26 Imp Eastman Corp Hose assembly
US3463728A (en) 1967-04-28 1969-08-26 Us Health Education & Welfare Dialysate capacity augmentation process
US3485245A (en) 1967-06-21 1969-12-23 Ibm Portable fluid heater
NO119547B (en) * 1967-07-04 1970-06-01 Nyctron A S
GB1189458A (en) 1967-09-27 1970-04-29 Nat Res Dev Improvements in or relating to dialysers
US3545438A (en) 1968-02-12 1970-12-08 Sarns Inc Intermittent dialysis method and apparatus therefor
US3799873A (en) 1968-04-19 1974-03-26 Hydronautics Artificial kidney
US3825493A (en) 1972-09-29 1974-07-23 Hydronautics Peritoneal artificial kidney
US3490479A (en) 1968-07-12 1970-01-20 Honeywell Inc Fluid pressure relay
DE1806654A1 (en) 1968-11-02 1970-05-21 Gerdts Gustav F Kg Device for measuring the flow rate of fluids under pressure
US3669878A (en) 1968-12-02 1972-06-13 Health Education And Welfare U Treatment of dialysate solution for removal of urea
US3581464A (en) 1968-12-16 1971-06-01 Trw Inc Method of and apparatus for separating a liquid from liquid vapor and dissolved gases
US3563381A (en) 1968-12-18 1971-02-16 Andrew Charles Edelson Dialysis apparatus
US3580712A (en) 1969-02-10 1971-05-25 Owens Illinois Inc Glass forming mold elements with yielding supports
FR2036413A5 (en) 1969-03-13 1970-12-24 Thomson Csf
US3540477A (en) 1969-03-18 1970-11-17 Honeywell Inc Pneumatic supply-exhaust circuit
US3598727A (en) 1969-04-07 1971-08-10 Charles B Willock Artificial kidney
US3677710A (en) 1969-06-02 1972-07-18 Nathan M Hirsch Apparatus for washing blood cells
GB1280521A (en) 1969-06-28 1972-07-05 Whitely Lang And Neill Ltd Peritoneal dialysis apparatus
US3667612A (en) 1969-09-04 1972-06-06 Joe H Leonard Artificial kidney system
BE759038A (en) 1969-11-17 1971-04-30 Cci Aerospace Corp RECIRCULATION DIALYSAT MODULE, INTENDED TO BE DISCARDED
US3619423A (en) 1970-04-20 1971-11-09 Us Health Education & Welfare Cascade dialysis apparatus and method
US3814249A (en) 1970-05-25 1974-06-04 Eaton Medical Electronics Inc Dialysis apparatus
US3685680A (en) 1970-06-08 1972-08-22 Battelle Development Corp Peritoneal dialysis delivery unit using home-prepared dialysate
US3682817A (en) 1970-08-02 1972-08-08 Bio Cal Instr Co Dialyzer
US3707967A (en) 1970-10-01 1973-01-02 Tecna Corp Steady flow regenerative peritoneal dialysis system and method
DE2239254C2 (en) 1970-12-30 1983-08-04 Organon Teknika Corp., Oklahoma City, Okla. "Column for regenerating a circulating dialysate solution and using this column".
FR2120507A5 (en) 1971-01-06 1972-08-18 Rhone Poulenc Sa
US3727612A (en) 1971-01-18 1973-04-17 R Sayers Dialysis method and apparatus
US3774762A (en) 1971-01-20 1973-11-27 E Lichtenstein Analogue fluid flow programming structures
US3946731A (en) 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
US3697418A (en) 1971-01-25 1972-10-10 Cci Aerospace Corp Method and apparatus for regenerating the dialyzing fluid for an artificial kidney
FR2129165A5 (en) * 1971-03-17 1972-10-27 Rhone Poulenc Sa
US3744492A (en) 1971-04-07 1973-07-10 S Leibinsohn Drip chamber
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US3830234A (en) 1971-06-04 1974-08-20 Vital Assists Dialysis control system and method
US3756234A (en) 1971-06-04 1973-09-04 Vital Assists Single needle dialysis
US3769207A (en) 1971-06-14 1973-10-30 E Baer Process of separation of emulsified or dispersed matter from water
US3771288A (en) 1971-10-08 1973-11-13 Tno Device for degassing a liquid
US3850835A (en) 1971-11-08 1974-11-26 Cci Life Systems Inc Method of making granular zirconium hydrous oxide ion exchangers, such as zirconium phosphate and hydrous zirconium oxide, particularly for column use
BE792314A (en) 1971-12-06 1973-06-05 Rhone Poulenc Sa DEVELOPMENT IN ARTIFICIAL KIDNEYS
FR2165006A5 (en) * 1971-12-14 1973-08-03 Rhone Poulenc Sa
BE792243A (en) 1971-12-23 1973-03-30 Baxter Laboratories Inc BUBBLE TRAP FOR THE REMOVAL OF BUBBLES FROM A BIOLOGICAL FLUID UNDER STERILITY CONDITIONS
US3795088A (en) 1972-03-03 1974-03-05 W Esmond Degassing particulate matter and oil filter device
US3878564A (en) 1972-04-14 1975-04-22 Shang J Yao Blood and tissue detoxification method
US3979284A (en) 1972-07-31 1976-09-07 Rhone-Poulenc S.A. Artificial haemodialysis kidneys
US3911915A (en) 1972-09-05 1975-10-14 Einstein Coll Med Dialytic introduction of maltose into bloodstream
US3834386A (en) 1972-09-07 1974-09-10 Sweden Freezer Blood drip chamber
US3827561A (en) 1972-09-20 1974-08-06 Milton Roy Co Deaerator for dialysis system
JPS5226076B2 (en) 1972-10-06 1977-07-12
US3849071A (en) 1972-12-21 1974-11-19 K Kayser Blood-gas separating system for perfusate circulation
US3809241A (en) 1973-02-23 1974-05-07 Electro Sys Eng Inc Self-container kidney dialysis apparatus
US4036747A (en) 1973-02-27 1977-07-19 Takeda Chemical Industries, Ltd. Adsorbent for recycling artificial kidney
US3976311A (en) 1973-03-19 1976-08-24 Spendlove Ray E Tubing connector apparatus and method
FR2231421B1 (en) 1973-05-30 1976-05-07 Rhone Poulenc Ind
US3884808A (en) 1973-06-20 1975-05-20 Res Dev Systems Inc Wearable, self-regenerating dialysis appliance
US4192748A (en) 1973-07-05 1980-03-11 Hyden Viktor H Dialysis apparatus with selective chemical activity
USRE32303E (en) 1973-07-31 1986-12-09 American Medical Products Corp. Peritoneal dialysis apparatus
JPS5225197B2 (en) 1973-09-19 1977-07-06
NL158390B (en) 1973-11-26 1978-11-15 Rhone Poulenc Sa DEVICE FOR EXTERNAL CIRCULAR DIALYSIS.
US4118314A (en) 1974-01-09 1978-10-03 Seisan Kaihatsu Kagaku Kenkyusho Apparatus for treatment of artificial kidney dialyzing fluid
US3908653A (en) 1974-01-23 1975-09-30 Vital Assists Blood chamber
JPS5929264B2 (en) 1974-02-12 1984-07-19 ハイドロナウテイクス インコ−ポレ−テツド artificial kidney
US4031010A (en) 1974-05-02 1977-06-21 Takeda Chemical Industries, Ltd. Combined dialyzer and adsorber unit
US3878095A (en) 1974-05-02 1975-04-15 Advanced Medical Sciences Inc Dialysis apparatus
IT1014620B (en) 1974-05-06 1977-04-30 Bellco Spa PROCEDURE FOR THE REGENERATION OF DIALIZING LIQUIDS IN HEMODIALYSIS SYSTEMS
FR2283167A1 (en) 1974-06-04 1976-03-26 Rhone Poulenc Ind USE IN SELECTIVE DIALYSIS OF MEMBRANES BASED ON ION EXCHANGER POLYMERS AND A BINDER
US3915802A (en) 1974-08-19 1975-10-28 Upjohn Co Dialysis process and apparatus
US4348280A (en) 1974-10-21 1982-09-07 Baxter Travenol Laboratories, Inc. Proportioning dialysis machine
US4137160A (en) 1974-10-31 1979-01-30 Baxter Travenol Laboratories, Inc. Device for separating low density material such as gas bubbles from a liquid, and the use thereof in a dialysis delivery system
US3996027A (en) 1974-10-31 1976-12-07 Baxter Laboratories, Inc. Swirling flow bubble trap
US3964479A (en) 1974-11-20 1976-06-22 Cobe Laboratories, Inc. Extracorporeal blood circulation system and drip chamber with adjustable blood level
US4060485A (en) 1975-06-09 1977-11-29 I T L Technology, Inc. Dialysis apparatus
US4048995A (en) 1975-08-15 1977-09-20 Baxter Travenol Laboratories, Inc. Injection site
US4054522A (en) 1975-09-03 1977-10-18 Harry Pinkerton Apparatus for exposing a fluid to a negative pressure
US4031891A (en) 1975-11-03 1977-06-28 Baxter Travenol Laboratories, Inc. Air eliminating filter
US4061031A (en) 1975-11-05 1977-12-06 Lars Grimsrud Combination of flow meter and bubble trap
US4081372A (en) * 1975-12-08 1978-03-28 University Of Utah Leakage indicator for recirculating peritoneal dialysis system
US4047563A (en) 1976-01-27 1977-09-13 Japan Medical Supply Co., Ltd. Heat exchanger for artificial heart and lung devices
IL49031A (en) 1976-02-13 1979-11-30 Ramot Plastics Peritoneal artificial kidney
US4325715A (en) 1976-03-24 1982-04-20 Bowman Donald B Apparatus for degassing hemodialysis liquid
US4096059A (en) 1976-05-12 1978-06-20 Pinkerton Harry E Proportioning fluids
DE2705734C3 (en) 1977-02-11 1982-04-22 Akzo Gmbh, 5600 Wuppertal Dialysis membrane for hemodialysis
JPS5347196A (en) 1976-10-12 1978-04-27 Masaaki Sugiyama Method of purifying dialyzed liquid in artificial liver
SE402212B (en) 1976-10-14 1978-06-26 Gambro Ab DIALYSIS SYSTEM
US4360323A (en) 1976-11-19 1982-11-23 Halbert Fischel Proportioning pumping system for dialysis machines
US4194536A (en) 1976-12-09 1980-03-25 Eaton Corporation Composite tubing product
NO140703C (en) 1977-02-23 1979-10-24 Nycotron As DIALYSE DEVICE FOR REGULATED BLOOD DIALYSIS
FR2385406A1 (en) 1977-03-28 1978-10-27 Akzo Nv ARTIFICIAL KIDNEY
US4102655A (en) 1977-05-02 1978-07-25 Cobe Laboratories, Inc. Bubble trap
US4173537A (en) 1977-05-23 1979-11-06 Newhart Earle E Integral artificial kidney unit
US4161264A (en) 1977-06-17 1979-07-17 Johnson Bryan E Fluid metering and mixing device having inlet and outlet valves
US4209402A (en) 1977-07-12 1980-06-24 Gentles William M Kidney dialysis filter washing process
US4200095A (en) 1977-08-15 1980-04-29 Millipore Corporation Arrangement for intravenous administration or the like
US4190047A (en) 1977-08-26 1980-02-26 University Of Utah Method and apparatus for peritoneal dialysis
US4364747A (en) 1977-08-29 1982-12-21 The Regents Of The University Of Minnesota System for regenerative thermally reversed adsorption
US4191182A (en) 1977-09-23 1980-03-04 Hemotherapy Inc. Method and apparatus for continuous plasmaphersis
FI59598C (en) 1977-10-03 1981-09-10 Star Oy Ab NYTT FOERFARANDE FOER FRAMSTAELLNING AV I 9-STAELLNINGEN EVENTUELLT METOXISUBSTITUERADE 7H-FURO (3,2-G) (1) BENSOPYRAN-7-ONER
DE2755214C3 (en) 1977-12-10 1980-12-11 Dr. Eduard Fresenius Chemisch-Pharmazeutische Industrie Kg Apparatebau Kg, 6380 Bad Homburg Device for periodic irrigation of the abdominal cavity
CS200909B1 (en) 1977-12-23 1980-10-31 Petr Slovak Haemodlialysation device
IT1092077B (en) 1978-01-20 1985-07-06 Bellco Spa PORTABLE MACHINE FOR REGENERATION DIALYSIS
US4151088A (en) 1978-01-23 1979-04-24 Baxter Travenol Laboratories, Inc. Membrane diffusion device with integral heat exchanger and reservoir
US4244816A (en) 1979-01-22 1981-01-13 Exxon Research & Engineering Co. Liquid membrane capsule systems resistant to coalescence by means of an irreversible coating
DE2806237C2 (en) 1978-02-14 1983-03-24 Sartorius GmbH, 3400 Göttingen Device for removing urinary substances from human blood
JPS54109291A (en) 1978-02-16 1979-08-27 Genshirou Ogawa Heater structure for instillation liquid* transfusion blood or like
US4181245A (en) 1978-02-17 1980-01-01 Baxter Travenol Laboratories, Inc. Casette for use with an I.V. infusion controller
US4581141A (en) 1978-02-27 1986-04-08 Purdue Research Foundation Dialysis material and method for removing uremic substances
PT69258A (en) 1978-02-27 1979-03-01 Lilly Co Eli Process for preparing a dialysis composition
US4256718A (en) 1978-03-20 1981-03-17 Organon Teknika Corporation Sodium zirconium carbonate compound and the method of its preparation
US4229299A (en) * 1978-03-22 1980-10-21 Hoechst Aktiengesellschaft Peristaltic dialysate solution pump
DE2818390C2 (en) 1978-04-27 1986-10-30 Fresenius AG, 6380 Bad Homburg Artificial organ
US4209392A (en) * 1978-05-15 1980-06-24 Wallace Richard A Portable hepatic-assist method and apparatus for same
US4149860A (en) 1978-06-05 1979-04-17 Kulik Donald A Gas liquid separator
JPS5532384A (en) 1978-08-30 1980-03-07 Nippon Electric Co Temperature control circuit
DE2838414C2 (en) 1978-09-02 1984-10-31 Fresenius AG, 6380 Bad Homburg Device for hemodialysis and for withdrawing ultrafiltrate
FR2397197A1 (en) 1978-11-03 1979-02-09 Sodip Sa Extracorporeal blood purificn. - by simultaneous haemodialysis and haemo-filtration with incorporated flow ewuilibrantion
US4209391A (en) 1978-11-06 1980-06-24 Cordis Dow Corp. Apparatus and method for automatically controlling hemodialysis at a pre-selected ultrafiltration rate
SE428427B (en) 1979-01-04 1983-07-04 Gambro Lundia Ab WANT TO DISPOSE WASTE METABOLITES SPECIFICALLY NON-GIFTING POISONS, FROM A SOLUTION THROUGH ALTERNATE ADSORPTION AND DESORPTION
US4247393A (en) 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
DE2901628A1 (en) 1979-01-17 1980-07-24 Hoh Automatic balancing haemofiltration appts. - with capacitive measurement of filtrate and automatic proportional replacement
US4360507A (en) 1979-01-24 1982-11-23 Organon Teknika Corporation Sodium zirconium carbonate compound and the method of its preparation
JPS5814223B2 (en) 1979-02-24 1983-03-17 株式会社メデクス Dialysis “filtration” device
JPS55122559A (en) 1979-02-27 1980-09-20 Seisan Kaihatsu Kagaku Kenkyus Artificial kidney device which is accompanied by blood filtration* require supplement of liquid and dialyze
US4304670A (en) 1979-04-03 1981-12-08 Terumo Corporation Blood filter with air trap and distributing chamber
SE7905956L (en) 1979-07-09 1981-01-10 Gambro Dialysatoren COLUMN FOR TREATMENT OF A LIQUID MEDIUM A PARTICULAR MATERIAL
US4303376A (en) 1979-07-09 1981-12-01 Baxter Travenol Laboratories, Inc. Flow metering cassette and controller
JPS5613222A (en) 1979-07-16 1981-02-09 Nissan Motor Co Ltd Device for alarming driving in a doze
US4941875A (en) 1979-07-18 1990-07-17 Brennan John F I.V. system for successive administration of two or more solutions at different rates
US4276175A (en) 1979-07-19 1981-06-30 Bower John D Regeneratable peritoneal dialysis bag
NO148701C (en) 1979-10-16 1983-11-30 Akers Mek Verksted As PROCEDURE FOR DEGRADING LIQUID, AND DEVICE FOR CARRYING OUT THE PROCEDURE
IT7943514A0 (en) 1979-10-26 1979-10-26 Buoncristiani Vincenzo AUTOMATIC EQUIPMENT FOR PERITONEAL DIALYSIS WITH RECYCLING OF THE DISCHARGE LIQUID DURING THE DIALYTIC SESSION
US4293413A (en) 1979-12-28 1981-10-06 Baxter Travenol Laboratories, Inc. Dialyzer blood circuit and bubble traps
US4344777A (en) 1980-01-07 1982-08-17 Siposs George G Directed flow bubble trap for arterial blood
US4368118A (en) 1980-01-07 1983-01-11 Siposs George G Blood-air separator and filter
US4366061A (en) 1980-01-23 1982-12-28 Cordis Dow Corp. Automated diaphragm apparatus and method for controlling negative pressure hemodialysis treatment
US4332264A (en) 1980-03-03 1982-06-01 United Healthcare Association Automated cleaning system for dialyzers
US4311137A (en) 1980-04-30 1982-01-19 Sherwood Medical Industries Inc. Infusion device
US4532414A (en) 1980-05-12 1985-07-30 Data Chem., Inc. Controlled temperature blood warming apparatus
SE423318B (en) 1980-06-27 1982-05-03 Gambro Ab MEMO Filtration System
DD157952A3 (en) 1980-08-13 1982-12-22 Wolfgang Simon DEVICE FOR EXTRACORPORAL TREATMENT OF BLOOD
US4386634A (en) 1980-10-10 1983-06-07 Renal Systems, Inc. Proportioning system
DE3101159C2 (en) 1981-01-16 1985-08-22 Udipi Ramakrishna Dr. 5100 Aachen Shettigar Process for purifying blood and artificial kidney for carrying out the process
US4345919A (en) 1981-01-19 1982-08-24 Texas Medical Products, Inc. Degasser for biological fluids
SE448518B (en) 1981-02-16 1987-03-02 Gambro Dialysatoren FLOW ROOM FOR BLOOD OR SIMILAR VENTURES
EP0064393A3 (en) 1981-05-04 1982-12-29 Purdue Research Foundation Sorbent mixture for use in hemodialysis
US4433971A (en) 1981-06-30 1984-02-28 Minnesota Mining And Manufacturing Company Integrated cardioplegia delivery system
US4427009A (en) 1981-06-30 1984-01-24 Minnesota Mining And Manufacturing Company Integrated cardioplegia delivery system
US4512163A (en) 1981-06-30 1985-04-23 Minnesota Mining And Manufacturing Company Integrated cardioplegia delivery system
US4363641A (en) 1981-07-02 1982-12-14 General Electric Company Liquid degasser with self-throttling exhaust orifice
SU1001945A1 (en) 1981-07-28 1983-03-07 Всесоюзный Научно-Исследовательский Институт Медицинского Приборостроения Apparatus for hemofiltration
US4464563A (en) 1981-08-28 1984-08-07 Jewett Warren R Intravenous fluid warmer
US4583981A (en) 1981-11-27 1986-04-22 Alza Corporation Parenteral controlled therapy, using a porous matrix with parenteral agent
SU1012918A1 (en) 1981-12-03 1983-04-23 Институт медико-биологических проблем Method of cleaning dialyzing solution in artificial kidney apparatus
US4415085A (en) 1981-12-21 1983-11-15 Eli Lilly And Company Dry pharmaceutical system
DD210385A3 (en) 1982-06-28 1984-06-06 Medizin Labortechnik Veb K DIALYSIS DEVICE WITH REGENERATION SYSTEM FOR THE CONTINUOUS AMBULANT PERITONEAL DIALYSIS
EP0100682A1 (en) * 1982-08-03 1984-02-15 Peritronic Medical Industries Plc Fluid flow control process and apparatus
US4493705A (en) 1982-08-10 1985-01-15 Bentley Laboratories, Inc. Blood reservoir
JPS5929264A (en) 1982-08-11 1984-02-16 Canon Inc Image forming apparatus
US4715959A (en) 1982-08-31 1987-12-29 Cd Medical Inc. Apparatus and method for controlling ultrafiltration during hemodialysis
US4477342A (en) 1982-08-31 1984-10-16 Becton, Dickinson And Company Apparatus and method for controlling ultrafiltration during hemodialysis
EP0103816B1 (en) 1982-09-09 1988-11-17 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Artificial organ and method for manufacturing thereof
US4460555A (en) 1983-08-25 1984-07-17 Organon Teknika Corporation Ammonia scavenger
SE432195B (en) 1982-09-10 1984-03-26 Gambro Lundia Ab SLANGSET PROVIDED FOR EXTRACORPORAL TREATMENT OF BLOOD AND SIMILAR EXPENSIVE LIQUIDS
US4473449A (en) 1982-09-22 1984-09-25 The Board Of Trustees Of The Leland Stanford Junior University Flowthrough electrochemical hemodialysate regeneration
US4703913A (en) 1982-09-22 1987-11-03 California Institute Of Technology Diaphragm valve
DD210425A1 (en) 1982-09-30 1984-06-13 Messgeraetewerk Zwonitz Veb K DEVICE FOR THE AUTOMATIC PREPARATION AND PREPARATION OF EXTRACORPOREAL BLOOD TREATMENT SYSTEMS
US5034135A (en) 1982-12-13 1991-07-23 William F. McLaughlin Blood fractionation system and method
US4531937A (en) 1983-01-24 1985-07-30 Pacesetter Systems, Inc. Introducer catheter apparatus and method of use
DE3307830A1 (en) 1983-03-05 1984-09-06 Hans Peter 5880 Lüdenscheid Berkenhoff Method and device for the extracorporeal purification of blood
US4568333A (en) 1983-04-12 1986-02-04 Sawyer Philip Nicholas Valve arrangement especially suitable for preventing introduction of air into vascular systems
US4722725A (en) 1983-04-12 1988-02-02 Interface Biomedical Laboratories, Inc. Methods for preventing the introduction of air or fluid into the body of a patient
DE3313421C2 (en) 1983-04-13 1985-08-08 Fresenius AG, 6380 Bad Homburg Device for regulating the ultrafiltration rate in devices for extracorporeal cleaning of blood
SE451541B (en) 1983-06-30 1987-10-19 Gambro Lundia Ab EXTRACORPORAL BLOOD TREATMENT SYSTEM
DE3333362C2 (en) * 1983-09-15 1986-03-20 Fresenius AG, 6380 Bad Homburg Peritoneal dialysis machine
DE3335744C1 (en) 1983-10-01 1984-12-13 B. Braun Melsungen Ag, 3508 Melsungen Dialysis machine
FR2554721B1 (en) 1983-11-14 1987-05-07 Sante Tech Rech Sarl HEMODIALYSIS APPARATUS
US5047147A (en) 1983-11-23 1991-09-10 Hospal Industrie Single-needle artificial kidneys
SE451801B (en) 1983-11-29 1987-11-02 Gambro Lundia Ab DEVICE FOR BREATHING A FLUID THROUGH A PIPE
SE8306574L (en) 1983-11-29 1985-05-30 Gambro Lundia Ab DEVICE FOR AIR FLUID
US4747950A (en) * 1983-12-16 1988-05-31 Cd Medical, Inc. Method and apparatus for controlled ultrafiltration during hemodialysis
US4734198A (en) 1984-02-06 1988-03-29 Minntech Corporation Dialysis solution mixing system
US4655941A (en) 1984-02-13 1987-04-07 Tomita Pharmaceutical Corp., Ltd. Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
US4765907A (en) * 1984-03-28 1988-08-23 Research Development Systems, Inc. Wearable, continuously internally operable and externally regenerable dialysis device
DE3416956C2 (en) 1984-05-08 1986-12-04 Fresenius AG, 6380 Bad Homburg Measuring device for determining the activity or the concentration of ions in solutions
CS248305B1 (en) 1984-06-18 1987-02-12 Miroslav Skala Blood cleaning instrument
SE458340B (en) 1984-06-18 1989-03-20 Gambro Lundia Ab BLOOD FILTERING SYSTEM AND DROP AND / OR EXPANSION ROOMS INTENDED FOR THIS SYSTEM
IT1209560B (en) 1984-06-25 1989-08-30 Pierrel Hospital Spa CONTAINER AND METHOD FOR WASHING AND OPERATIONAL INTEGRATION OF THE FUNCTIONING OF CIRCUITS AND FILTERS FOR DIALYSIS.
SU1344362A1 (en) 1984-06-28 1987-10-15 Ф.И.Михеев, Б.Г.Захаров, Е.Г.Патрушев и В.К.Гусев Apparatus for dialysis
US4747822A (en) 1984-07-09 1988-05-31 Peabody Alan M Continuous flow peritoneal dialysis system and method
US4718890A (en) 1984-07-09 1988-01-12 Peabody Alan M Continuous flow peritoneal dialysis system and method
US5643201A (en) 1984-07-09 1997-07-01 Peabody; Alan M. Continuous peritoneal dialysis apparatus
US4586920A (en) 1984-07-09 1986-05-06 Peabody Alan M Continuous flow peritoneal dialysis system and method
JPS6125564A (en) * 1984-07-17 1986-02-04 日機装株式会社 Artificial kidney apparatus
US4664891A (en) 1984-07-23 1987-05-12 Renal Systems, Inc. Dialysis solution preparation from prepackaged dry chemicals
DE3582772D1 (en) 1984-09-06 1991-06-13 Genshiro Ogawa ELECTRONICALLY CONTROLLED HEATING UNIT FOR INFUSION LIQUIDS.
US4661246A (en) 1984-10-01 1987-04-28 Ash Medical Systems, Inc. Dialysis instrument with dialysate side pump for moving body fluids
JPS61103451A (en) 1984-10-27 1986-05-21 テルモ株式会社 Blood storage tank
US4643713A (en) 1984-11-05 1987-02-17 Baxter Travenol Laboratories, Inc. Venous reservoir
DE3442744A1 (en) 1984-11-23 1986-06-05 Fresenius AG, 6380 Bad Homburg Dialyser having a unit for the re-use of haemodialysers
DE3444671A1 (en) * 1984-12-07 1986-06-12 Fresenius AG, 6380 Bad Homburg HAEMODIA FILTRATION DEVICE
US4756706A (en) 1985-01-23 1988-07-12 American Hospital Supply Corporation Centrally managed modular infusion pump system
US4678460A (en) 1985-02-11 1987-07-07 Rosner Mark S Portable rapid massive parenteral fluid warming and infusion apparatus
JPS61143074U (en) 1985-02-25 1986-09-04
US4657490A (en) 1985-03-27 1987-04-14 Quest Medical, Inc. Infusion pump with disposable cassette
US4722731A (en) 1985-04-08 1988-02-02 Vailancourt Vincent L Air check valve
US4873623A (en) 1985-04-30 1989-10-10 Prometrix Corporation Process control interface with simultaneously displayed three level dynamic menu
FR2585251B1 (en) 1985-05-02 1989-10-20 Murisasco Antoine PROCESS AND DEVICE FOR PURIFYING A HEMOFILTRAT
US4734269A (en) 1985-06-11 1988-03-29 American Hospital Supply Corporation Venous reservoir bag with integral high-efficiency bubble removal system
US4650464A (en) * 1985-06-21 1987-03-17 Minneapolis Medical Research Foundation, Inc. Method for monitoring infusion of intravenous fluid into a patient
US5091094A (en) 1985-06-24 1992-02-25 Veech Richard L Hemodialysis processes & hemodialysis solutions
US4666598A (en) 1985-06-25 1987-05-19 Cobe Laboratories, Inc. Apparatus for use with fluid flow transfer device
DE3529973A1 (en) 1985-08-22 1987-03-05 Braun Melsungen Ag DEVICE FOR HAEMODIAFILTRATION
US4804950A (en) 1985-11-07 1989-02-14 Spacelabs, Inc. Table driven multichannel data acquisition and display for signal monitoring
IT1182675B (en) 1985-11-12 1987-10-05 Sorin Biomedica Spa CONTROL DEVICE FOR BLOOD PURIFICATION EQUIPMENT
US4769134A (en) 1985-11-20 1988-09-06 C D Medical Open patient fluid management method and system
US4650857A (en) 1985-12-18 1987-03-17 Morse Capital Corporation Bland protein concentrates from peanuts and process for making
IT1204820B (en) 1986-02-20 1989-03-10 Giovanni Civati PERFECTED DEVICE FOR HEMOFILTRATION
US4681606A (en) 1986-02-26 1987-07-21 Cobe Laboratories, Inc. Drip chamber
US5401342A (en) 1986-03-04 1995-03-28 Deka Products Limited Partnership Process and energy director for ultrasonic welding and joint produced thereby
US4778451A (en) 1986-03-04 1988-10-18 Kamen Dean L Flow control system using boyle's law
US5088515A (en) 1989-05-01 1992-02-18 Kamen Dean L Valve system with removable fluid interface
US4828543A (en) 1986-04-03 1989-05-09 Weiss Paul I Extracorporeal circulation apparatus
HU196265B (en) 1986-04-11 1988-10-28 Rolitron Mueszaki Fejlesztoe K Method and apparatus for producing flow of wanted temperature of a physiological solution, as well as temperature control method and a heating device for the previously mentioned method and apparatus
ATE65416T1 (en) 1986-05-01 1991-08-15 Alan M Peabody DEVICE FOR PERITONEAL DIALYSIS IN CONTINUOUS CURRENT.
US4976683A (en) 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
US5167921A (en) 1986-07-14 1992-12-01 Baxter International Inc. Liquid and gas separation system
US4735609A (en) 1986-07-24 1988-04-05 Medical Industrial Technologies, Inc. IV fluid warmer
BE905615R (en) 1986-09-10 1987-04-17 Hombrouckx Remi O J METHOD AND EQUIPMENT FOR SINGLE NEEDLE MODIALYSIS.
FR2605228B1 (en) 1986-10-20 1988-12-02 Hospal Ind PUMPING METHOD FOR ARTIFICIAL KIDNEY OF TWO EQUAL QUANTITIES AND PUMPING DEVICE USING THE SAME
US4769151A (en) 1986-10-30 1988-09-06 Cobe Laboratories, Inc. Heater control for liquid flowing through a chamber
US4767399A (en) 1986-12-05 1988-08-30 Fisher Scientific Group Inc. Dba Imed Corporation Volumetric fluid withdrawal system
DE3641843A1 (en) 1986-12-08 1988-06-16 Fresenius Ag HAEMODIALYSIS DEVICE WITH STERILIZER
NL8701233A (en) 1987-05-22 1988-12-16 Medistad Holland BLOOD HEATER.
US5073167A (en) 1987-06-26 1991-12-17 M/A-Com, Inc. In-line microwave warming apparatus
JPS6411560A (en) 1987-07-07 1989-01-17 Terumo Corp Blood storage tank
IL83259A (en) 1987-07-20 1992-05-25 D F Lab Ltd Disposable cell and diaphragm pump for use of same
EP0306241B1 (en) 1987-09-01 1993-11-03 Shibuya Kogyo Co., Ltd Dialysis system
EP0310699B1 (en) 1987-10-09 1991-05-08 Hewlett-Packard GmbH Input device
USD311061S (en) 1987-09-21 1990-10-02 Airsep Corporation Air separator
JPH01148266A (en) 1987-12-04 1989-06-09 Terumo Corp Blood filter
GB8723931D0 (en) * 1987-10-12 1987-11-18 Hsc Res Dev Corp Peritoneal dialysis catheter
GB2212739B (en) 1987-10-21 1991-08-21 Hick Hargreaves & Co Ltd Liquid deaerating apparatus
US4804474A (en) 1987-12-10 1989-02-14 Robert Blum Energy efficient dialysis system
US4847470A (en) 1987-12-14 1989-07-11 Bakke Allan P Electric blood warmer utilizing metallic ribbon flow cartridge and low thermal mass heating units
US4898578A (en) 1988-01-26 1990-02-06 Baxter International Inc. Drug infusion system with calculator
US4806135A (en) 1988-03-01 1989-02-21 Siposs George G Bubble trap for phase-separating gas bubbles from flowing liquids
ES2040773T3 (en) 1988-04-13 1993-11-01 Med-Tech Inc. METHOD OF CONTROL OF THE AMOUNT OF WATER EXTRACTED BY ULTRAFILTRATION, AND DEVICE OF CONTROL OF THE AMOUNT OF WATER EXTRACTED BY ULTRAFILTRATION IN HEMODIALISIS.
US4914624A (en) 1988-05-06 1990-04-03 Dunthorn David I Virtual button for touch screen
US4976685A (en) 1988-06-15 1990-12-11 Block Jr Frank E Method of blood-gas interface control in surgical gas traps
JPH0622614B2 (en) 1988-06-21 1994-03-30 テルモ株式会社 Blood reservoir
US4923612A (en) 1988-07-26 1990-05-08 Trivett Gordon S Fluid recovery and transfer system
US4946439A (en) 1988-08-15 1990-08-07 Critikon, Inc. Dual source parenteral infusion system with secondary infusion module
US4916441A (en) 1988-09-19 1990-04-10 Clinicom Incorporated Portable handheld terminal
DE3837498A1 (en) 1988-11-04 1990-05-17 Fresenius Ag METHOD AND DEVICE FOR ULTRAFILTRATION IN HAEMODIALYSIS
DE3841863A1 (en) 1988-12-13 1990-06-21 Braun Melsungen Ag DEVICE FOR CONTINUOUS HAEMOFILTRATION AND HAEMODIAFILTRATION
DE3910331A1 (en) 1989-03-30 1990-10-04 Infus Hospitalbedarf Gmbh & Co ELECTROMAGNETICALLY CONTROLLABLE DIAPHRAGM PUMP AND THEIR USE
US4932987A (en) 1989-05-25 1990-06-12 Jorge Molina Extra corporeal air eliminator
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
US5049146A (en) 1989-05-31 1991-09-17 Baxter International, Inc. Blood/gas separator and flow system
ATE98498T1 (en) 1989-06-15 1994-01-15 Alan M Peabody SYSTEM FOR CONTINUOUS CYCLIC PERITONEAL DIALYSIS.
US5763266A (en) 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5114580A (en) 1989-06-20 1992-05-19 The Board Of Regents Of The University Of Washington Combined hemofiltration and hemodialysis system
US5062774A (en) 1989-12-01 1991-11-05 Abbott Laboratories Solution pumping system including disposable pump cassette
US5256371A (en) 1989-12-13 1993-10-26 Medical Support Gmbh Method and arrangement for disinfecting a dialysis fluid circuit
US5125069A (en) 1989-12-22 1992-06-23 Netherlands Health Sciences Blood warmer
US5141493A (en) * 1990-01-26 1992-08-25 Sarcos Group Peritoneal dialysis system
DE4003452A1 (en) 1990-02-06 1991-08-08 Bloching Hans Peter Medical equipment for continuous arterio-venous haemofiltration - provides filtrate outlet of haemo-filter with closure device as well as measuring appts.
US5356376A (en) 1990-03-08 1994-10-18 Zoran Milijasevic Flow controllers for fluid infusion sets
IT1241588B (en) 1990-03-09 1994-01-19 Sorin Biomedica Emodialisi S R BLOOD PURIFICATION EQUIPMENT, PARTICULARLY FOR THE TREATMENT OF PATIENTS WITH RENAL INSUFFICIENCY, AND PROCEDURE FOR THE PRODUCTION OF REINFUSION LIQUID FOR HEMODIAFILTRATION (HDF)
US5049492A (en) 1990-03-14 1991-09-17 The United States Of America As Represented By The United States National Aeronautics And Space Administration Biofilm monitoring coupon system and method of use
US4997464A (en) 1990-03-23 1991-03-05 Kopf Henry B Deaeration apparatus
US5274434A (en) 1990-04-02 1993-12-28 Hitachi, Ltd. Method and apparatus for inspecting foreign particles on real time basis in semiconductor mass production line
US5059173A (en) 1990-04-04 1991-10-22 Sacco John J IV apparatus
FR2660866B1 (en) 1990-04-13 1992-06-12 Hogamed PROCESS AND DEVICE FOR PREPARING A SUBSTITUTION LIQUID.
JPH042060A (en) 1990-04-18 1992-01-07 Japan Storage Battery Co Ltd Sealed type lead acid battery
SE9001890L (en) 1990-05-25 1991-11-26 Gambro Ab SYSTEM FOR MANAGING A MEDICAL TREATMENT, TEX DIALYSIS
US5032265A (en) 1990-06-20 1991-07-16 Millipore Corporation Method and system for producing sterile aqueous solutions
GB2246718B (en) 1990-07-06 1995-01-18 Limited Renalaid Fluid control apparatus
US5061236A (en) 1990-07-16 1991-10-29 Baxter International Inc. Venous reservoir with improved inlet configuration and integral screen for bubble removal
EP0544839A4 (en) 1990-08-20 1993-08-11 Abbott Laboratories Medical drug formulation and delivery system
FR2666739B1 (en) 1990-09-13 1998-01-02 Soludia Sa DEVICE FOR THE EXTEMPORANEOUS AND CONTINUOUS PREPARATION OF DIALYSATE.
US5180896A (en) 1990-10-11 1993-01-19 University Of Florida System and method for in-line heating of medical fluid
US5221267A (en) 1990-11-30 1993-06-22 Fresenius Usa, Inc. Breakable tubing coupling
US5336173A (en) 1990-11-30 1994-08-09 Fresenius Usa, Inc. Peritoneal dialysis tubing set and method of operation
IT1242940B (en) 1990-12-07 1994-05-18 Sifra S P A HIGH PERFORMANCE PLANT FOR THE IMPLEMENTATION OF HEMODIALYSIS, PLASMAFERESIS HEMOFILTRATION, HEMODIAFILTRATION
JPH04348757A (en) 1990-12-27 1992-12-03 Shiyadan Zenninkai Method and device for treating dialyzate
US5061365A (en) 1991-01-22 1991-10-29 Utterberg David S Medical fluid flow set
DE69215123T2 (en) 1991-02-08 1997-06-05 Alan M Peabody Continuous peritoneal dialysis system
SE9100471D0 (en) 1991-02-18 1991-02-18 Gambro Ab HOSE KIT PROVIDED FOR PERITONEAL DIALYSIS
DE4106140C2 (en) 1991-02-27 1994-11-24 Escher Wyss Gmbh Device and its application for venting a pulp suspension
FR2673382B1 (en) 1991-03-01 1994-04-08 Hospal Industrie DEVICE FOR REMOVING GAS BUBBLES FROM A FLOWING LIQUID.
US5381510A (en) 1991-03-15 1995-01-10 In-Touch Products Co. In-line fluid heating apparatus with gradation of heat energy from inlet to outlet
US5245693A (en) 1991-03-15 1993-09-14 In-Touch Products Co. Parenteral fluid warmer apparatus and disposable cassette utilizing thin, flexible heat-exchange membrane
DE4208054C2 (en) 1991-03-21 1995-04-20 Schiwa Gmbh Line system for flushing an extracorporeal circuit during hemodialysis, hemofiltration and hemodiafiltration
US5326476A (en) 1991-04-19 1994-07-05 Althin Medical, Inc. Method and apparatus for kidney dialysis using machine with programmable memory
RU2001638C1 (en) 1991-04-23 1993-10-30 Sagatovich Viktor A Method for administering peritoneal dialysis
CA2042449C (en) 1991-05-13 1997-02-04 Joseph E. Dadson Peritoneal dialysis apparatus
DE4122754A1 (en) 1991-07-10 1993-01-21 Martin Prof Dr Med Vlaho Substitute soln. for haemo-filtration in dialysing processes - contains sodium, potassium, calcium, magnesium, chloride ions, glucose, lactate and bi:carbonate, esp. for patients with weakened liver function
FR2680318B1 (en) * 1991-08-14 1994-01-21 Hospal Industrie ARTIFICIAL KIDNEY AND ORDERING METHOD.
US5902476A (en) 1991-08-21 1999-05-11 Twardowski; Zbylut J. Artificial kidney for frequent (daily) hemodialysis
US5336165A (en) 1991-08-21 1994-08-09 Twardowski Zbylut J Artificial kidney for frequent (daily) Hemodialysis
FR2680975B1 (en) 1991-09-10 1998-12-31 Hospal Ind ARTIFICIAL KIDNEY WITH MEANS FOR DETERMINING A SUBSTANCE IN BLOOD.
US5698090A (en) 1991-09-10 1997-12-16 Hospal Industrie Artificial kidney for adjusting a concentration of substance in blood
US5246560A (en) 1991-10-04 1993-09-21 Electric Power Research Institute, Inc. Apparatus for monitoring biofilm activity
US5211849B1 (en) 1991-10-11 1997-05-27 Childrens Hosp Medical Center Hemofiltration system and method
US6471872B2 (en) 1991-10-11 2002-10-29 Children's Hospital Medical Center Hemofiltration system and method based on monitored patient parameters
DE4139165C2 (en) 1991-11-28 1994-12-08 Fresenius Ag Device for the production of a medical fluid
US5259954A (en) 1991-12-16 1993-11-09 Sepratech, Inc. Portable intravenous solution preparation apparatus and method
US5282783A (en) 1991-12-17 1994-02-01 Minnesota Mining And Manufacturing Company Blood reservoir
US5330420A (en) 1992-01-13 1994-07-19 Therakos, Inc. Hemolysis detector
US5204000A (en) 1992-01-31 1993-04-20 Zcl Mfg Canada Inc. Tank for separating water and hydrocarbon fuels from contaminated water
US5919369A (en) 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5277820A (en) 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
US5536412A (en) 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
FR2687307B1 (en) 1992-02-14 1999-06-04 Lascombes Jean Jacques DEVICE FOR THE PREPARATION OF A SOLUTION FOR MEDICAL USE.
US5236476A (en) 1992-02-21 1993-08-17 Klick Ronald C Air purification system for enclosed arenas
DE4208274C1 (en) 1992-03-13 1993-10-21 Medical Support Gmbh Method and arrangement for rinsing and filling the extracorporeal blood circuit of dialysis machines
US5960160A (en) 1992-03-27 1999-09-28 Abbott Laboratories Liquid heater assembly with a pair temperature controlled electric heating elements and a coiled tube therebetween
US5616248A (en) 1992-04-06 1997-04-01 Schal; Wilfried Method for the preparation of hemodialysis fluids containing bicarbonate
CA2094102A1 (en) 1992-04-30 1993-10-31 David S. Utterberg Blood air trap chamber
US5578070A (en) 1992-04-30 1996-11-26 Medisystems Technology Corporation Blow molded venous drip chamber for hemodialysis
JPH05317414A (en) * 1992-05-22 1993-12-03 Kanegafuchi Chem Ind Co Ltd Humor treating circuit with bypass passage
US5227820A (en) 1992-06-01 1993-07-13 Ctx-Electronics Corporation Shading device of the LCD projecting plate
US5411472A (en) 1992-07-30 1995-05-02 Galen Medical, Inc. Low trauma blood recovery system
US5643250A (en) 1992-08-07 1997-07-01 O'donnell, Jr.; Francis E. Laser probe hand piece
SE9202506D0 (en) 1992-09-01 1992-09-01 Gambro Ab SYSTEM FOR PREPARING A MEDICAL SOLUTION EXTRA DIALYSIS
US6156007A (en) * 1992-09-04 2000-12-05 Hemotherm, Inc. Apparatus for whole-body hyperthermia
EP0590810B1 (en) 1992-09-30 1998-07-15 Cobe Laboratories, Inc. Differential conductivity recirculation monitor
US5385564A (en) 1992-10-05 1995-01-31 Fresenius Usa, Inc. System for preparation and use of dialysis solution
JPH07110455B2 (en) 1992-10-27 1995-11-29 住友電気工業株式会社 Wafer fixing device
US5408576A (en) 1992-10-28 1995-04-18 Bishop; Robert A. IV fluid warmer
US5284470A (en) 1992-11-02 1994-02-08 Beltz Alex D Wearable, portable, light-weight artificial kidney
US5429595A (en) 1992-11-12 1995-07-04 Wright, Jr.; Fred G. Arterial safety air diverter
DE4336336A1 (en) 1992-11-23 1994-05-26 Lang Volker Cassette infusion system
USD357312S (en) 1992-12-11 1995-04-11 Hospal Industrie Fluid cassette
JP2769592B2 (en) 1992-12-14 1998-06-25 富田製薬株式会社 Method for producing artificial kidney perfusion agent for bicarbonate dialysis and artificial kidney perfusion agent
JPH08504916A (en) 1992-12-18 1996-05-28 アボツト・ラボラトリーズ Solution pumping system for maximum output while minimizing pumping pressure
US5368555A (en) 1992-12-29 1994-11-29 Hepatix, Inc. Organ support system
SE470377B (en) 1993-02-11 1994-02-07 Gambro Dialysatoren Drip and / or expansion chamber with built-in filter and method for making one
US5441636A (en) 1993-02-12 1995-08-15 Cobe Laboratories, Inc. Integrated blood treatment fluid module
US5910252A (en) 1993-02-12 1999-06-08 Cobe Laboratories, Inc. Technique for extracorporeal treatment of blood
US5540808A (en) 1993-02-24 1996-07-30 Deka Products Limited Partnership Energy director for ultrasonic welding and joint produced thereby
US6001201A (en) 1993-02-24 1999-12-14 Deka Products Limited Partnership Process and energy director for welding and joint produced thereby
USD350822S (en) 1993-02-24 1994-09-20 Deka Products Limited Partnership Disposable parenteral-fluid cassette
USD350823S (en) 1993-02-24 1994-09-20 Deka Products Limited Partnership Rigid portion of disposable parenteral-fluid cassette
US5350357A (en) 1993-03-03 1994-09-27 Deka Products Limited Partnership Peritoneal dialysis systems employing a liquid distribution and pumping cassette that emulates gravity flow
US5474683A (en) 1993-03-03 1995-12-12 Deka Products Limited Partnership Peritoneal dialysis systems and methods employing pneumatic pressure and temperature-corrected liquid volume measurements
JP3113886B2 (en) * 1993-03-03 2000-12-04 デカ、プロダクツ、リミテッド、パートナーシップ Peritoneal dialysis system using liquid dispensing and pump cassettes with built-in air isolation and removal
US5438510A (en) 1993-03-03 1995-08-01 Deka Products Limited Partnership User interface and monitoring functions for automated peritoneal dialysis systems
SE9300728L (en) 1993-03-05 1994-02-28 Gambro Ab Ways to measure the effect of a dialysis treatment
DE4309410A1 (en) * 1993-03-19 1995-02-16 Stange Jan Material, process and equipment for the selective separation of freely dissolved and substance-bound substances from liquid substance mixtures as well as process for the production of the material
US5370674A (en) 1993-03-22 1994-12-06 Farrell; Harriet M. Method of heating medical liquids
FR2702962B1 (en) * 1993-03-22 1995-04-28 Hospal Ind Device and method for controlling the balance of fluids on an extracorporeal blood circuit.
US5385540A (en) 1993-05-26 1995-01-31 Quest Medical, Inc. Cardioplegia delivery system
US5358481A (en) 1993-06-03 1994-10-25 Research Medical, Inc. Apparatus and methods for controlling mixtures of blood and cardioplegia
JP3553627B2 (en) 1993-06-30 2004-08-11 株式会社瀬田技研 Electromagnetic induction heat converter
DE4321927C2 (en) 1993-07-01 1998-07-09 Sartorius Gmbh Filter unit with degassing device
HU216042B (en) 1993-07-14 1999-04-28 B. Braun Medical Kft. Apparatus for regenerating fluid contaminated with organic materials preferably one of dialysis as well as method and electrode for combined measuring of organic materials and hypochlorit-ion
EP0646380B1 (en) 1993-09-01 1997-06-25 Fresenius AG Air separator
US5394732A (en) 1993-09-10 1995-03-07 Cobe Laboratories, Inc. Method and apparatus for ultrasonic detection of air bubbles
US5685988A (en) 1993-09-15 1997-11-11 Malchesky; Paul Dialysis process and system
US5420962A (en) 1993-10-25 1995-05-30 Bakke; Allan P. Convection blood warming system with disposable flattened tube envelope having vent incorporating a hydrophobic filter
US5503801A (en) 1993-11-29 1996-04-02 Cobe Laboratories, Inc. Top flow bubble trap apparatus
US5591251A (en) 1993-11-29 1997-01-07 Cobe Laboratories, Inc. Side flow bubble trap apparatus and method
US5421815A (en) 1993-12-14 1995-06-06 Nof Corporation Method for blood dialysis using anticoagulent composition
US5637081A (en) 1993-12-14 1997-06-10 Nof Corporation Anticoagulant composition for use in blood dialysis circuit
US5484239A (en) 1993-12-22 1996-01-16 Baxter International Inc. Peristaltic pump and valve assembly for fluid processing systems
US5411705A (en) 1994-01-14 1995-05-02 Avecor Cardiovascular Inc. Combined cardiotomy and venous blood reservoir
SE502222C2 (en) 1994-01-17 1995-09-18 Althin Medical Ab Method of dialysis
FR2715393B1 (en) * 1994-01-25 1996-04-12 Saumur Ateliers Aeronautiques Method and device for transferring liquids and their use in a peritoneal dialysis system.
SE9400347L (en) 1994-02-03 1995-07-17 Gambro Ab Apparatus for peritoneal dialysis
US5527272A (en) 1994-02-14 1996-06-18 Fresenius Usa, Inc. Bacteriocidal dialysis collection bag and method
WO1995027520A2 (en) 1994-04-06 1995-10-19 Baxter International, Inc. Method and apparatus for a tidal oscillating pulse peritoneal dialysis
US5545131A (en) 1994-04-28 1996-08-13 White Eagle International Technologies, Lp Artificial kidney
JP3479340B2 (en) 1994-05-09 2003-12-15 ダイセル化学工業株式会社 Water production equipment for artificial dialysis
DE69531292T2 (en) 1994-05-13 2004-05-13 Abbott Laboratories, Abbott Park DISPOSABLE INFUSION CASSETTE WITH A PUSHBUTTON-OPERATED BOLT VALVE
DE4419593A1 (en) 1994-06-03 1995-12-07 Fresenius Ag Device for measuring the pressure of a medium
DE4421126A1 (en) 1994-06-16 1995-12-21 Fresenius Ag Peritoneal dialysis machine
DK0714312T3 (en) 1994-06-17 2001-12-10 Baxter Int Apparatus for purified pulsed peritoneal dialysis
DE19523505A1 (en) 1994-07-13 1996-01-18 Fresenius Ag Haemodiafiltration appliance with blood filter divided by membrane into two chambers
ES2139783T5 (en) 1994-07-13 2005-10-16 Fresenius Medical Care Deutschland Gmbh PREPARATION OF SUBSTITUTE LIQUID IN A HEMOFILTRATED OR FILTERED HEMO-DAY APPLIANCE.
JPH0829224A (en) 1994-07-14 1996-02-02 Mitsubishi Electric Corp Flow rate detection device
FR2723002B1 (en) 1994-07-26 1996-09-06 Hospal Ind DEVICE AND METHOD FOR PREPARING A FILTRATION PROCESSING LIQUID
SE504166C2 (en) 1994-08-15 1996-11-25 Gambro Ab Drip chamber head
US5685989A (en) * 1994-09-16 1997-11-11 Transonic Systems, Inc. Method and apparatus to measure blood flow and recirculation in hemodialysis shunts
EP0722744A1 (en) 1995-01-19 1996-07-24 Ube Industries, Ltd. Apparatus for continous blood purification
US5932110A (en) * 1995-02-13 1999-08-03 Aksys, Ltd. Dialysate conductivity adjustment in a batch dialysate preparation system
US5591344A (en) 1995-02-13 1997-01-07 Aksys, Ltd. Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof
US5932103A (en) 1995-02-13 1999-08-03 Aksys, Ltd. Withdrawal of priming fluid from extracorporeal circuit of hemodialysis machines or the like
US5640995A (en) 1995-03-14 1997-06-24 Baxter International Inc. Electrofluidic standard module and custom circuit board assembly
US5873853A (en) 1995-05-23 1999-02-23 Baxter International Inc. Portable pump apparatus for continuous ambulatory peritoneal dialysis and a method for providing same
CA2177442A1 (en) 1995-05-29 1996-11-30 Massimo Fini Cardiotomy reservoir with internal filter
US5624572A (en) 1995-06-07 1997-04-29 Cobe Laboratories, Inc. Power management system and method for maximizing heat delivered to dialysate in a dialysis machine
US5685835A (en) 1995-06-07 1997-11-11 Cobe Laboratories, Inc. Technique for using a dialysis machine to disinfect a blood tubing set
US5729653A (en) 1995-06-07 1998-03-17 Urosurge, Inc. Fluid warming system
US6364857B1 (en) 1995-06-07 2002-04-02 Deka Products Limited Partnership Cassette for intravenous-line flow-control system
US5650071A (en) 1995-06-07 1997-07-22 Cobe Laboratories, Inc. Technique for priming and recirculating fluid through a dialysis machine to prepare the machine for use
US6024720A (en) * 1995-07-18 2000-02-15 Aquarius Medical Corporation Fluid management system for arthroscopic surgery
US5925011A (en) 1995-08-30 1999-07-20 Baxter International Inc. System and method for providing sterile fluids for admixed solutions in automated peritoneal dialysis
US5944684A (en) * 1995-08-31 1999-08-31 The Regents Of The University Of California Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications
US6146359A (en) 1995-09-06 2000-11-14 Microwave Medical Systems, Inc. Apparatus for controlledly warming low flow rate infusates
US5690614A (en) 1995-09-06 1997-11-25 Microwave Medical Systems, Inc. Microwave apparatus for warming low flow rate infusates
US5938634A (en) 1995-09-08 1999-08-17 Baxter International Inc. Peritoneal dialysis system with variable pressure drive
DE19534413C1 (en) 1995-09-16 1997-05-28 Fresenius Ag Connection arrangement and method for connecting two individual parts of a medical system
DE19534455C1 (en) 1995-09-16 1996-12-12 Fresenius Ag Multilayer plastics tube free from PVC, for medical purposes
US5681294A (en) 1995-09-21 1997-10-28 Abbott Laboratories Fluid delivery set
US5730730A (en) 1995-09-29 1998-03-24 Darling, Jr.; Phillip H. Liquid flow rate control device
AU7016396A (en) 1995-10-10 1997-04-30 Donald Kuhnel Fluid heater with improved heating elements controller
US5830185A (en) 1995-10-12 1998-11-03 Instrumentarium Corp. Position-independent fluid trap
DE19546028C2 (en) 1995-12-09 2000-04-27 Fresenius Ag Balancing disposable for balancing liquids for a medical treatment device and a medical treatment device with a system insert for receiving such a balancing disposable
DE19546027C1 (en) 1995-12-09 1997-04-03 Fresenius Ag Appts. removing toxic substances from blood by dialysis or related techniques
US5790752A (en) 1995-12-20 1998-08-04 Hytec Flow Systems Efficient in-line fluid heater
JPH1071201A (en) * 1996-01-19 1998-03-17 Terumo Corp Hemocatharsis drainage regenerating device, hemocatharsis liquid circuit, and hemocatharsis device
EP0892664A4 (en) 1996-03-08 1999-09-15 Baxter Research Medical Inc Selective membrane/sorption techniques for salvaging blood
IT1285624B1 (en) 1996-03-18 1998-06-18 Bellco Spa EQUIPMENT FOR DIALYSIS TREATMENTS
US5774042A (en) 1996-04-04 1998-06-30 Williams Control Industries, Inc. Device for providing tactile indication of pedal position
DE19617036C2 (en) 1996-04-27 2003-12-04 Fresenius Ag Device for separating gas bubbles from blood
US5724478A (en) 1996-05-14 1998-03-03 Truheat Corporation Liquid heater assembly
DE19620591B4 (en) 1996-05-22 2004-08-26 Fresenius Medical Care Deutschland Gmbh Device for removing gases from liquids
JPH09327511A (en) * 1996-06-12 1997-12-22 A S A Sangyo Kk Method for recovering and regenerating peritoneal dialysis liquid and treating device and ancillary appliance for this purpose
FR2749761B1 (en) 1996-06-18 1998-07-31 Hospal Ind DISINFECTION PROCESS FOR A DIALYSIS MACHINE
JPH1085324A (en) 1996-09-19 1998-04-07 A S A Sangyo Kk Sterilization and disinfecting of recovering and reclaiming apparatus of peritoneal dialyzing fluid, and sterilization and storage of dialyzing liquid
US5895368A (en) 1996-09-23 1999-04-20 Medisystems Technology Corporation Blood set priming method and apparatus
IL119310A (en) 1996-09-26 1999-07-14 Metabogal Ltd Cell/tissue culturing device and method
US5902336A (en) 1996-10-15 1999-05-11 Mirimedical, Inc. Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
US5875282A (en) 1996-10-21 1999-02-23 Gaymar Industries, Inc. Medical apparatus for warming patient fluids
US6409699B1 (en) 1996-10-22 2002-06-25 Renal Solutions, Inc. Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
US6238366B1 (en) * 1996-10-31 2001-05-29 Ethicon, Inc. System for fluid retention management
US6129699A (en) 1997-10-31 2000-10-10 Sorenson Development, Inc. Portable persistaltic pump for peritoneal dialysis
JP3970938B2 (en) 1996-11-22 2007-09-05 セラコス・インコーポレイテッド Fluid pump device with constant flow rate
DE69732249T2 (en) 1996-11-22 2005-12-08 Therakos, Inc. CASSETTE FOR CONTROLLING AND PUMPING FLUIDS
WO1998023353A1 (en) 1996-11-26 1998-06-04 Medisystems Technology Corporation Wide bubble traps
US6117342A (en) 1996-11-26 2000-09-12 Medisystems Technology Corporation Bubble trap with directed horizontal flow and method of using
DE19650407A1 (en) 1996-12-05 1998-06-10 Kevin Business Corp Blood-gas separation method and device
DE19650406A1 (en) 1996-12-05 1998-06-18 Kevin Business Corp Blood suction device
US5876611A (en) * 1997-06-16 1999-03-02 Shettigar; U. Ramakrishna Intraoperative blood salvaging system and method
DE19700466A1 (en) 1997-01-09 1998-07-16 Polaschegg Hans Dietrich Dr Hemodiafiltration device and method
FR2758394B1 (en) 1997-01-14 1999-03-19 Hospal Ind MEANS FOR THE SPECIFIC BIO-PURIFICATION OF A BIOLOGICAL FLUID
US6193684B1 (en) 1997-01-21 2001-02-27 Vasca, Inc. Device for percutaneous peritoneal dialysis
US5879329A (en) 1997-01-22 1999-03-09 Radiant Medical, Inc. Infusion systems and methods for introducing fluids into the body within a desired temperature range
IL120070A (en) 1997-01-24 2000-12-06 Zicherman Yehuda Peritoneal dialysis apparatus and method
DE19702441C1 (en) 1997-01-24 1998-02-26 Fresenius Medical Care De Gmbh Dialysis recirculation monitoring
US6589482B1 (en) 1997-02-14 2003-07-08 Nxstage Medical, Inc. Extracorporeal circuits for performing hemofiltration employing pressure sensing without an air interface
US6673314B1 (en) 1997-02-14 2004-01-06 Nxstage Medical, Inc. Interactive systems and methods for supporting hemofiltration therapies
US20010016699A1 (en) * 1997-02-14 2001-08-23 Jeffrey H. Burbank Hemofiltration system
US6638478B1 (en) 1997-02-14 2003-10-28 Nxstage Medical, Inc. Synchronized volumetric fluid balancing systems and methods
US6638477B1 (en) 1997-02-14 2003-10-28 Nxstage Medical, Inc. Fluid replacement systems and methods for use in hemofiltration
US6830553B1 (en) 1997-02-14 2004-12-14 Nxstage Medical, Inc. Blood treatment systems and methods that maintain sterile extracorporeal processing conditions
US6554789B1 (en) 1997-02-14 2003-04-29 Nxstage Medical, Inc. Layered fluid circuit assemblies and methods for making them
EP1235613B1 (en) 1997-02-14 2011-02-09 NxStage Medical, Inc. Fluid processing systems using extracorporeal fluid flow panels oriented within a cartridge
US6595943B1 (en) 1997-02-14 2003-07-22 Nxstage Medical, Inc. Systems and methods for controlling blood flow and waste fluid removal during hemofiltration
US6852090B2 (en) 1997-02-14 2005-02-08 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US5858239A (en) 1997-02-14 1999-01-12 Aksys, Ltd. Methods and apparatus for adjustment of blood drip chamber of dialysis machines using touchscreen interface
US6979309B2 (en) * 1997-02-14 2005-12-27 Nxstage Medical Inc. Systems and methods for performing blood processing and/or fluid exchange procedures
US20040243047A1 (en) 1997-02-14 2004-12-02 Brugger James M. Single step fluid circuit engagement device and method
DE19708391C1 (en) 1997-03-01 1998-10-22 Fresenius Medical Care De Gmbh Method and device for ultrafiltration in hemodialysis
US5983947A (en) 1997-03-03 1999-11-16 Medisystems Technology Corporation Docking ports for medical fluid sets
US6051134A (en) 1997-03-28 2000-04-18 Medisystems Technology Corporation Bubble trap having common inlet/outlet tube
US5980481A (en) 1997-05-08 1999-11-09 Transvivo, Inc. Method and apparatus for continuous peritoneal cascade dialysis and hemofiltration (CPCD/H)
US5919357A (en) 1997-05-20 1999-07-06 United States Filter Corporation Filter cartridge assembly
AU7696198A (en) 1997-05-22 1998-12-11 Medtrain, Inc. Apparatus and method for high efficiency hemofiltration
FR2771931B1 (en) 1997-12-09 2000-01-07 Hospal Ind METHOD FOR DETERMINING A SIGNIFICANT PARAMETER OF THE PROGRESS OF AN EXTRACORPOREAL BLOOD TREATMENT
SE509602C2 (en) 1997-06-05 1999-02-15 Gambro Med Tech Ab Two-way valve
DE19825158C1 (en) * 1997-07-09 1999-04-08 Fresenius Medical Care De Gmbh Disposable film container containing dialysis fluid concentrate
US6069343A (en) 1997-07-17 2000-05-30 Kolowich; J. Bruce Peritoneal dialysis solution warmer
US6228047B1 (en) 1997-07-28 2001-05-08 1274515 Ontario Inc. Method and apparatus for performing peritoneal dialysis
CA2211848C (en) 1997-07-28 2002-06-11 Joseph E. Dadson Peritoneal dialysis apparatus
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US6010623A (en) 1997-08-01 2000-01-04 Medisystems Technology Corporation Bubble trap with flat side
DE19734002C1 (en) 1997-08-06 1998-09-17 Fresenius Medical Care De Gmbh Blood dialysis process with process monitoring system on dialysis machine
DE59814205D1 (en) 1997-08-13 2008-05-21 Fresenius Medical Care De Gmbh A blood treatment device comprising a device for determining parameters of hemodialysis and methods for its determination
AU9028498A (en) 1997-08-22 1999-03-16 Deka Products Limited Partnership System, method and cassette for mixing and delivering intravenous drugs
DE19738816A1 (en) 1997-09-05 1999-03-11 November Ag Molekulare Medizin Method for marking solid, liquid or gaseous substances
SE510286C2 (en) 1997-09-22 1999-05-10 Gambro Med Tech Ab Method and Device for Monitoring Infusion Pump in a Hemo or Hemodia Filtration Machine
US6187198B1 (en) 1997-10-21 2001-02-13 Dsu Medical Corporation Automatic priming of connected blood sets
US5951870A (en) 1997-10-21 1999-09-14 Dsu Medical Corporation Automatic priming of blood sets
JPH11137672A (en) 1997-11-05 1999-05-25 Asa Sangyo Kk Method for recovering and regenerating peritoneal dialyzane and apparatus therefor
US5931990A (en) 1997-12-03 1999-08-03 Coronator Tank for removing unabsorbed gas from a mixture of unabsorbed gas and liquid
US6139528A (en) 1998-01-13 2000-10-31 Jireh International Corporation Intravenous warming system
US7004924B1 (en) 1998-02-11 2006-02-28 Nxstage Medical, Inc. Methods, systems, and kits for the extracorporeal processing of blood
US5928889A (en) 1998-02-13 1999-07-27 S.C. Johnson & Son, Inc. Protocol for simulated natural biofilm formation
JPH11226121A (en) 1998-02-19 1999-08-24 Nikkiso Co Ltd Maintaining method and maintaining device for extracorporeal circulation teletherapeutic unit
US6582385B2 (en) * 1998-02-19 2003-06-24 Nstage Medical, Inc. Hemofiltration system including ultrafiltrate purification and re-infusion system
US6046806A (en) 1998-03-25 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Flow-through cell culture chamber
DE19814047C1 (en) 1998-03-30 1999-05-06 Fresenius Medical Care De Gmbh Patient connector for kidney dialysis machine
DE19814695C2 (en) 1998-04-01 2001-09-13 Fresenius Medical Care De Gmbh Cassette for conveying liquids, in particular dialysis liquids, dialysis machine and method for conveying, balancing, dosing and heating a medical fluid
DE19814687C1 (en) 1998-04-01 1999-02-18 Fresenius Medical Care De Gmbh Blood dialysis assembly
US6071269A (en) 1998-05-13 2000-06-06 Medisystems Technology Corporation Blood set and chamber
US5989318A (en) 1998-05-19 1999-11-23 International Fuel Cells Corporation Apparatus for separating water from a two-phase stream
US6019824A (en) 1998-06-09 2000-02-01 Medisystems Technology Corporation Bubble trap chamber
JP2000072658A (en) * 1998-06-17 2000-03-07 Nissho Corp Peritoneal dialysing liquid and peritoneal dialysis
EP0980685B1 (en) 1998-06-17 2006-01-25 Nipro Corporation Use of a fluid for the manufacture of a dialysis fluid for continuous recirculating peritoneal dialysis
DE19828923C5 (en) 1998-06-29 2010-10-28 Fresenius Medical Care Deutschland Gmbh Heating for heating of medical fluids
US6293921B1 (en) 1998-07-06 2001-09-25 Jms Company, Ltd. Automatic exchanger for peritoneal dialysis
DE19830928C1 (en) 1998-07-10 1999-05-06 Fresenius Medical Care De Gmbh Kidney dialysis balance has two chambers each sub-divided by flexible membrane
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US6175688B1 (en) 1998-07-10 2001-01-16 Belmont Instrument Corporation Wearable intravenous fluid heater
DE19831235C1 (en) 1998-07-11 2000-03-16 Fresenius Ag Sterile connector for containers containing medical liquids
IT1304042B1 (en) 1998-07-17 2001-03-02 Gvs S R L DRIP CHAMBER FOR TRANSFUSIONAL SETS, FOR DIALYSIS, SIMILAR INFUSIONS.
US6331252B1 (en) 1998-07-31 2001-12-18 Baxter International Inc. Methods for priming a blood compartment of a hemodialyzer
WO2000009182A1 (en) 1998-08-11 2000-02-24 Alpamed S.A. Fluid driving device
JP4053154B2 (en) 1998-09-16 2008-02-27 株式会社クラレ Blood treatment device with improved water removal control accuracy
US5957153A (en) 1998-09-18 1999-09-28 Frey Turbodynamics, Ltd. Oscillating dual bladder balanced pressure proportioning pump system
US6142974A (en) 1998-09-18 2000-11-07 Estill Medical Technologies, Incorporated Portable I.V. fluid warming system
US6245039B1 (en) 1998-10-05 2001-06-12 Vasca, Inc. Methods and apparatus for performing flow-through peritoneal dialysis
JP2000107286A (en) * 1998-10-07 2000-04-18 Akira Sakai Perfusion apparatus for peritoneal dialyzate and perfusion method
JP3695506B2 (en) 1998-10-07 2005-09-14 ニプロ株式会社 Dialysis machine and washing priming method
FR2785200B1 (en) * 1998-10-30 2001-03-30 Centre Nat Rech Scient USE OF AN ADSORBENT GEL TO ELIMINATE AND PURIFY BIOMOLECULES
DE19850830B4 (en) 1998-11-04 2004-12-30 Fresenius Medical Care Deutschland Gmbh Process for the preparation of a solution, in particular a dialysis or infusion solution
JP4348757B2 (en) 1998-11-12 2009-10-21 ソニー株式会社 Semiconductor device
JP2000156822A (en) 1998-11-19 2000-06-06 Sony Corp Clamp circuit
SE512683C2 (en) * 1998-11-20 2000-05-02 Gambro Ab Method and apparatus for preventing protein loss in peritoneal dialysis
DE19854338B4 (en) 1998-11-25 2005-11-17 Ulrich Dr.med. Saueressig Method and device for renal replacement therapy
US20100332149A1 (en) 1998-12-17 2010-12-30 Hach Company Method and system for remote monitoring of fluid quality and treatment
US9056783B2 (en) 1998-12-17 2015-06-16 Hach Company System for monitoring discharges into a waste water collection system
US6142975A (en) 1998-12-31 2000-11-07 Advanced Cardiovascular Systems, Inc. Guidewire having braided wire over drawn tube construction
US6261261B1 (en) 1999-01-05 2001-07-17 Lawrence O. Gordon Infrared heating device for prewarming IV solutions
JP2000217908A (en) 1999-01-29 2000-08-08 Asahi Medical Co Ltd Blood collection device
US6168578B1 (en) 1999-02-18 2001-01-02 Melvin Diamond Portable kidney dialysis system
US6254567B1 (en) 1999-02-26 2001-07-03 Nxstage Medical, Inc. Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration
US6274103B1 (en) 1999-03-26 2001-08-14 Prismedical Corporation Apparatus and method for preparation of a peritoneal dialysis solution
EP1177025A4 (en) 1999-03-03 2003-05-02 Prismedical Corp Improved water purification pack
WO2000057928A1 (en) 1999-03-30 2000-10-05 Gambro Lundia Ab Method and apparatus for sterilising a heat sensitive fluid
FR2791574B1 (en) 1999-03-30 2002-06-14 Hospal Ind METHOD AND DEVICE FOR STERILIZING AND DISPENSING A LIQUID FOR MEDICAL USE
FR2791575B1 (en) 1999-03-30 2002-06-28 Hospal Ind METHOD AND DEVICE FOR STERILIZING AND DISPENSING A LIQUID FOR MEDICAL USE
FR2791576B1 (en) 1999-03-30 2002-06-14 Hospal Ind METHOD AND DEVICE FOR STERILIZING AND DISPENSING A LIQUID FOR MEDICAL USE
JP3928910B2 (en) 1999-04-12 2007-06-13 旭化成メディカル株式会社 Polysulfone blood treatment module
AU759854C (en) * 1999-04-23 2004-01-08 Cytopherx, Inc. Extracorporeal circuit and related methods
IL145897A0 (en) 1999-04-30 2002-07-25 Childrens Hosp Medical Center Hemofiltration system
US6229957B1 (en) 1999-05-14 2001-05-08 Joseph Baker Physiological fluid warming process and apparatus
AU782343B2 (en) 1999-05-28 2005-07-21 Cepheid Apparatus and method for analyzing a fluid sample
EP1200182A4 (en) 1999-06-04 2005-02-23 Dialysis Systems Inc Centralized bicarbonate mixing system
EP1059083B1 (en) 1999-06-07 2004-04-14 Nipro Corporation A solid pharmaceutical preparation for dialysis and a process for producing the same
US6447491B1 (en) 1999-06-18 2002-09-10 Genzyme Corporation Rolling seal suction pressure regulator, apparatus and system for draining a body cavity and methods related thereto
JP2001020483A (en) 1999-07-06 2001-01-23 Hasegawa Kogyo Co Ltd Step canceling apparatus
US6322551B1 (en) 1999-07-09 2001-11-27 Gambro Inc. Break-apart tubing connectors for use in dialysis blood tubing sets
US6302653B1 (en) 1999-07-20 2001-10-16 Deka Products Limited Partnership Methods and systems for detecting the presence of a gas in a pump and preventing a gas from being pumped from a pump
US6416293B1 (en) 1999-07-20 2002-07-09 Deka Products Limited Partnership Pumping cartridge including a bypass valve and method for directing flow in a pumping cartridge
US6382923B1 (en) 1999-07-20 2002-05-07 Deka Products Ltd. Partnership Pump chamber having at least one spacer for inhibiting the pumping of a gas
US6406631B1 (en) 1999-07-30 2002-06-18 Nephros, Inc. Two stage diafiltration method and apparatus
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
JP2003511103A (en) 1999-10-06 2003-03-25 メムブラーナ ゲゼルシャフト ミット ベシュレンクテル ハフツング Membrane module for hemodiafiltration with integrated pre-dilution or post-dilution of blood
US6251167B1 (en) 1999-10-21 2001-06-26 Berson Research Corp. Machine and process for removing dissolved gasses from liquids
US6517508B1 (en) 1999-11-03 2003-02-11 Dsu Medical Corporation Set for blood processing
FR2800618B1 (en) 1999-11-08 2002-02-22 Bert Christophe HEMO-FILTRATION APPARATUS FOR INDEPENDENTLY CONTROLLING THE CONCENTRATION OF AT LEAST TWO IONIC SUBSTANCES IN THE INTERIOR OF A PATIENT
DE19953837A1 (en) 1999-11-09 2001-05-23 Fresenius Medical Care De Gmbh Software update for a medical device
EP1240494A2 (en) 1999-11-29 2002-09-18 NxStage Medical, Inc. Systems and methods for detecting air in an arterial blood line of a blood processing circuit
WO2001047576A2 (en) 1999-11-29 2001-07-05 Nxstage Medical, Inc. Compositions for replacement fluid and associated systems and methods usable in the performance of frequent hemofiltration
ATE454917T1 (en) 1999-11-29 2010-01-15 Nxstage Medical Inc ARRANGEMENTS FOR SYNCHRONIZED VOLUMETRIC ACCOUNTING OF LIQUIDS
DE19959230C1 (en) * 1999-12-08 2001-04-05 Fresenius Medical Care De Gmbh Two-sheet pouch, used as disposable haemodialysis container, comprises top and bottom closed by convex weld seams and is repeatedly folded parallel to its vertical axis
US6251279B1 (en) 1999-12-09 2001-06-26 Dialysis Systems, Inc. Heat disinfection of a water supply
US6776912B2 (en) * 1999-12-23 2004-08-17 Membrana Gmbh Hemodiafiltration system and method
IT1308687B1 (en) 1999-12-28 2002-01-09 Gambro Dasco Spa METHOD AND DEVICE FOR THE DETECTION OF ACCESS TO THE CARDIVASCULAR SYSTEM IN AN EXTRA-BODY BLOOD TREATMENT IN A
US6315895B1 (en) 1999-12-30 2001-11-13 Nephros, Inc. Dual-stage hemodiafiltration cartridge
DE10011208C1 (en) 2000-03-08 2001-09-27 Fresenius Medical Care De Gmbh Blood dialysis and/or filtration device filling and/or rinsing method uses sterile liquid filtered by passing through dialysis membrane or sterile filter with collection in empty reinfusion container
JP2001270856A (en) 2000-03-24 2001-10-02 Dainippon Ink & Chem Inc Method for producing n-(meth) acryloyloxyethylacrylamide
GB2362337A (en) 2000-05-18 2001-11-21 Millipore Corp Bubble trap for removing gas/gas and solids from flowing liquid
JP2001346868A (en) 2000-06-12 2001-12-18 Teijin Ltd Dialysate preparation device and artificial dialyzing device
US6595944B2 (en) 2000-06-17 2003-07-22 Fresenius Medical Care Deutschland Gmbh Dialysis machine and method of operating a dialysis machine
US6607669B2 (en) 2000-06-23 2003-08-19 Scilog, Inc. Method and apparatus for enhancing filtration yields in tangential flow filtration
DK1175917T3 (en) 2000-07-07 2008-01-07 Fresenius Medical Care De Gmbh hemodialysis
JP4000584B2 (en) 2000-07-14 2007-10-31 ニプロ株式会社 Dialysate preparation device
JP3719375B2 (en) 2000-07-26 2005-11-24 ニプロ株式会社 Solution preparation equipment
US6845886B2 (en) 2000-08-23 2005-01-25 Paul Henry Valve for dispensing two liquids at a predetermined ratio
DE10042324C1 (en) 2000-08-29 2002-02-07 Fresenius Medical Care De Gmbh Blood dialysis device has feed line provided with 2 parallel branches for single needle and dual needle operating modes
DE10047421C1 (en) 2000-09-26 2003-01-02 Klaus Sodemann Method and device for ultrafiltration control in blood treatment methods
JP2002102336A (en) 2000-09-27 2002-04-09 Nipro Corp Solid dialyzing pharmaceutical preparation and method of preparing for the same
JP3899506B2 (en) 2000-09-27 2007-03-28 ニプロ株式会社 Preparation for solid dialysis and method for producing the same
JP4643815B2 (en) * 2000-10-04 2011-03-02 テルモ株式会社 Peritoneal dialysis machine
DE10049393A1 (en) 2000-10-05 2002-04-25 Braun Melsungen Ag Extracorporeal blood treatment system
EP1343576B1 (en) 2000-10-19 2007-02-21 Nephros, Inc. Method and apparatus for generating a sterile infusion fluid
US6627164B1 (en) * 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
CA2430575C (en) 2000-12-08 2009-04-07 Nephros, Inc. Valve mechanism for infusion fluid systems
WO2002049745A1 (en) 2000-12-20 2002-06-27 Nephros, Inc. Multistage hemodiafiltration/hemofiltration method and apparatus
DE10100146B4 (en) 2001-01-03 2004-11-25 Fresenius Medical Care Deutschland Gmbh Dialysis machine and method for operating the same
US20030034305A1 (en) 2001-01-05 2003-02-20 Gambro, Inc. Purified water supply system for high demand devices and applications
US6730267B2 (en) * 2001-02-09 2004-05-04 Cardiovention, Inc. Integrated blood handling system having active gas removal system and methods of use
WO2002066099A2 (en) * 2001-02-16 2002-08-29 Piedmont Renal Clinics, P.A. Automated peritoneal dialysis system and process with in-line sterilization of dialysate
CN1372978A (en) 2001-02-19 2002-10-09 尼普洛株式会社 Dialysis system and its operation method
US6572641B2 (en) 2001-04-09 2003-06-03 Nxstage Medical, Inc. Devices for warming fluid and methods of use
CN100351006C (en) 2001-05-14 2007-11-28 沃特海尔斯国际公司 Powered sterile solution device
US20050020960A1 (en) 2001-05-24 2005-01-27 Brugger James M. Blood treatment cartridge and blood processing machine with slot
ITBO20010353A1 (en) 2001-06-05 2002-12-05 Gambro Dasco Spa DIALIZING LIQUID PREPARATION DEVICE FOR A DIALYSIS MACHINE
JP2003010317A (en) * 2001-07-02 2003-01-14 Nippon Colin Co Ltd Dialyzer
US6572576B2 (en) 2001-07-07 2003-06-03 Nxstage Medical, Inc. Method and apparatus for leak detection in a fluid line
US6702561B2 (en) 2001-07-12 2004-03-09 Nxstage Medical, Inc. Devices for potting a filter for blood processing
US6649063B2 (en) 2001-07-12 2003-11-18 Nxstage Medical, Inc. Method for performing renal replacement therapy including producing sterile replacement fluid in a renal replacement therapy unit
US20030010718A1 (en) 2001-07-12 2003-01-16 Nxstage Medical, Inc. Hemodilution cap and methods of use in blood-processing procedures
US20030010717A1 (en) 2001-07-13 2003-01-16 Nx Stage Medical, Inc. Systems and methods for handling air and/or flushing fluids in a fluid circuit
US6743193B2 (en) 2001-07-17 2004-06-01 Nx Stage Medical, Inc. Hermetic flow selector valve
CA2455410C (en) 2001-07-27 2011-09-13 Jms Co., Ltd. Blood dialyzer
US6843779B1 (en) 2001-09-17 2005-01-18 Mirimedical, Llc Hemodialysis system
WO2003040042A1 (en) 2001-11-05 2003-05-15 Bionomics Ltd. Apparatus and method for producing purified water having high microbiological purity by using a reverse osmosis membrane assembly
US6960179B2 (en) * 2001-11-16 2005-11-01 National Quality Care, Inc Wearable continuous renal replacement therapy device
US7309323B2 (en) * 2001-11-16 2007-12-18 National Quality Care, Inc. Wearable continuous renal replacement therapy device
EP1314442A1 (en) * 2001-11-26 2003-05-28 Infomed S.A. Intra- and extracorporeal purification device
ITMI20012829A1 (en) 2001-12-28 2003-06-28 Gambro Dasco Spa APPARATUS AND METHOD OF CONTROL IN A BLOOD EXTRACORPOREAL CIRCUIT
US6752928B2 (en) 2002-01-10 2004-06-22 Delphi Technologies, Inc. Flow matching method and system using two transducers
US6746606B2 (en) 2002-01-11 2004-06-08 Delphi Technologies, Inc. Method and system for matching flow rate
US7153285B2 (en) 2002-01-17 2006-12-26 Baxter International Inc. Medical fluid heater using radiant energy
US6796955B2 (en) 2002-02-14 2004-09-28 Chf Solutions, Inc. Method to control blood and filtrate flowing through an extracorporeal device
US6745903B2 (en) 2002-03-14 2004-06-08 Peter Grandics Methods for the on-line, on-demand preparation of sterile, water-for-injection grade water
US7175606B2 (en) 2002-05-24 2007-02-13 Baxter International Inc. Disposable medical fluid unit having rigid frame
DE10224750A1 (en) 2002-06-04 2003-12-24 Fresenius Medical Care De Gmbh Device for the treatment of a medical fluid
AU2003237403A1 (en) 2002-06-06 2003-12-22 Nxstage Medical, Inc. Last-chance quality check and/or air/pyrogen filter for infusion systems
JP4129726B2 (en) * 2002-07-17 2008-08-06 ニプロ株式会社 Peritoneal dialysis machine
US7008403B1 (en) 2002-07-19 2006-03-07 Cognitive Ventures Corporation Infusion pump and method for use
ATE505223T1 (en) * 2002-07-19 2011-04-15 Baxter Int SYSTEM FOR PERITONEAL DIALYSIS
ES2339239T3 (en) 2002-07-19 2010-05-18 Baxter International Inc. SYSTEM FOR PERITONEAL DIALYSIS.
US7112273B2 (en) 2002-09-27 2006-09-26 Nxstage Medical, Inc. Volumetric fluid balance control for extracorporeal blood treatment
US8071055B2 (en) 2002-12-04 2011-12-06 Blue Water Technologies, Inc. Water treatment techniques
JP2004205146A (en) 2002-12-26 2004-07-22 Fuji Electric Fa Components & Systems Co Ltd Steam generator
US20080210606A1 (en) 2004-01-07 2008-09-04 Jeffrey Burbank Filtration System Preparation of Fluids for Medical Applications
JP2004209103A (en) 2003-01-07 2004-07-29 Terumo Corp Peritoneal dialysis apparatus
US9700663B2 (en) 2005-01-07 2017-07-11 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
DE602004021672D1 (en) 2003-01-07 2009-08-06 Nxstage Medical Inc CHARGE FILTRATION SYSTEM FOR PRODUCING A STERILE SPARELIFE FLUID FOR NURSING TREATMENTS
WO2004066121A2 (en) 2003-01-15 2004-08-05 Nxstage Medical Inc. Waste balancing for extracorporeal blood treatment systems
DE10302580B4 (en) 2003-01-22 2008-12-11 Danfoss A/S Water-cleaning device
US6890157B2 (en) 2003-02-05 2005-05-10 Delphi Technologies, Inc. Matching or not matching flow rates in two fluidly-unconnected flow paths
US7314554B2 (en) 2003-02-07 2008-01-01 Gambro Lundia Ab Extracorporeal blood treatment machine
US7223336B2 (en) 2003-02-07 2007-05-29 Gambro Lundia Ab Integrated blood treatment module and extracorporeal blood treatment apparatus
US6902670B2 (en) 2003-03-19 2005-06-07 Kuo-Hsin Ho Hemodialysis machine
ITMO20030080A1 (en) 2003-03-21 2004-09-22 Gambro Lundia Ab CIRCUIT FOR THE EXTRACORPOREAL BLOOD CIRCULATION.
US7169303B2 (en) * 2003-05-28 2007-01-30 Hemocleanse Technologies, Llc Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
JP4352775B2 (en) 2003-06-19 2009-10-28 株式会社ジェイ・エム・エス Hemodiafiltration machine
US7435236B2 (en) 2003-06-27 2008-10-14 Navilyst Medical, Inc. Pressure actuated valve with improved biasing member
JP4089530B2 (en) 2003-06-30 2008-05-28 澁谷工業株式会社 Dialysis machine
MX351817B (en) 2003-10-28 2017-10-30 Baxter Healthcare Sa Improved priming, integrity and head height methods and apparatuses for medical fluid systems.
US8038639B2 (en) 2004-11-04 2011-10-18 Baxter International Inc. Medical fluid system with flexible sheeting disposable unit
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
AU2004286782B2 (en) 2003-11-07 2010-08-26 Gambro Lundia Ab Fluid distribution module and extracorporeal blood circuit including such a module
EP1578314B1 (en) * 2003-11-07 2007-05-30 Impliant Ltd. Spinal prostheses
US7435342B2 (en) * 2003-12-24 2008-10-14 Chemica Technologies, Inc. Dialysate regeneration system for portable human dialysis
ATE462456T1 (en) 2004-07-08 2010-04-15 Peter Taboada S L SYSTEM FOR PRETREATING WATER FOR HEMODIALYSIS
NZ562961A (en) 2005-04-07 2011-03-31 Benjamin Paul Baker Heat exchangers for cooling beverages, the exchanger having adjustable baffles to change the heat transfer characteristics
US20100137693A1 (en) 2005-11-01 2010-06-03 Fresenius Medical Care Holdings, Inc. Methods and systems for patient care
EP1813302A1 (en) 2006-01-25 2007-08-01 Debiotech S.A. Fluid volume measurement device for medical use
FR2896792B1 (en) 2006-01-27 2008-07-18 Millipore Corp SYSTEM AND METHOD FOR PURIFYING WATER
DE102006012198A1 (en) 2006-03-16 2007-09-27 Seccua Gmbh Controls of a filtration system
ATE477438T1 (en) 2006-04-07 2010-08-15 Nxstage Medical Inc HOSE CLAMP FOR MEDICAL APPLICATIONS
JP4004523B1 (en) 2006-04-21 2007-11-07 株式会社日本トリム Dialysate preparation water, dialysate using the same, dialysate production method and dialyzer
US20080045877A1 (en) 2006-08-15 2008-02-21 G&L Consulting, Llc Blood exchange dialysis method and apparatus
FR2909013B1 (en) 2006-11-28 2011-02-25 Commissariat Energie Atomique THIN FILM COATING PROCESS
US20090008318A1 (en) 2006-12-04 2009-01-08 Prismedical Corporation Modular Water Purification and Delivery System
DE102007009269B4 (en) 2007-02-26 2010-11-11 Fresenius Medical Care Deutschland Gmbh Device and method for filling and / or emptying a dialysis machine
KR101861192B1 (en) 2007-02-27 2018-05-28 데카 프로덕츠 리미티드 파트너쉽 Hemodialysis apparatus and methods
DE102007022547A1 (en) 2007-05-15 2008-11-20 Völker, Manfred Device for supplying water to a dialysis machine
CA2686319C (en) 2007-05-25 2012-11-13 Gambro Lundia Ab A device for connecting to a liquid source
US8078333B2 (en) 2007-07-05 2011-12-13 Baxter International Inc. Dialysis fluid heating algorithms
US8597505B2 (en) 2007-09-13 2013-12-03 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
CN107376045B (en) 2008-01-18 2020-08-07 弗雷塞尼斯医疗保健控股公司 Removal of carbon dioxide gas from a fluid circuit of a dialysis device
US7892423B2 (en) 2008-02-14 2011-02-22 Baxter International Inc. Dialysis system including multi-heater power coordination
US20100051546A1 (en) 2008-07-03 2010-03-04 Dxv Water Technologies, Llc Water treatment systems and methods
US10265454B2 (en) 2008-07-25 2019-04-23 Baxter International Inc. Dialysis system with flow regulation device
DE102008038751B3 (en) 2008-08-12 2010-04-15 Fresenius Medical Care Deutschland Gmbh Reverse osmosis system with a device for noise reduction and method for noise reduction of a reverse osmosis system
FR2937968B1 (en) 2008-10-30 2012-10-26 Commercialisation Rech S Realisation WATER TREATMENT AND DISTRIBUTION SYSTEM FOR DIALYSIS
GB0910247D0 (en) 2009-06-15 2009-07-29 Imi Vision Ltd Dialysis machine calibration
US8801922B2 (en) 2009-06-24 2014-08-12 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Dialysis system
US8685251B2 (en) 2009-12-05 2014-04-01 Home Dialysis Plus, Ltd. Ultra-pasteurization for dialysis machines
JP2011115783A (en) 2009-10-30 2011-06-16 Fujifilm Corp Apparatus and method for purifying water
US20110189048A1 (en) 2009-12-05 2011-08-04 Curtis James R Modular dialysis system
DE102010022201A1 (en) 2010-05-20 2011-11-24 Fresenius Medical Care Deutschland Gmbh Medical treatment arrangement
EP2684147B2 (en) 2011-03-08 2022-06-08 Gambro Lundia AB Method, control module, apparatus and system for transferring data
EP2688602B1 (en) 2011-03-23 2019-11-06 NxStage Medical, Inc. Peritoneal dialysis systems, devices, and methods
FR2980712B1 (en) 2011-10-03 2013-10-04 Physidia DIALYSIS MACHINE COMPRISING MEANS FOR ULTRAFILTRATION AND RETROFILTRATION

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669880A (en) * 1969-06-30 1972-06-13 Cci Aerospace Corp Recirculation dialysate system for use with an artificial kidney machine
FR2154983A5 (en) * 1971-10-01 1973-05-18 Thomson Csf Artificial kidney machine - uses closed circuit regeneration of small volume of dialysis liquid
US4137168A (en) * 1976-10-02 1979-01-30 Klauschenz & Perrot Kg Device for dialysation of blood
US4213859A (en) * 1977-04-12 1980-07-22 Akzo N.V. Dialysis with ion exchange extraction of phosphates
US4269708A (en) * 1978-05-03 1981-05-26 Vittorio Bonomini Hemodialysis and/or ultrafiltration apparatus
US4464172A (en) * 1979-04-30 1984-08-07 Lichtenstein Eric Stefan Computer-control medical care system
DE3110128A1 (en) * 1981-03-16 1982-09-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Process and apparatus for the detoxication and regeneration of blood, blood constituents and solutions resulting from the purification of blood, as well as kit for carrying out the process
US4684460A (en) * 1984-12-14 1987-08-04 Gerald Issautier Haemodialysis device automatically monitoring loss of weight
US5522998A (en) * 1993-03-18 1996-06-04 Fresenius Ag Hemodialysis apparatus having a single balance chamber and method of dialyzing blood therewith
WO2002030489A2 (en) * 2000-10-12 2002-04-18 Baxter International Inc. Peritoneal dialysis catheters
WO2003041764A1 (en) * 2001-11-13 2003-05-22 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US20030113931A1 (en) * 2001-12-14 2003-06-19 Li Pan Ammonia and ammonium sensors

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572922B2 (en) 2003-01-27 2009-08-11 Merck & Co., Inc. Substituted pyrazoles, compositions containing such compounds and methods of use
US7598285B2 (en) 2004-06-04 2009-10-06 Merck & Co., Inc Pyrazole derivatives, compositions containing such compounds and methods of use
US7799818B2 (en) 2004-06-04 2010-09-21 Merck Sharp & Dohme Corp. Pyrazole derivatives, compositions containing such compounds and methods of use
US7625938B2 (en) 2004-07-22 2009-12-01 Merck & Co., Inc. Substituted pyrazoles, compositions containing such compounds and methods of use
US7709658B2 (en) 2005-07-26 2010-05-04 Merck Sharp & Dohme Corp. Process for synthesizing a substituted pyrazole
WO2007028056A3 (en) * 2005-09-02 2007-06-28 Advanced Renal Therapies Inc Extracorporeal renal dialysis system
WO2007028056A2 (en) * 2005-09-02 2007-03-08 Advanced Renal Therapies, Inc. Extracorporeal renal dialysis system
CN100435863C (en) * 2006-01-10 2008-11-26 赵滨宇 One-way hematodialysis circulating device
WO2007103411A3 (en) * 2006-03-08 2007-11-01 Fresenius Med Care Hldg Inc Wearable kidney
AU2007223935B2 (en) * 2006-03-08 2010-02-18 Fresenius Medical Care Holdings, Inc. Wearable kidney
US8715221B2 (en) 2006-03-08 2014-05-06 Fresenius Medical Care Holdings, Inc. Wearable kidney
WO2007103411A2 (en) 2006-03-08 2007-09-13 Fresenius Medical Care Holdings, Inc. Wearable kidney
US8012118B2 (en) 2006-03-08 2011-09-06 Fresenius Medical Care Holdings, Inc. Artificial kidney dialysis system
WO2009006498A3 (en) * 2007-07-05 2009-07-02 Baxter Int Dialysis system having dual patient line connection and prime
WO2009006498A2 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Dialysis system having dual patient line connection and prime
US10857281B2 (en) 2007-09-13 2020-12-08 Fresenius Medical Care Holdings, Inc. Disposable kits adapted for use in a dialysis machine
US10258731B2 (en) 2007-09-13 2019-04-16 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US11318248B2 (en) 2007-09-13 2022-05-03 Fresenius Medical Care Holdings, Inc. Methods for heating a reservoir unit in a dialysis system
US11071811B2 (en) 2007-09-13 2021-07-27 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
US11224841B2 (en) 2007-09-25 2022-01-18 Fresenius Medical Care Holdings, Inc. Integrated disposable component system for use in dialysis systems
EP2237814A4 (en) * 2007-11-29 2017-10-11 Fresenius Medical Care Holdings, Inc. System and method for conducting hemodialysis and hemofiltration
US10758662B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
US10758661B2 (en) 2007-11-29 2020-09-01 Fresenius Medical Care Holdings, Inc. Disposable apparatus and kit for conducting dialysis
EP3511034A1 (en) 2007-11-29 2019-07-17 Fresenius Medical Care Holdings, Inc. Manifold for conducting hemodialysis and hemofiltration
US11439738B2 (en) 2007-11-29 2022-09-13 Fresenius Medical Care Holdings, Inc. Methods and Systems for fluid balancing in a dialysis system
WO2010024963A1 (en) * 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
US11400193B2 (en) 2008-08-28 2022-08-02 Baxter International Inc. In-line sensors for dialysis applications
US11169137B2 (en) 2008-10-30 2021-11-09 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US10758868B2 (en) 2008-10-30 2020-09-01 Fresenius Medical Care Holdings, Inc. Methods and systems for leak detection in a dialysis system
US8777892B2 (en) 2008-11-03 2014-07-15 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
US10808861B2 (en) 2009-01-12 2020-10-20 Fresenius Medical Care Holdings, Inc. Valve system
US10197180B2 (en) 2009-01-12 2019-02-05 Fresenius Medical Care Holdings, Inc. Valve system
US9943633B2 (en) 2009-09-30 2018-04-17 Medtronic Inc. System and method to regulate ultrafiltration
CN103237567A (en) * 2010-10-12 2013-08-07 费森尤斯医疗控股有限公司 Systems and methods for compensation of compliant behavior in regenerative dialysis systems
KR101764255B1 (en) 2010-10-12 2017-08-03 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 Systems and methods for compensation of compliant behavior in regenerative dialysis systems
WO2012050781A3 (en) * 2010-10-12 2012-11-01 Fresenius Medical Care Holdings, Inc. Systems and methods for compensation of compliant behavior in regenerative dialysis systems
US8784668B2 (en) 2010-10-12 2014-07-22 Fresenius Medical Care Holdings, Inc. Systems and methods for compensation of compliant behavior in regenerative dialysis systems
AU2011314192B2 (en) * 2010-10-12 2016-04-14 Fresenius Medical Care Holdings, Inc. Systems and methods for compensation of compliant behavior in regenerative dialysis systems
EA026018B1 (en) * 2011-01-10 2017-02-28 Фрезениус Медикел Кэар Дойчланд Гмбх Dialysis supply system
AU2012206748B2 (en) * 2011-01-10 2015-02-05 Fresenius Medical Care Deutschland Gmbh Dialysis supply system
CN103313739A (en) * 2011-01-10 2013-09-18 弗雷森纽斯医疗护理德国有限责任公司 Dialysis supply system
US9259522B2 (en) 2011-01-10 2016-02-16 Fresenius Medical Care Deutschland Gmbh Dialysis supply systems and related components
WO2012095301A3 (en) * 2011-01-10 2012-09-20 Fresenius Medical Care Deutschland Gmbh Dialysis supply system
US10179198B2 (en) 2011-04-29 2019-01-15 Medtronic, Inc. Electrolyte and pH monitoring for fluid removal processes
US9968721B2 (en) 2011-04-29 2018-05-15 Medtronic, Inc. Monitoring fluid volume for patients with renal disease
US10406268B2 (en) 2011-04-29 2019-09-10 Medtronic, Inc. Blood fluid removal system performance monitoring
US9750862B2 (en) 2011-04-29 2017-09-05 Medtronic, Inc. Adaptive system for blood fluid removal
EP2701760B1 (en) * 2011-04-29 2020-02-26 Medtronic, Inc. Blood fluid removal system performance monitoring
US10293092B2 (en) 2011-04-29 2019-05-21 Medtronic, Inc. Electrolyte and pH monitoring for fluid removal processes
US9642960B2 (en) 2011-04-29 2017-05-09 Medtronic, Inc. Monitoring fluid volume for patients with renal disease
US9302036B2 (en) 2011-04-29 2016-04-05 Medtronic, Inc. Blood fluid removal system performance monitoring
US10967112B2 (en) 2011-04-29 2021-04-06 Medtronic, Inc. Adaptive system for blood fluid removal
US9700661B2 (en) 2011-04-29 2017-07-11 Medtronic, Inc. Chronic pH or electrolyte monitoring
US11759557B2 (en) 2011-04-29 2023-09-19 Mozarc Medical Us Llc Adaptive system for blood fluid removal
US10064985B2 (en) 2011-04-29 2018-09-04 Medtronic, Inc. Precision blood fluid removal therapy based on patient monitoring
CN103857420A (en) * 2011-10-03 2014-06-11 菲斯蒂亚 Dialysis machine including ultrafiltration and backfiltration means
US9717837B2 (en) 2011-10-03 2017-08-01 Physidia Dialysis machine including ultrafiltration and backfiltration means
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
US11525798B2 (en) 2012-12-21 2022-12-13 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction
US11187572B2 (en) 2012-12-24 2021-11-30 Fresenius Medical Care Holdings, Inc. Dialysis systems with a suspended reservoir
US10539450B2 (en) 2012-12-24 2020-01-21 Fresenius Medical Care Holdings, Inc. Load suspension and weighing system for a dialysis machine reservoir
US11064894B2 (en) 2013-11-04 2021-07-20 Medtronic, Inc. Method and device to manage fluid volumes in the body
US10076283B2 (en) 2013-11-04 2018-09-18 Medtronic, Inc. Method and device to manage fluid volumes in the body
US10817004B2 (en) 2013-11-11 2020-10-27 Fresenius Medical Care Holdings, Inc. Valve system with a pressure sensing displacement member
US10994064B2 (en) 2016-08-10 2021-05-04 Medtronic, Inc. Peritoneal dialysate flow path sensing
US11883576B2 (en) 2016-08-10 2024-01-30 Mozarc Medical Us Llc Peritoneal dialysis intracycle osmotic agent adjustment
US11013843B2 (en) 2016-09-09 2021-05-25 Medtronic, Inc. Peritoneal dialysis fluid testing system
US11679186B2 (en) 2016-09-09 2023-06-20 Mozarc Medical Us Llc Peritoneal dialysis fluid testing system
US11806457B2 (en) 2018-11-16 2023-11-07 Mozarc Medical Us Llc Peritoneal dialysis adequacy meaurements
US11806456B2 (en) 2018-12-10 2023-11-07 Mozarc Medical Us Llc Precision peritoneal dialysis therapy based on dialysis adequacy measurements
US11207452B2 (en) 2019-08-30 2021-12-28 Fresenius Medical Care Holdings, Inc. Multi-lumen tube assemblies for medical fluid pumping systems
WO2021041313A1 (en) * 2019-08-30 2021-03-04 Fresenius Medical Care Holdings, Inc. Multi-lumen tube assemblies for medical fluid pumping systems

Also Published As

Publication number Publication date
WO2004009158A3 (en) 2004-04-08
US10179200B2 (en) 2019-01-15
US20180185561A1 (en) 2018-07-05
AU2003249296A8 (en) 2004-02-09
US8998839B2 (en) 2015-04-07
US10363352B2 (en) 2019-07-30
AU2003249296A1 (en) 2004-02-09
US8597227B2 (en) 2013-12-03
US20040019312A1 (en) 2004-01-29
JP5657726B2 (en) 2015-01-21
ATE505223T1 (en) 2011-04-15
EP1523350A2 (en) 2005-04-20
US20110303590A1 (en) 2011-12-15
US20130131582A1 (en) 2013-05-23
US20140083944A1 (en) 2014-03-27
US7867214B2 (en) 2011-01-11
US8357113B2 (en) 2013-01-22
JP2013144128A (en) 2013-07-25
US20180078691A1 (en) 2018-03-22
EP1523350B1 (en) 2011-04-13
US9814820B2 (en) 2017-11-14
JP2011172961A (en) 2011-09-08
US11235094B2 (en) 2022-02-01
US9764074B1 (en) 2017-09-19
MXPA05000816A (en) 2005-04-28
JP5054073B2 (en) 2012-10-24
JP5458242B2 (en) 2014-04-02
JP2009291629A (en) 2009-12-17
JP4890761B2 (en) 2012-03-07
US20100010429A1 (en) 2010-01-14
JP2005533573A (en) 2005-11-10
DE60336724D1 (en) 2011-05-26
US20190344004A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
US11235094B2 (en) System for peritoneal dialysis
EP2338543B1 (en) Systems for performing peritoneal dialysis
US8815095B2 (en) Peritoneal dialysis systems and methods that regenerate dialysate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003765630

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004523474

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/000816

Country of ref document: MX

WWP Wipo information: published in national office

Ref document number: 2003765630

Country of ref document: EP